Exploring the potential of a new linker system cleaved using samarium(II) iodide by Rudkin, Iain
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
UNIVERSITY
o f
GLASGOW
EXPLORING THE POTENTIAL OF A NEW LINKER 
SYSTEM CLEAVED USING SAMARIUM(II) IODIDE
Iain Rudkin
PhD
Department of Chemistry 
February 2006
© Iain Rudkin 2006
P roQ uest N um ber: 10753986
All rights re s e rv e d
INFORMATION TO ALL USERS 
T he q u a lity  of this r e p ro d u c tio n  is d e p e n d e n t  u p o n  the q u a lity  of the c o p y  su b m itte d .
In the  unlikely e v e n t  that the a u th o r  did not send  a  c o m p le te  m a n u sc r ip t 
and there  a re  missing p a g e s ,  th e se  will be n o te d .  Also, if m a te ria l had to be r e m o v e d ,
a  n o t e  will in d ic a te  the  d e le tio n .
uest
P ro Q u e s t 10753986
Published by P roQ uest LLC(2018). C o p y rig h t of the Dissertation is held by the A uthor.
All rights re se rv ed .
This work is p ro te c te d  a g a in s t  u n a u th o r iz e d  c o p y in g  under Title 17, United S ta te s  C o d e
M icroform  Edition © P roQ uest LLC.
P roQ uest LLC.
789 E ast E isenhow er Parkw ay  
P.O. Box 1346 
Ann Arbor, Ml 4 8 1 0 6 -  1346
(GLASGOW  
UNIVERSITY  
LIBRARY: „
“Behind every great scientist, 
lie a heap o f  failed experiments  ”
Abstract
Exploring the potential of a new linker system cleaved using Sml2
The well known reduction of a-heterosubstituted carbonyl compounds using Sml2 has been 
employed in the design for a new linker for phase tag assisted synthesis. Building on work 
previously reported by the group, the research over the past 3 years has concentrated on 
increasing the synthetic utility of these new linker systems. The work culminated in what 
we believe to be the first instance of asymmetry being introduced in the final step of a 
phase tag assisted synthesis.
To illustrate further the potential of the linker system, studies into the synthesis of 
azepinones, a common structural motif found in many natural products, drugs and their pre­
cursors, has been undertaken. Whilst a number of solution phase routes have been 
developed and optimised, their adaptation to a phase tag synthesis has proved difficult. 
Nevertheless, the foundations for a feasible route to such targets have been laid.
A sequential cleavage-asymmetric protonation strategy has also been developed that allows 
enantiomerically enriched compounds to be prepared from a phase tag assisted synthesis 
using our linker design. Chirality is introduced in the final step of the phase tag assisted 
synthesis via the enantioselective protonation of a samarium(III) enolate formed upon 
release of substrates from the phase tag. Our studies have resulted in many curious 
observations regarding the reactivity and behaviour of samarium(III) enolates.
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Chapter 1: The formation of samarium(III) enolates and their
applications in organic synthesis
1.1 Introduction
Samarium(II) iodide (S111I2) is a single electron transfer reagent. Its use in organic synthesis 
was first described by Kagan in 1977,1 who carried out a thorough investigation of the 
basic organic transformations that could be performed using the reagent. Following its 
introduction it has been used extensively in organic synthesis.
Due to the reagent’s inclination to revert to the more stable samarium(III) oxidation state, it 
operates as a single electron donor. It is this property which enables it to mediate both 
radical and anionic processes or a mixture of both. The reagent has been used for a wide 
range of synthetic organic transformations such as functional group interconversions, 
Reformatsky reactions, Barbier-type reactions, aldol-type reactions, radical cyclisations,
• 3 6pinacolic coupling reactions, ketyl-olefin coupling reactions and conjugate additions. '
Part of the reagent’s popularity arises through its ability to carry out transformations in a 
highly chemoselective manner and reactions with Sml2 often also proceed with a high 
degree of stereoselectivity. Added to this, the reactivity, chemoselectivity, and 
stereoselectivity can be modified through the use of catalysts, co-solvents, or additives,
• • 7 1 nthus increasing the scope of this already versatile reagent. '
The mechanisms of many Sml2 reactions are believed to go via samarium(III) enolates, and 
this has proved to be an important factor in many of the reactions mentioned above. This 
chapter will give a summary of samarium-mediated reactions in which the key step 
involves a samarium(III) enolate intermediate.
9
1.2 Reduction of a-heteroatom substituted carbonyl
compounds
The reduction of a-heteroatom substituted carbonyl compounds is recognised as an 
important organic transformation and has previously been the subject of intense research. 
In 1986, Molander carried out the first detailed studies into the reduction of a-heteroatom 
substituted ketones with Sm^.11 At that time, the common reagents for the reduction were 
zinc metal and chromous ions. However, these reagents often required the use of acidic
19 1 fimedia and extended reaction times. ' Alternative methods for the transformation
ii io onincluded dissolving metal reductions ’ ’ or the use of phosphorous or silica based
reagents.21'27 Initially, Molander investigated a range of a-oxygenated ketones which were 
reduced with SmH to give the parent ketones in good yields (scheme 1.1).
THF/MeOH*
X -78 °C
X = OAc, OSiMe3l 
OCOCH2Ph,
OTs
Scheme 1.1
In order to explore the chemoselectivity of the reaction, Molander reduced a-acetoxy 
ketone 1 in the presence of a primary iodide in the p-position. Chemoselective reduction of 
the a-acetoxy group was observed in the presence of the iodide (scheme 1.2).
O
Jl ^  Sml2-
THF/MeOH, *
OAc -78 °C, (87 %)
1
Scheme 1.2
H
yield = 75-100%
10
Molander also performed the reduction of an a-acetoxy ketone in the presence of 
cyclohexanone. No cyclohexanol was detected upon work up indicating that the reaction 
had taken place in the presence of an unfunctionalised ketone group.
Other analogous substrates that also underwent mild reduction were a-halosubstituted 
cyclohexanones and a-thiosubstituted cyclohexanones. Once again, good yields were 
observed in all cases (scheme 1.3).
O O
X
Sml2, MeOH,
THF, -78 °C
X = Cl, SPh, S(0)Ph, yield = 7 6 - 100%
S 0 2Ph, HgCI
Scheme 1.3
In 1987, following Molander’s success in the reduction of a-heteroatom substituted 
ketones, Inanaga and co-workers decided to investigate the opening of a,p-epoxy esters.
In optimising conditions, Inanaga based his initial research on the reduction of ethyl 2,3- 
epoxybutyrate 2 to give ethyl 3-hydroxy butyrate 3. The addition of 
hexamethylphosphoramide (HMPA) was found to highly accelerate the rate of the reaction 
and the yield was increased greatly upon the addition of propanol as a proton source. The 
presence of a strong chelating agent such as tetramethylethylenediamine (TMEDA) or N,N- 
dimethylaminoethanol (DMAE) was crucial in attaining a high level of regioselectivity. 
The optimum conditions were found to be 2.5 equivalents of Sml2 , 5 equivalents of HMPA 
and 2 equivalents of DMAE which led to ethyl 3-hydroxybutyrate 3 in 68 % yield with a 
negligible amount of ethyl 2-hydroxy butyrate being formed (scheme 1.4).
^  O OH O O
[J Sml2) HMPA, DMAE, 1 LI I
^ ■ ^ O E t  RT, 1 min, (68 %) ^ ^ N ) E t  + ^ Y ^ Et 
2 3 OH
ratios of 3-OH : 2-OH, > 200 : 1
Scheme 1.4
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Inanaga surmises that DMAE, when used as an additive, plays an important role in the 
reaction. It not only acts as a proton source, but also as an efficient chelating agent which 
removes the Lewis acidic samarium(III) species from the reaction mixture.28 Removal of 
the samarium(III) species prevents it from ring-opening the epoxide in a non-regioselective 
manner, therefore reducing the formation of the 2-hydroxy ester. The optimised conditions 
were then applied to a number of other a,P-epoxy esters and good yields and selectivities 
were obtained.
Inanaga converted optically pure a,p-epoxy ester 4 to p-hydroxy ester 5 with complete 
retention of configuration at the p-carbon (scheme 1.5). When combined with the Sharpless 
asymmetric epoxidation, this is an efficient route to optically active P-hydroxy esters.
OMe Sml2, HMPA, 
DMAE, RT
Scheme 1.5
In 2002, Concellon et al. described a similar reaction to Inanagas’, however, in this case, 
reduction of a,p-epoxy esters led to the formation of (£)-a,P-unsaturated esters with total or 
high diastereoselectivity. Using 4 equivalents of SmU, Concellon was able to reduce a,p- 
epoxy esters such as 6 bearing a wide range of different alkyl and aryl groups to give di-, 
tri- or tetra-substituted (£)-alkenes such as 7 (scheme 1.6).
OEt Sml2, THF, OEt
RT, (90 %)
MeO MeO
7 > 98 de
Scheme 1.6
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The mechanism proposed by Concellon for the formation of the alkene goes via a 6- 
membered ring transition state. The Sml2-promoted reduction of the a-carbon-oxygen 
bond, results in formation of a samarium(III) enolate intermediate. A 6-membered chelate 
intermediate 8 is now formed due to coordination of the oxophilic samarium(III) centre 
with the second oxygen from the epoxide. Diastereoselectivity can be explained simply 
through the minimisation of steric interactions. The bulkier R-group, in this case p- 
methoxyphenyl sits in an equatorial position to avoid steric clashes with the samarium 
coordination sphere (scheme 1.7).
Sm
OEt
Sml2 OEtMeO
MeO'
8
MeO
OEt
Sm1
Scheme 1.7
In 2004, Concellon used the reduction of a-chlorosubstituted carbonyls to construct (Z)-a- 
chloro-a,P-unsaturated esters which are important building blocks in organic synthesis. 
Following two single electron transfers, a samarium(III) enolate 9 is formed which then 
undergoes P-elimination. The stereochemistry of the double bond in the product can be 
explained through chelation in enolate 9 giving rise to Z-alkene 10 (scheme 1.8).
13
Scheme 1.8
The following year, Concellon reported the reaction of (Z)-a-chloro-a,p-unsaturated esters 
with ketones or aldehydes to provide an alternative route to Baylis-Hillman adducts.31 In 
scheme 1.9, reaction of the unsaturated ethyl ester 11 with butanone led to P-hydroxy ester 
12 in good yield, with none of the £-isomer being observed.
O O OH O
P h ^ Y ^ E t  +
Cl 
11
Sml2, THF, 
RT, (90 %)
OEt
Ph
12
Scheme 1.9
In 1989, Inanaga and co-workers investigated the reduction of a range of a-oxygenated 
esters. Deoxygenation of both a-acetoxy and a-methoxy esters proceeded well at room 
temperature using HMPA to increase the reducing potential of SmH. Direct reduction of a- 
hydroxy esters was unsuccessfully attempted. Inanaga found that a much more acidic 
proton source in pivalic acid was required for the reduction to occur (scheme 1.10).
14
o o
Sml2. HMPA, MeOH,
P h - 1 4 0M e — W s % j — -  LOAc Ph
II Sml2, HMPA, C8Hi 7OH, j ?
^ X > C 8H17 RT, (73 %) ^ ^ O C sH !-
\ r/ ^ OFt Sml2, HMPA, pivalic acid, C4H9^ J L ( 
Xu RT, (89 %)
Scheme 1.10
The dehydroxylation conditions were applied to the direct conversion of the naturally 
occurring (7?,i?)-tartrates to the unnatural (^)-malates. The best result was given by the 
reduction of (i?,^)-diisopropyl tartrate 13 to give (7?)-diisopropyl malate 14 using ethylene 
glycol as the additive (scheme 1.11).
OH OH
'PrOoO JL Sml2, ethylene glycol /Pro , o  JL
2 T ^ C 0 2'Pr f  HF, RT, (99 %)' 2^ ^ C 0 2'Pr
OH
13 14
Scheme 1.11
De Clercq et al. have utilised the Sml2 reduction of a-heteroatom substituted carbonyl
-1 a
compounds in a novel synthesis of an A-ring precursor to 1 a-hydroxyvitamin D 15. Sml2 
is used to reduce ketone 16 bearing a bridging oxygen atom at the a-position, thus opening 
the ether bridge (scheme 1.12).
15
OMPM OMPM OH
THF/MeOH,
-78 °C, (56 %) O' 'OH
16
TBDMSO'' OTBDMS
15
Scheme 1.12
The reduction of an a-sulfanyl ketone has also been used in the final step of an asymmetric 
Pauson-Khand reaction to remove a chirality-controlling, chelating group.34 Alkyne 17, 
which was prepared from (15)-camphor-(10)-thiol, underwent an asymmetric Pauson- 
Khand reaction with norbomadiene and was then alkylated to give 18. Treatment of this 
compound with Sml2 allowed the chiral a-sulfanyl group to be removed to give tricycle 19 
(scheme 1.13).
17
S
18
Sml2, THF, MeOH,
0 °C, (64 %)
Scheme 1.13
Procter and co-workers have applied this organic transformation in a linker system for 
phase-tag assisted synthesis. Either an oxygen or sulfur heteroatom at the a-position of a 
carbonyl compound has been used as a linking atom to bind substrates to a phase-tag. 
Treatment of substrates immobilised in this way with Sml2 cleaves the phase-tag in a 
traceless manner to release products.
In 2002, Procter reported the solid phase synthesis of amides and ketones in high purity. ’ 
36 a-Bromo-y-butyrolactone was immobilized using a phenol resin developed within the 
group. It could then be modified to give resin bound a-aryloxy amides, such as 20, and
16
ketones. Treatment of these with Sml2 gave the free carbonyl compounds, such as amide 
21, in good yields and purity (scheme 1.14).
0H K2C 0 3i DMF, 60 °C
Sml2, THF
OTBDPS DMPU, RT
OTBDPS
21
31 % yield, over 4 steps 
88 % HPLC purity
20
Scheme 1.14
Procter has also used the linker in conjunction with the first Pummerer cyclisations on solid 
phase to construct oxindoles.37 a-Sulfanyl N-aryl acetamides are attached to the polymer 
backbone via a sulfur linking atom. Activation of the sulfur link allows the substrate to 
undergo Pummerer cyclisation to give immobilized oxindoles 22, which can be cleaved 
tracelessly from the support using Sml2 (scheme 1.15).
's ^ V r.
—R2
-R 1 Sml2, DMPU, R3
THF, RT
22
Scheme 1.15
Products were obtained in good yields after four steps on resin to create a small library of 
functionalized oxindoles, a selection of which is shown below (figure 1.1).
17
47 % over 4 steps 38 % over 4 steps 30 % over 6 steps
Figure 1.1
The methodology has been extended further still with the replacement of the polymer tag 
with a fluorous tag. A new Pummerer process was also developed which allowed the
fluorous tag to be introduced whilst simultaneously constructing the heterocyclic ring 
system. A fluorous thiol was used in a cyclative capture process with glyoxamide 
substrates 23. The resultant tagged heterocycles 24 could then be further modified and 
purified easily using fluorous solid-phase extraction (FSPE) before cleavage with Smk 
released the heterocycles 25 from the phase tag (scheme 1.16).
O R1
O M
i
R p— CH2CH2C8r 17 y 
23
RF-SH +
ifX
cyclative-capture r f^ S
Pummerer
Y
X
24
modification
Sml2 cleavage Rp^
Y'
25
Scheme 1.16
The methodology was used to prepare a small library of nitrogen heterocycles, including 
oxindoles, tetrahydroisoquinolinones and tetrahydrobenzazepinones. Selected examples of 
products obtained from the fluorous-phase synthesis are shown below (figure 1.2).
n  I ^  .OMe
OMe
Figure 1.2
1.3 Enantioselective protonation of samarium(III) enolates
In 1988, Fehr and Galinda reported the asymmetric synthesis of (-/?)-(+) and (£)-(-)- 
damascone using a Grignard addition to a ketene followed by the asymmetric protonation 
of the resulting lithium enolate.39 Takeuchi applied this principle to the asymmetric 
protonation of samarium(III) enolates formed from ketenes.40 Initially he screened a 
number of chiral protonating agents for use in the samarium-mediated allylation of 
phenylethyl ketene 26. o-Xylene derived proton source 27 gave the enantiomerically 
enriched ketone 28 in 84 % ee (scheme 1.17).
Sml2l HMPA, 
-78 °C
26
Ph
OH
yield = 62 % 
ee = 84 %Q OH
27 Ph
Scheme 1.17
Takeuchi et al. investigated various alkylating agents and their reactions with a range of 
unsymmetrical ketenes with the best result being observed for the conversion of ketene 29
19
into ketone 30 in 97 % ee.41 The enantiomeric excesses were not high in every case 
however and Takeuchi speculated that this was due to the nature of the enolate double 
bond. In order to investigate further, the enolate was trapped as the enol acetate 31, and its 
double bond geometry determined by lH NMR and 2D !H NOESY. It was apparent that the 
E/Z selectivity increases with the increasing difference in bulkiness of the two substituents 
of the ketene, with a corresponding rise in the enantiomeric excess of the ketone from the 
reaction also observed (scheme 1.18).
Sml2, HMPA, -45 °C
,  ^ ^ ^  yield = 65 %
Ph" Y  ^  ee  = 97 %
30
Scheme 1.18
Yanagisawa and Yamamoto reported the catalytic enantioselective protonation of lithium 
enolates42 so it was logical for Takeuchi to look into the catalytic enantioselective 
protonation of samarium(III) enolates.43 Using the best example from his previous work, 
Takeuchi applied it in a catalytic system where an achiral proton source protonates and thus 
regenerates the chiral proton source 27.
As before, the SmU-mediated reaction of ketene 29 with allyl iodide affords a 
samarium(III) enolate intermediate. Previously, Takeuchi had used a stoichiometric amount 
of proton source 27 to enantioselectively protonate the enolate leading to enantiomerically 
enriched ketone 30.40 In this case however, a catalytic amount of 27 was used in 
combination with trityl alcohol (scheme 1.19). The trityl alcohol re-protonated the 
conjugate base of the proton source returning it to its original state, whilst itself having a 
sufficiently low protonating ability so as not to achirally protonate the samarium(III)
20
enolate.43 This led to a highly selective catalytic process yielding enantioselectivities up to 
93 %, which is only 4 % lower than the analogous stoichiometric reaction 41
O
Sml2, HMPA, 
-45 °C
29
Ph
O
yield = 55 % 
ee = 93 %
Ph
OH OSm1
OH OSm1
Ph
2 x (Ph)3COSmm 
Scheme 1.19
2 x (Ph)3COH 
Achiral proton source
In 1997, Takeuchi’s attention turned to Molander’s original work on the reduction of a- 
heteroatom substituted carbonyl compounds and began to investigate the feasibility of 
forming the requisite samarium(III) enolates using this process 44 Takeuchi looked at the 
reduction of a-heterosubstituted cyclohexanone 32 bearing an a-phenyl substituent. A 
number of ketones were screened with BINOL derived chiral proton source 33 leading to 
ketone 34 in all cases. The yields were all reasonably high and the enatioselectivity ranged 
between 82 % and 91 % enantioselectivity (scheme 1.20).
21
Scheme 1.20
Subsequent work gave rise to a series of tetradentate chiral protonating agents used to 
protonate the enolate formed upon reduction of a number of different a-heterosubstituted 
ketones, and which often gave good enantioselectivities (figure 1.3).44'46
Ph _  Ph Ph
O OH . . .  ^  O OH Ph OH
35
c.
O OH r  |T \  /  ^  ^ — O OH Ph 'N  OH
M  U M Ph M  M
Ph Ph Ph
Figure 1.3
Takeuchi reduced a number of a-methoxy, a-acetoxy and a-halo cyclohexanones bearing 
different a-alkyl and aryl groups. In addition to this, Sml2 was used to reduce a-halo 
lactones and some acyclic substrates. Illustrated below is a selection of Sml2 reductions- 
asymmetric protonations performed by Takeuchi et al. (scheme 1.21).
22
Sml2, 33
THF, (75 %) 94 % ee
O O
i l  Br Sml2, 35 ;
U ^ Ph THF, (88%) V T 72 % ee
QAc Sml2, 33 
Ph THF, (83 %)
Scheme 1.21
83 % ee
Takeuchi has proposed a transition state model to explain the enantioselectivities obtained 
from the reaction (figure 1.4). In transition state T1 - 36, the substituent at the a-position of 
the enolate is far from the phenyl ring at the left hand side of the model and therefore has 
no steric interaction with it. As a result, protonation from the OH of the chiral proton 
source takes place from the si face giving the product of (/^-configuration. Conversely in 
transition model T2 - 36, steric interactions between the substituent on the enolate, and the 
phenyl ring on the left of the model on the proton source gives rise to a higher energy 
conformation and protonation via this path is less favourable.
H
A / ° ' \
H
Ti -36 To - 36
Figure 1.4
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Takeuchi and Curran synthesised fluorous chiral BINOL derivative 37 and used it in the 
catalytic enantioselective protonation of the samarium(III) enolate derived from 38 
(scheme 1.22) 47 As a consequence of using fluorous solid phase extraction (FSPE), the 
proton source could be easily recovered from the reaction mixture and used for subsequent 
runs, with little loss in yield and enantioselectivity.
OMe OH Sml2, THF, - 45 °C 
OHPh
38
37
Rp — C H 2CH 2C 6Fi3
Run Yield % ee % Config. Recovered 37 °/<
1 82 81 98
2 81 85 R (+) 97
3 78 8 6 R (+) 98
4 74 89 * (+ ) 99
5 73 87 *(+ ) 99
Scheme 1.22
Apart from the work of Takeuchi and co-workers, there are few examples of the 
enantioselective protonation of samarium(III) enolates. The recent work done by Lin and 
co-workers on the reductive coupling of ketones with methyl methacrylate also involves 
the interception of a samarium(III) enolate with a chiral proton source (scheme 1.23).48 
Fukuzawa looked into the role of the proton donor in this reaction in 1988, and through 
deuterium labelling experiments determined that a proton was introduced into the a-carbon 
of the lactone.4 9 , 50
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Lin looked into the possibility that enantioselective protonation of the samarium(III) 
enolate intermediate would allow the controlled construction of a-carbon stereocentres 
during the formation of y-butyrolactones.
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Scheme 1.23
Lin looked at chiral alcohols, amides and amino alcohols amongst others as potential 
proton donors. Whilst the initial results did not give particularly high ee’s, they did show 
the potential of asymmetric protonation in this reaction. Chiral sulfonamides were the most 
promising proton sources, and Lin chose to look into these further. After screening a 
number of sulfonamide derivatives, both with and without HMPA as an additive, he 
obtained lactone 39 in 84 % ee using 40 (scheme 1.24).
O O
O
II m Sml2, THF, HMPA \ * A n  . n/
P h A h  + V ^ O M e  -------2------ !---------   \  ?  y|eld = 65%
Kn ™  I NHTs — f s ph ee  = 84 %
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Scheme 1.24
Lin followed up this work by replacing the methyl ester group of the methacrylate with 
carbohydrate derived auxiliaries bearing amide substituents (figure 1.5). These groups 
acted both as chiral auxiliaries and as chiral proton sources in a new method for the 
asymmetric synthesis of optically active a,y-substituted y-butyrolactones. 51
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Figure 1.5
Lin investigated the reductive coupling between a number of ketones and chiral acrylates, 
with varying results. Firstly, the diastereomeric ratio obtained from the reaction varied 
greatly from 50:50 mixtures of both trans and cis isomers to greater than 99:1 in favour of 
the trans isomer as shown in scheme 1.25. The enantiomeric excesses of the two isomers 
also varied greatly with those of the trans isomers being generally high, while the cis 
isomers were formed with lower selectivities.
O O
Sml2, THF, -78 °C +  A Q
'Ph O k A  NHTs (74 %) '—^-Ph
°  H = Ph
t ra n s : cis 
> 9 9 : 1 
ee  = 97 (+): 15 (-)
Scheme 1.25
*
1.4 Cleavage of C-C bonds a to carbonyl groups
SmL can be used to break a-carbon-carbon bonds as well as a-heteroatom-carbon bonds in 
carbonyl compounds. In 1991, Motherwell et ah used the reagent to open a,p-cyclopropane 
rings. In trapping the enolate formed, he isolated a variety of synthetically useful 
intermediates (scheme 1.26).
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Scheme 1.26
O
The reduction of a-cyano compounds has been performed by treatment of such compounds 
with lithium naphthalide. Liu and co-workers have shown SmL to also be a useful reagent 
for this transformation. 54 Subsequent quenching of the enolate with allyl bromide led, in 
most cases, to a single diastereoisomer in yields of 60-80 %. The reaction allows 
regioselective a ,a ’-alkylation of ketones with retention of stereochemistry at the a ’ position 
(scheme 1.27).
O O
1. Sml2, HMPA, THF, RT r 
7^ y  Bn 2. allyl bromide, (80 %) (
1. Sml2, HMPA, THF, RT
2. allyl bromide, (60 %)
Scheme 1.27
In 1999, Reutrakul et al. reported the regioselective cleavage of phenylsulfonyl cyclopropyl 
ketones using SmL to give p,y-unsaturated ketones.55 Treatment of 41 with SmL 
regioselectively cleaves bond a  of the cyclopropane ring to give a p-phenylsulfonyl radical 
which undergoes p-elimination to form extended samarium(III) enolate 42. The main 
driving force for the reaction is the stability of the radical intermediate as well as the 
formation of the conjugated enolate intermediate (scheme 1.28).
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Scheme 1.28
In 2005, Chiu and co-workers reported the cyclopropanation of an oxabicyclic template 43 
using either rhodium or copper catalysts. 56 The strain in the cyclopropane ring, and its 
propensity for ring opening, make this type of molecule a useful synthetic intermediate. 
Unsuccessful opening of the cyclopropane ring was attempted with "BU3S11H/AIBN, 
however the transformation was achieved using SmU to give 44. This allowed for 
desymmetrisation of 45 with no concomitant opening of the ether bridge (scheme 1.29).
43
Sml2, HMPA, THF,Bu
RT, (80 %)Rh2(OAc)4, CH2CI2, 
RT, (68 %)
■Bu
4445
Scheme 1.29
1.5 Reduction of a,P-unsaturated carbonyl compounds
In 1991, Inanaga et al. reported the conjugate reduction of a,P-unsaturated esters and 
amides using Sml2 . 57 Although this transformation had already been documented through
co c*\
the use of a number of varied reagents, ' Inanaga’s SmU-DMA-proton source system 
was a milder method for the reduction (scheme 1.30). Reduction with CD3OD as the proton 
source showed deuterium incorporation on both a and p-carbons indicating a likely enolate 
intermediate.
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Scheme 1.30
A year later, Alper and co-workers extended the applicability of the reduction to include 
a,p-unsaturated acids and anhydrides. 63 Whereas Inanaga did not see any beneficial effects 
from using HMPA as an additive, Alper found it to be an excellent promoter for the 
reaction (scheme 1.31).
H 0Y ^ 1  Sml2,HMPA, .  H O ^ I  H
°  cA oh t h f ' r t ' (" %) Y
Scheme 1.31
Fukuzumi and Otera extended the study further still in 1997 by performing the reduction on 
a number of unsaturated carbonyl compounds including a,p-unsaturated cyclic ketones and 
lactones.64 Ring size obviously plays an important role in this reaction as both 
cyclohexenone and a,P-unsaturated valerolactone failed to undergo reduction with 
essentially quantitative recovery of starting material being obtained. Larger, macrocyclic 
ketones and lactones, however, underwent reduction in good yields (scheme 1.32).
O O
O Sml2, HMPA, 
THF, RT, (88 %)
O
11 11
O
Sml2, DMA, THF, 
'BuOH, RT, (89 %)
Scheme 1.32
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To summarise, Inanaga et al. showed that a number of a,p-unsaturated amides and esters 
could be rapidly and selectively reduced in the presence of alkenes, alkynes and protected 
amides. 57 Alper and co-workers then extended this reaction to acids63 whilst Fukuzumi and 
Otera looked at cyclic systems.64 The extensive functional group tolerance in the reaction 
once again shows the chemoselective nature of the reagent.
More recently, Davies et al have performed a diastereoselective Smh and D2O promoted 
conjugate reduction to gain access to isotopically labelled a-amino acids. 6 5 , 66 Reduction of 
diketopiperazine derived 46 gave a samarium(III) enolate intermediate which was then 
diastereoselectively deuterated to give 47. Further synthetic steps yielded protected a- 
amino acid 48 (scheme 1.33).
I PMB I PMB
Y r °  Sml„THF, .  ACHN C 0 2Me
O ^ N ^ Ph D A R T ,  (90%) 0 A N> y Ph ----------- " Ph'" D
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Scheme 1.33
1.6 Cyclisation reactions involving samarium(III) enolates
Imamoto and co-workers reported the one-pot synthesis of cyclopropanols from esters
• fflusing Sml2 . He envisaged that cyclopropanols could be synthesised from carboxylic acid 
derivatives via a tandem one-carbon homologation route involving samarium(III) enolate 
49 (scheme 1.34).
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Scheme 1.34
Imamoto’s best result was with ethyl benzoate 50, from which he obtained 1-phenyl 
cyclopropanol 51 in 76 % yield (scheme 1.35). Other lanthanide metals were tried, though 
none were as successful as samarium.
9 CH2I2-Sm, THF, ^
P h ^ O E t 5 0  °C- <7 6  %) Ph^
50 51
Scheme 1.35
In 2001, Namy et al. were investigating the Sml2-promoted reactions of a diphenyl a- 
iminoketone 52.68 Initially hoping to prepare hydroxyaminoketones, 52 was treated with 
Sml2 followed by quenching with a ketone. However, this unexpectedly led to pyrroles 53 
in good yields (scheme 1.36). Namy suggests that the initial step in the reaction mechanism 
involves a two-electron transfer from two equivalents of Sml2 to give samarium(III) 
enolate intermediate 54.
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Scheme 1.36
Namy synthesised pyrroles from ketones bearing a single methylene unit as well as from 
ketones bearing two non-equivalent methylene units and found that, in the latter case, a 
mixture of products was generally formed as illustrated in scheme 1.37.
Scheme 1.37
Figure 1.6 shows a number of varied pyrrole derivatives synthesised using Namy’s method. 
He also attempted an analogous reaction aiming to assemble furan derivatives, but early 
results were not encouraging.
PhPh
Ph PhPh
Ph Ph
Ph Ph
Figure 1.6
The indole unit is a core structure of many natural products and pharmaceutically important 
compounds. In 2003, Reissig and co-workers published a novel stereoselective synthesis of 
highly functionalised benzannulated pyrrolizidines and indolizidines through the Smh- 
induced cyclisations of indole derivatives. 69 The cyclisation occurs through a samarium 
ketyl radical 55. After cyclisation, a second one-electron transfer occurs to form the 
samarium(III) enolate 56 which is subsequently quenched during work up by a proton 
(scheme 1.38).
Sm f OSm1
55
OMe
OSm1
56
OH
Scheme 1.38
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Reissig introduced yet further functionality through quenching the enolate with an 
electrophile other than a proton to create an efficient one-pot tandem reaction. These 
cascade reactions selectively generate three continuous stereogenic centres including a 
difficult to construct quaternary centre at the 3-position of the indole moiety, a structural 
motif found in many indole alkaloids. Figure 1.7 contains some of the diverse N- 
heterocycles prepared by Reissig.
OTBS
Figure 1.7
1.7 Samarium(II) iodide-mediated aldol reactions
The aldol reaction has long been recognised as one of the synthetic organic chemist’s most 
versatile tools for the formation of carbon-carbon bonds. In recent years, Mukaiyama et al. 
have investigated various aspects of this reaction. In 2000, they developed a new method 
for the synthesis of unsymmetrical bis-aldols via a Sml2 -mediated reaction between 
aldehydes and aryl or alkyl oxiranyl ketones, an example of which is outlined in scheme
70 •1.39. Only the anti,anti 57 and syn,syn 58 bis aldols were observed and it is important to 
note that the optical purity of the starting material is preserved in the reaction. The 
mechanism proceeds through an enolate intermediate which then attacks the carbonyl of 
the aldehyde.
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Scheme 1.39
Substituted p-amino acids, particularly p’-hydroxy derivatives, have attracted considerable 
attention in recent years as unnatural amino acid building blocks. In 2004, Mukaiyama 
looked into the synthesis of p-amino-p’-hydroxy ketones via a similar method to that 
illustrated above. In this case, it was a Sml2 -mediated aldol reaction between aldehydes and 
aryl or alkyl aziridinyl ketones.71 Once again the reaction proposed proceeds through a 
samarium(III) enolate intermediate. The reaction which gave the best results afforded 
anti,syn-amino ketone 59 in high diastereoselectivity with a minor amount of syn,anti- 
ammo ketone 60 being formed (scheme 1.40).
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Scheme 1.40
Mukaiyama followed up this work by looking at the construction of 5-amino-p’-hydroxy- 
p,y-unsaturated carbonyls using the Sml2 -mediated aldol reaction between aldehydes and 
y,8 -aziridinyl-a,p-unsaturated carbonyls.72 Firstly he investigated the reactions of esters 
which led to reasonable syn/anti selectivity, in yields of 8 6  % and above. Mukaiyama then 
turned his attention to reactions of the corresponding amides and found that the reaction 
was also successful, obtaining similar yields and selectivities (scheme 1.41).
NHTs
Sml2l THF,
-78 °C, (83%) Ph
Scheme 1.41
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Whilst investigating the potential of the reaction with unsaturated amides, Mukaiyama 
developed an asymmetric aldol reaction by incorporating an oxazolidinone chiral auxiliary 
in the unsaturated aziridine. Using oxazolidinone 61, the reaction proceeded well in good 
yield with high syn diastereoselectivity to give 62 and 63 (scheme 1.42). Simple removal of 
the auxiliary using sodium methoxide in methanol released the unsaturated methyl ester.
Is o o ii NHTs 0 9 NHTs °  9
 < I - v A n A 0  .
Bi^  -78°C,’ (86%) P h ^ ^ ' O H ^  P h ' ^ - ^ O H  ^
61 62 63
> 95  < 5
Scheme 1.42
It is interesting to note that in the first two cases, Mukaiyama exploited the well known 
reduction of a-heteroatom substituted carbonyls in order to form the enolate which 
subsequently facilitates the aldol reaction. In the latter two cases, he employed the 
reduction of a carbon-heteroatom bond in the y-position of an a,P-unsaturated carbonyl 
compound. In 2005, Mukaiyama proposed an enantioselective synthesis of the Cl 1-C l7 
segment 64 of Mycinolide IV 65 using his novel method (scheme 1.43) . 73
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Mycinolide IV 65
Scheme 1.43
Starting from unsaturated y,8 -epoxide 6 6  bearing the chiral oxazolidinone auxiliary, and its 
reaction with propanal, Mukaiyama was able to obtain the syn product as the major 
diastereoisomer 67. The reaction went in good yield with the minor diastereoisomer being 
easily removed using chromatography. Protection of the primary alcohol followed by 
reductive cleavage of the auxiliary gave the segment Cl 1-C17 64 (scheme 1.44).
o o  9 o  o
< V A  ------- — ------►    64\ _ J  Sml2, THF, I \_ J   -
Bn -78 °C, (85 %) "OH ^
66 67
Scheme 1.44
Branched-chain sugar nucleosides are biologically important targets in medicinal chemistry 
and a number of different methods for their preparation have been reported. In 2002, Shuto 
and Matsuda reported a highly stereoselective Sml2 -promoted aldol reaction to construct 
l ’a-branched uridine derivatives.74 The reaction once again initially begins with the 
reduction of an a-heteroatom substituted carbonyl to form an enolate. This is then 
quenched with benzaldehyde to give 6 8  (scheme 1.45).
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Scheme 1.45
In some cases the aldol product underwent a further Tischenko reaction to afford the 
corresponding anti-\,3-dio\ monoesters through a chelation-controlled pathway. This Sml2- 
promoted tandem aldol-Tischenko reaction of 2’-keto nucleoside 69 gives the l ’-branched 
nucleoside 70. These “arabino-type” nucleosides are biologically important as a number of 
them have shown potent antitumor and/or antiviral effects (scheme 1.46).
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Recently, Concellon and co-workers have reported a stereoselective method for the 
formation of (£)-a,P-unsaturated esters via a sequential aldol reaction followed by a 
subsequent elimination reaction.75 Dibromoacetate 71 reacts with a number of different 
aldehydes to form samarium alkoxide 72 which undergoes two single-electron transfers to 
give samarium(III) enolate intermediate 73. Collapse of the enolate and (3-elimination 
affords the (£)-a,p-unsaturated esters 74 (scheme 1.47).
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Concellon attempted the transformation using various aldehydes all with ethyl or methyl 
dibromoacetate. The best result came from the reaction of ethyl dibromoacetate with 
benzaldehyde which proceeded in good yield to give solely the (£)-a,p-unsaturated ester 75 
(scheme 1.48).
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1.8 Reform a tsky-type reactions
Kagan et al documented the use of samarium for modified Reformatsky reactions in their 
seminal paper in 1980,2 and in the mid 1980’s Inanaga reported the construction of medium
7 fkand large ring lactones through a Sml2-mediated intramolecular Reformatsky reaction. In 
1991, Inanaga then developed a general synthesis for both medium and large-sized 
carbocycles by means of the Reformatsky reaction.77 The mechanism goes through 
samarium(III) enolate intermediate 76 following two single-electron transfers from 
samarium to the carbonyl (scheme 1.49). The final coupling step, believed to be aided by
39
the large ionic radius, flexible co-ordination and high oxophilicity of samarium, gives 
carbocycle 77 after work up.
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Scheme 1.49
The Sml2-mediated Reformatsky reaction has since been used as a key ring forming step in 
the synthesis of a number of natural products and their precursors. In 1997, Tachibana and
• 78co-workers reported its use in the formation of the fused oxonene ring F of ciguatoxm. 
Structure 78, bearing a number of ether linkages as well as aldehyde and a-bromoketone 
moieties, undergoes the intramolecular SmI2-promoted Reformatsky reaction to give 79. 
The yield is given for three steps, namely an oxidation, Reformatsky cyclisation followed 
by acetylation of the secondary alcohol (scheme 1.50).
^  1. Sml2) THF, 
H -78 °CH S 0 3-Pyr., DMSO,
2. Ac20 , DMAP 
0°C OAcOH
78 79
62 % over 3 steps
Scheme 1.50
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In the late 1990’s, Mukaiyama et al. used this transformation in the stereocontrolled 
synthesis of the B ring in Taxol.7 9 , 80 a-Bromoketo aldehyde 80 was treated with Sml2 and 
the cyclisation proceeded efficiently to give the eight-membered B ring in high yield with 
good stereoselectivity as a mixture of aldol products at the P-carbon (scheme 1.51).
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Scheme 1.51
More recently, Xu and co-workers have utilised this reaction to form a six-membered ring 
during model studies on the total synthesis of clavulactone. 81 Treatment of 
bromopropionate 81 with Sml2 gave cyclised product 82 in modest yield (scheme 1.52). Xu 
found that Sml2 , was superior to other reagents such as aluminium and activated zinc.
0 °C, (56 %) OBn v ’ OBn
8281
clavulactone
Scheme 1.52
In 2000, Skrydstrup et al. presented a mild and simple method for the selective introduction 
of carbinol side chains onto glycine residues in peptides and showed its potential as a route 
for the preparation of peptide libraries. 82 A series of polypeptides were prepared according 
to a modified Reformatsky-type reaction (scheme 1.53), where treatment of a peptide 
backbone with A-bromosuccinimide followed by sulfide formation yielded a-sulfanyl 
amides 83. These were then reduced at room temperature using Sml2 , to give a
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samarium(III) enolate intermediate 84. The enolate was then quenched with different 
aldehydes and ketones to give functionalised peptides 85.
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Scheme 1.53
The low basicity of alkyl lanthanide species as well as the strong complexing abilities of 
lanthanide(III) ions to oxygen led Skrydstrup to use Sml2 as the reducing agent. The use of 
strong bases to deprotonate a glycine residue could have led to competitive deprotonation 
of the amide protons and the method would have depended upon the stability of the 
intermediate enolate species and its ability to avoid protonation either inter- or 
intramolecularly. This is another demonstration of the mild and chemoselective nature of 
Sml2 . A selection of peptides prepared via this methodology is illustrated below (figure 
1.8).
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Figure 1.8
1.9 Samarium(II) iodide-mediated coupling reactions
Fang and co-workers have reported the Sml2-mediated reductive cyclisations of 1,1’-
O'!
dicinnamoylferrocenes to give the corresponding [3]-ferrocenophane diol. The reaction 
utilises Sml2 to effect the intramolecular coupling, aldol reaction and reduction in a one-pot 
operation. The reaction pathway arises through a samarium chelated transition state having 
both s-cis and (Z)-enolate character. In the best example, 8 6  undergoes the transformation 
with Sml2 to give diol 87 in good yield and with good selectivity (scheme 1.54).
THF, 0 °C
Ar = -C6H4OMe
O - S m 1
HO
87
major isomer 
97 % yield 
ratio of isomers (86 : 14)
Scheme 1.54
Recently, Zhang and co-workers have documented a facile synthesis of trisubstituted
OA
alkenes via a Sml2-mediated coupling of two identical Baylis-Hillman substrates. The 
reaction proceeds initially through a single electron transfer to furnish a samarium(III) 
enolate intermediate 8 8  which then undergoes a radical coupling of one samarium species 
to another to give 89. This collapses to form diene 90 (scheme 1.55).
88
self coupling
Scheme 1.55
The reaction is highly temperature dependant however. An example of the transformation 
is outlined in scheme 1.56, which proceeded at - 20 °C to give aromatic diene 91 in 92 % 
yield, with 7 % of the trisubstituted alkene 92. When the reaction was attempted under 
reflux conditions though, only 11 % of the desired diene was observed with 83 % of the 
trisubstituted alkene being isolated. In all cases, total (^-selectivity was observed.
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1.10 Reductive deamination
In 1999, Honda et al. published their work on the reduction of a-amino carbonyl
able to reduce primary, secondary and tertiary amines using SmH with HMPA and in the 
pre sence of a proton source. He then turned his attention to cyclic systems, and in particular 
the reductive deamination of proline derivatives. Proline derived isopropyl ester 93 was 
reduced in the presence of HMPA and methanol to give acyclic ester 94 in good yield 
(scheme 1.57)
compounds using SmH-85 The initial work was done on the reduction of acyclic a-amino 
substituted esters. The results for the reaction were positive and Honda found that he was
TBDMSQ
TBDMSO/,
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THF, 0 °C - RT, (99 %)
Bn
93 94
Scheme 1.57
Honda has applied his reductive deamination in the synthesis of a number of naturally 
occurring alkaloids. Illustrated in figure 1.9 are two examples. He has reported a concise 
enantioselective synthesis of (-)-adalinine 95, a coccinellied alkaloid, citing a regioselective
samarium-mediated carbon-nitrogen bond cleavage as well as a stereoselective Michael 
addition as key steps. 86 (-)-Deoxynupharidine 96 has been shown to exhibited an 
immunosuppressive effect as well as a central paralysis effect and weak anti-metastic
* • 87activity. Once again, a reductive carbon-nitrogen bond cleavage is one of the key steps in 
Honda’s synthesis of this target.
95 96
Figure 1.9
As stated above, one of the key steps in the synthesis of both these natural products is a 
regioselective samarium-mediated carbon-nitrogen bond cleavage. Honda has utilised the 
reduction of a-heterosubstituted carbonyls, in this case the reduction of an a-amino ester, to 
gain access to the 5-lactam motif. Treatment of 97 with SmH in the presence of pivalic 
acid leads to samarium(III) enolate intermediate 98 (scheme 1.58). 98 then undergoes 
cydative ring closure to yield the protected precursor to (-)-adalinine 95 . 86
TBDMSO TBDMSO
EtO. Sml2, pivalic acid,
THF-HMPA, (70 %)
EtO.
OSm1
98
.OTBDMS
Scheme 1.58
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1.11 Conclusions
Throughout the course of this introduction, the formation of samarium(III) enolates and 
their synthetic utility has been outlined. There is a vast amount in the literature concerning 
samarium(III) enolates and their reactivity, and the aim of this introduction was to provide 
an overview of the area. The next two chapters will be concerned with work undertaken 
over the last three years, firstly towards a samarium-mediated cleavage strategy for phase- 
tag assisted synthesis, and then the development of an asymmetric approach where 
asymmetry is introduced in the cleavage step through enantioselective protonation of a 
samarium(III) enolate.
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C h a p te r  2: N ew  ap p lica tio n s  o f a l in k e r  system  cleaved  using
s a m a r iu m (II )  iod ide
2.1 L in k e r  system s
Phase tags have been used to assist the synthesis o f  m olecules for over fifty years; firstly in
oo oq qn # #
peptide synthesis ’ , then for small m olecule synthesis and finally in nucleotide and
oligosaccharide synthesis.91 Since its introduction, a large num ber o f  transform ations have
92 • •been perform ed on substrates bound to resin w ith varying results. “ C ritical to the success 
o f any phase-tag assisted synthesis is the linker design.
The linker can be described as a structural m otif w hich tem porarily  jo ins the support, be it 
polym eric, fluorous, etc., and the substrate under m anipulation. The two m ain requirem ents 
for a good linker are that ideally it should allow  facile attachm ent and cleavage, and 
secondly it should not be adversely affected by any chem istry used to m odify or extend the 
attached com pound.
One o f  the draw backs o f  some early linkers was that, having undergone the final cleavage 
step, there rem ained an undesirable indication o f  the site o f  attachm ent. On occasion an 
additional step was necessary in order to rem ove the unw anted functional group. As a 
result, m any later linkers are term ed ‘traceless’, the best definition o f  this being w hen an
QT
arom atic or aliphatic proton is introduced at the point o f  cleavage. M y studies have been 
concerned w ith the developm ent o f  traceless linkers utilising an ether or sulfur link at the 
position a-to  a carbonyl group which are cleaved using Sm l2 (schem e 2.1).
R
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Scheme 2.1
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In recent years within the group, a new linker strategy has been developed that has been
■If ^  -JO
applied in both solid phase ' and fluorous phase organic synthesis where the link to the 
phase tag is cleaved using Sml2 . We refer to this new class of linkers as a-Hetero-Atom 
Substituted Carbonyl (HASC) linkers and their cleavage is based on the well known 
reduction of a-heteroatom substituted carbonyl compounds using Sml2 .
2.2 Related linker systems
In 1997, Janda and co-workers reported the cleavage of an amide from a PEG-based thiol 
resin linked through a sulfur heteroatom (scheme 2.2).94 Reaction of thiol resin 99 with 
bromide 100 gave sulfide 101. Oxidation to sulfone 102, followed by reductive cleavage 
using a sodium amalgam gave 103. Janda reported only one such reductive cleavage and 
unfortunately did not perform further modification on the supported amide before cleavage. 
In addition, the use of a sodium-mercury amalgam is far from ideal.
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-40 °C to 0 °C, (98 %)
103
k h s o 5) h2o ,
20 °C, 3 h, (94 %) 
O
A / OHN' PEG-OMe
OMeO
N
102
Scheme 2.2
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In 1998, Ellman et al. reported the immobilisation of amides and ketones via an a-ether 
linkage.95 He immobilised a-hydroxy amide 104 using bromo-Wang resin to give 
supported amide 105 (scheme 2.3). Subsequent Grignard addition to the carbonyl yielded 
106, which was then reduced to give secondary alcohol 107. Further steps on resin were 
performed to modify the substrate further to afford 108. Finally, simple cleavage of 109 
from resin was executed using trifluoroacetic acid (TFA). Ellman used his methodology to 
produce a range of aspartyl protease inhibitors.
Br
+
OH NaH, TBAI,
O.
( ! )
104
OMMT 18-crown-6,
THF, 45 °C, 2 h .N
O
O OMMT
o
o
THF, 0 °C o. OMMT
R
105 106
Zn(BH4)2, Et20, 
THF, -20 °C
109 108
Scheme 2.3
H O^^k^OM M T
R
107
Whilst Sml2 had not previously been used for the cleavage of substrates from resin bound 
through a heteroatom a-to a carbonyl group,35'37 the reagent has been used to selectively 
cleave N -0 bonds to release products from a polymer backbone. In 2000, Abell and co­
workers performed the reduction whilst developing a new oxime based linker for the 
synthesis of amides and ureas (scheme 2.4).96
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'O . X  2
N R 25 °C, 3 h 
R1
R1
O
u
N ^ R 2
H
Scheme 2.4
Then, in 2003, De Clerq et al. reported the polymer-supported formation of carbon-carbon
07bonds via application of the classical Julia-Lythgoe olefination reaction. Reductive 
elimination of p-benzoyloxysulfones using Sml2 , leads to the preferential formation of 
trans alkenes in as high as 94:6 selectivity. Thiophenol resin 110 was deprotonated and the 
resulting thiolate treated with a primary tosylate (scheme 2.5). Oxidation with meta- 
chloroperoxybenzoic acid (mCPBA) led to sulfone 111. Following deprotonation of 111, 
the a-sulfonyl carbanion reacts with benzaldehyde to give 112. The final cleavage step uses 
Sml2 as a replacement for the more traditional sodium amalgam.
1. KOteu, THF, DMSO,
OTs
2. mCPBA, CH2CI2, RT
SH
111110
1. nBuLi, 0 °C - RT
2. p-methoxy benzaldehyde, 
THF, RT
3. PhCOCI, THF, RT OMe
OMe
Sml2, THF, DMPU OBz
112
27 % over 4 steps
E:Z, 94:6
Scheme 2.5
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More recently in 2004, L inhardt and co-w orkers used the reagent in a solid phase synthesis. 
Instead o f  using S m ^  as a cleavage reagent, L inhardt used it to m ediate C-glycosylation on
QO
a solid support. T reatm ent o f  m ethyl ester 113 w ith acetyl chloride in m ethanol and acetic 
acid yielded the neuram inic acid chloride donor. C -glycosylation was then carried out using 
SmL and dibenzyl ketone before cleavage under basic conditions afforded a-C -glycoside 
114 in 61 % yield  over 5 steps (schem e 2.6).
OH
°  I OH
A c H ^ i ^ C 0 2Me~
OH OH 
113
1. AcCI, MeOH, AcOH_______
2. dibenzyl ketone, Sml2, THF
3. NaOMe, MeOH
C 02Me 
OH
AcHN
Scheme 2.6
2.3 Studies on an ether-based linker system
My initial goal was to develop conditions for efficient enolate alkylations at the point o f  
attachm ent to the solid support using our linker system  (schem e 2.7). Such an approach 
would allow  the introduction o f  additional diversity and perm it access to a w ider range o f  
products using the linker system.
X = O, S, S02
Scheme 2.7
In order to evaluate the feasibility o f  any solid phase route, prelim inary solution phase 
model studies are generally carried out. In our case, these involved developing the potential 
o f one o f the solid phase linker designs previously developed w ithin the group. ’ 4-
Benzyloxyphenol 115 was used as an approxim ate m odel for phenol resin 116 (figure 2.1).
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115 116
Figure 2.1
In order to begin the solution model studies we first reacted 115 with a-bromo-y- 
butyrolactone in the presence of potassium carbonate. This led to the formation of 117, our 
solution model for lactone 118, immobilised through an oxygen version of our linker 
design (scheme 2 .8 ).
O
BnO
BnO.
K2C 0 3, DMF, 
RT, (67 %)
115 117
Scheme 2.8
118
We then began our investigation of enolate generation and alkylation. We were able to 
alkylate 117 using lithium diisopropylamide (LDA) at - 45 °C and either benzyl or allyl 
bromide to give alkylated lactones 119 and 120 in reasonable yields (scheme 2.9). Using 
these substrates, the feasibility of the key SmU reduction could be assessed for the 
‘cleavage’ of modified lactones.
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117
1.LDA, TH F,-4 5  °C
2. Benzyl bromide
(68 %)
1. LDA, THF, - 45 °C
2. Allyl bromide
(73 %)
BnO. BnO.
Bn1
119 120
Scheme 2.9
In the case of benzylated lactone 119, it was possible to reduce off, or ‘cleave’, the aryloxy 
group using Sml2 in THF with methanol as a co-solvent to give 121 in 84 % yield (scheme 
2.10). However in the case of allylated lactone 120, we were unable to isolate much of the 
desired lactone 122. However, a quantitative yield of benzyloxyphenol was recovered 
which implied that the reduction proceeded well. It was assumed that 122 was lost during 
work up due to volatility.
119 K Bn
o
T H F,-45°C , d" V X 3
(84 %) '— 1
121
Sml2l MeOH,
1 2 0    -
TH F,-45°C ,
(9%)
Scheme 2.10
122
A route to prepare simple alkylated lactones, using our linker, therefore appeared feasible. 
The next step was to transfer the solution studies onto solid phase.
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In order to apply this route on solid phase, phenol resin 116 was prepared using a route 
previously developed within the group. 3 5 , 36 Benzyloxyphenol 115 was treated first with 
imidazole and TBDMSC1 to protect the free phenol giving 123 in good yield. This was 
followed by selective deprotection of the benzyl group to give 124 (scheme 2.11).
imidazole, BnGS f ^ i  h 2, Pd/C, EtOH, H0 ^ T ^ ]
^ QH TBDMSCI, ^ o i B D M S  RT’ ("  %) ^ O T B D M S
DMF, RT, (92 %)
115 123 124
Scheme 2.11
The next step in the process involved the immobilisation of 124 using commercially 
available bromo-Wang resin 125. Treatment of 124 with sodium hydride in the presence of 
125 afforded protected resin 126. Simple deprotection using TBAF gave the immobilised 
phenol 116. Immobilisation of a-bromo-y-butyrolactone was achieved by stirring with 
phenol resin 116 and potassium carbonate. Lactone 118, immobilised using our linker 
system, displayed a characteristic carbonyl IR stretch at 1788 cm’ 1 (scheme 2.12).
Br NaH, 124, DMF, RT
125
118
“'A
'O
V2C 0 3, DMF, RT
OTBDMS
126
TBAF, 
THF, RT
OH
116
Scheme 2.12
We were now in a position to attempt the potentially difficult deprotonation and alkylation 
of the immobilised lactone using LDA and suitable carbon electrophiles. The first attempts
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at alkylation to give the benzylated lactone 127 were assessed by subsequent cleavage with 
Sml2 in exactly the same manner as in the solution studies (scheme 2.13). This method 
provided us with only a trace amount of the desired lactone 121 in less than 5 % overall 
yield for the five step sequence. Despite the fact that our initial studies proved 
disappointing, we believed our problem lay chiefly in not knowing whether it was the 
alkylation or cleavage step that was not proceeding efficiently.
1.LDA, TH F,-4 5  °C
118 2. Benzyl bromide
Bn'
127
Sml2)
THF, MeOH
over 5 steps from 125
121
5%
Scheme 2.13
In solution, the alkylation conditions had^to be optimised carefully. It was therefore 
expected that completing this step on resin would also be difficult. To optimise the 
reaction, an effective way to monitor the alkylation step was required. It was decided to 
take advantage of the Wang-based support and its ability to be cleaved at a point remote 
from the lactone through the use of TFA (figure 2.2). This would allow us to assess 
whether or not alkylation was occurring, and if so, to what extent, thus determining 
whether the problem with the overall sequence was arising through the alkylation or 
cleavage step.
Sml<VO.
TFA
127
Figure 2.2
Cleavage of the linker using TFA would also circumvent any problems associated with the 
volatility of the cleavage product. The TFA cleavage also involved a simple work up 
procedure. The resin could be cleaved, filtered, and washed using dichloromethane before
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concentration. The crude *H NMR spectrum allowed us to then assess the extent of 
alkylation by simply comparing the ratio of protons from the unalkylated lactone 128 and 
the alkylated lactone 129 (scheme 2.14).
127
HO.
TFA, CH2CI2, RT O
HX  °
128
Scheme 2.14
HO.
+
Ph
129
Entry Temp. (°C) T.(h) T2 (h) eq. LDA 128 : 129
1 - 45 °C to - 20 °C 0.5 1.5 3 4 : 1
2 - 45 °C to - 20 °C 0.5 1.5 8 3 : 1
3 - 45 °C to - 20 °C 1 . 0 4.5 3 5 : 1
4 - 45 °C to - 20 °C 1 . 0 4.5 8 >33 : 1
T i : Time for enolate formation
T2 : Time allowed for stirring with benzyl bromide
Table 2.1
From table 2.1 it can be seen that the alkylation was proceeding, although even in the best 
case (table 2.1, entry 2), the reaction only went about 25 %. It can be deduced from the 
table that allowing a longer period for the formation of the enolate (Ti) does not have a 
desirable effect on the reaction. Similarly, using eight equivalents of LDA did not improve 
the reaction; indeed over a prolonged period of stirring with benzyl bromide it would 
appear to have had an adverse effect. It should also be noted that following TFA cleavage 
from the resin, the IR spectrum of the recovered resin showed no carbonyl stretches which 
indicated that all immobilised lactone, both alkylated and unalkylated was being cleaved 
from the resin.
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Another major problem encountered with this reaction and its transferral onto solid phase 
was the difficulty involved in the addition of a pre-swollen polymer to a solution of LDA 
under an inert atmosphere. It was therefore assumed that the alkylation, rather than the 
cleavage, was problematic.
To summarise, a solid phase route to simple lactones has been developed using our linker 
system. Solid phase alkylation and cleavage of benzylated lactone 121 was achieved 
following a successful solution phase model study. Whilst the yield of 121 (5 % from a five 
step sequence) was disappointing, we had made progress and this led us to next explore an 
analogous linker system that would make the alkylation step more straightforward.
2.4 Studies on a sulfone-based linker system
Other members of the group have had success using sulfur as the heteroatom link a-to a 
carbonyl group. 37 The advantages of using a sulfide linker lie in the ability to adjust the 
oxidation state of the linking sulfur atom. The different sulfide oxidation states allow 
different types of process to be carried out. For example, in the case of the oxygen linker, a 
strong base such as LDA was required to form the lithium enolate that was subsequently 
quenched with the alkyl bromide. It was felt that the higher oxidation states of the linking 
sulfur atom would allow alkylation to be carried out using milder bases under more solid- 
phase-compatible conditions. The next logical step for us was to construct compounds of 
generic structure 130 as mimics of the corresponding immobilised lactones 131 (figure 
2.3).
130 131
Figure 2.3
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The proton at the a-position in the sulfoxide and sulfone is more acidic. Deprotonation at 
the a-position can therefore be achieved more easily with a weaker base and should not 
require the use of harsher, more basic conditions.
Once again, our studies began with a solution phase model system. Using the procedure of 
Routledge et al,"  commercially available 4-mercaptophenol 132 was protected using trityl 
chloride and pyridine to give 133 in good yield (scheme 2.15). The free phenol was then 
protected as a benzyl ether using sodium hydride and benzyl bromide to give 134. Removal 
of the trityl group with TFA afforded thiol 135. Finally, treatment of 135 with 
triethylamine and a-bromo-y-butyrolactone led to 136, the solution model for a lactone 
immobilised through a sulfur version of our linker.
HO
SH
_ BnO.
TrCI, pyr., H i  NaH, BnBr, TBAI,
CH2CI2, (98 %) ^ J \ STr THF, 0 °C - RT, (85 %) STr
132 133 134
BnO
o
Et3SiH, TFA, CH2CI2,
O RT (67 %)
^   BY i^  NEt3, DMF, RT (66 %)
SH
136 135
Scheme 2.15
Oxidation of sulfide 136 using wCPBA led to sulfone 137 in an excellent 92 % yield 
(scheme 2.16).
Bn0V ^ i BnCS ^ N
T f f  ■ U M
136 '— 1 137 '— 1
Scheme 2.16
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We also examined the transformation of sulfide 136 to the corresponding sulfoxide. Many 
of the existing methods for this transformation require careful control of the stoichiometry 
of the oxidant to prevent over-oxidation to sulfone 137. This is extremely difficult to 
achieve on resin. In addition to this, the oxidation must also take place in a solvent that is 
compatible with polymers. Many conventional methods for sulfoxidation, such as the use 
of NalCU, require polar solvents such as methanol. As such solvents cause the resin to 
shrink and contract, this would result in a slow, inefficient reaction.
We accomplished the transformation using the conditions originally developed by Begue et 
al, namely H2 O2/HFIP (scheme 2.17).100 Selective oxidation of 136 to sulfoxide 138 was 
thus achieved using solid phase compatible conditions without over-oxidation to the 
sulfone.
BnO.BnO.
136 138
Scheme 2.17
The rate of the oxidation of sulfur by H2 O2 is rapid and depends on the nucleophilicity of 
the sulfur atom. Over oxidation can be prevented through the use of hexfluoroisopropanol 
(HFIP) as co-solvent. It has been proposed that HFIP has two roles to play in the reaction 
mechanism. Firstly, it is thought to accelerate the sulfoxidation step by forming a hydrogen 
bond to the H2O2 , thus activating the hydroxyl leaving group. Following this initial 
oxidation, HFIP then prevents over-oxidation to the sulfone by forming a strong hydrogen 
bond to the oxygen of the sulfoxide, thus decreasing the nucleophilicity of the sulfur atom 
and preventing it from reacting further with the H2O2 . 100
Initially, alkylation of 137 was carried out using potassium carbonate as the base and 
benzyl bromide (scheme 2.18). However, despite heating the reaction to 60 °C, we never 
obtained more than 21 % yield of benzylated lactone 139 with no starting material 137 
recovered. When we switched to using sodium hydride as the base, the yield improved
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greatly to 96 % . 101 Whilst the yield itself was good, we had concerns that the use of sodium 
hydride would not be ideal for use on solid phase with a sulfone linker. Subsequent 
‘cleavage’ of 139 with Sml2 proceeded well with the ‘cleavage’ product 121 being formed 
in a reasonable, unoptimised yield.
137
BnBr, K2C 0 3l Kl, I ll O _ O
DMF, 60 °C, (21 %)
&
139
2. BnBr, (96 %)
Sml2, THF, 
MeOH, (52 %)
121
Scheme 2.18
Alkylation of sulfoxide 138 using sodium hydride led to desired sulfoxide 140 by crude !H 
NMR analysis, though the reaction was never clean (scheme 2.19). Due to the 
diastereomeric nature of both starting material and desired product, isolation of 140 proved 
problematic and was never achieved.
BnO.
138
BnO.
1. NaH, DMF, 0°C
2. BnBr
Bn
140
Scheme 2.19
Thiol resin 141, previously described by Routledge, was prepared from bromo-Wang resin 
125 and 133 in two steps (scheme 2.20)." Treatment of 133 with sodium hydride and 
heating in DMF with bromo-Wang resin gave trityl-protected thiol resin 142. Deprotection 
was achieved using TFA and triethyl silane to remove the trityl group and give thiol 141 
which showed an S-H band in the IR spectrum at 2599 cm'1. The use of triethyl silane with 
TFA is reported as acting as a carbocation scavenger in the acidic deblocking of protecting
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i fyygroups in peptide synthesis and is performing a similar role in this transformation. 141 
was then reacted with triethylamine and a-bromo-y-butyrolactone to give immobilised 
lactone 143. The success of the immobilisation step was monitored by IR -  the product 
showing a strong carbonyl stretch at 1787 cm'1. Finally, oxidation of 143 to sulfone 144 
was achieved using mCPBA.
125 133, NaH, t 
DMF, 60 °C
O
STr
TFA, Et3SiH,| 
CH2CI2, RT
142
'O
14
NEt3, 
DMF, 60 °C
SH
- A
144
mCPBA, CH2CI2, RT
143
‘ • A
Scheme 2.20
The final two steps in the solid phase synthesis were the alkylation and subsequent 
cleavage reaction (scheme 2.21). Despite attempting these two steps numerous times, using 
different conditions, we were never able to isolate any of desired lactone 1 2 1  from resin 
145.
144
1. NaH, DMF, 0°C
2. BnBr *
0  
S:
Bn
O
Sml2, THF, 
MeOI-f RT
121
145
Scheme 2.21
In the case of the sulfur linker, we believe the problem may be less to do with the chemistry 
used to modify the substrate and more to do with the nature of the linker itself. In order to 
remove the trityl protecting group, Routledge reports the use of a strong acid such as
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TFA." As mentioned in the previous section, TFA was used to cleave the Wang resin at a 
point remote from the substrate (chapter 2.3). It seems possible that we were removing at 
least some of linking unit from the support during the deprotection step.
2.5 Application of the HASC linker system in a synthesis of
azepinones
Azepinones are a common motif found in a number of natural products, drugs and their 
precursors. Illustrated in figure 2.4 are three such structures. Azepinone 146 has been 
targeted and synthesised as a potential treatment for inflammatory diseases, 103 whilst in 
structure 147 the azepinone motif is being used as a conformational constraint in the design 
of K-opioid receptor agonists. 104 Another example is Bengamide E 148, a naturally 
occurring azepinone isolated from a marine sponge from the genus Japus.105 This class of 
azepinone has shown a useful array of biological activity, and 148 has shown particular 
activity towards a human breast carcinoma cell line as well as significant anti-proliferative 
effects. In order to evaluate our linker system further, we decided to undertake the solid 
phase synthesis of a small library of fimctionalised azepinones using our technology.
Cl
Cl
HO.
146
OH OMe
OH OH O
147
Figure 2.4
V ^ N H
148
Our projected route to azepinones began with the opening of an allylated lactone 149 with 
an allyl amine to give 150, the amide precursor for ring closing metathesis (RCM). RCM
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on this substrate would yield lactam 151 which could then be treated with Sml2 , thus 
releasing the modified azepinone 152 from the polymer backbone (scheme 2.22).
Ring opening
HN
149 150
X = O, S (0)n (n = 0-2)
RCM
Sml
152 151
Scheme 2.22
Once again, our studies began by looking at a solution phase model system. Initially a route 
to a simple lactam starting from five-membered lactone 120 bearing an a-ether link was 
explored. The first step was ring opening of allylated lactone 120 (scheme 2.23). 120 was 
treated with trimethyl aluminium and Af-methylallylamine in hot toluene to give 153 in 
good yield. Diallyl amide 153 underwent RCM readily with Grubbs’ first generation 
catalyst in reasonable yield to afford lactam 154. The final step in the sequence was once 
again a cleavage step using Sml2 . ‘Cleavage’ of lactam 154 appeared to proceed well 
according to TLC, however, upon work up none of desired product 155 was apparent in the 
crude *H NMR spectrum, despite there being an almost quantitative amount of 115.
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BnO.
BnO.
HOAIMe3, toluene, 
50 °C, (77 %)
O
153120
N'
CH2CI2, 
reflux, (62 %)
PCy3
cl" R u ^  
C r  • ~ Ph 
PCy3
BnO. HO.
+
OH
115 155
BnO.
/  Sml2, THF,
MeOH, RT HO
154
Scheme 2.23
This, we postulated, was a problem arising from 155 being lost during the aqueous work 
up. In order to circumvent this problem the synthetic route was amended slightly by having 
an additional step to protect the primary hydroxyl as a silyl ether (scheme 2.24). Diallyl 
amide 153 bearing the primary hydroxyl group was protected using TBDPSC1 and 
imidazole in 71 % yield to give protected amide 156. This then underwent RCM using 
Grubbs’ first generation catalyst to give lactam 157. The final reductive step using Sml2 
and methanol as a co-solvent proceeded to give 158 in moderate yield, though this step was 
not optimised.
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BnO.
HO
153
N'
TBDPSCI, imidazole, 
DMF, RT, (71 %)
BnO
156
N'
O
TBDPSO.
158
Sml2, THF,
MeOH, RT, (47 %)
CH2CI2, 
reflux, (84 %)
BnO
TBDPSO
PCy3
cl" R u ^  
Cl* i P h  
PCy3
O
N
157
Scheme 2.24
Confident that a viable route to azepinones had been developed, the proposed route was 
then transferred to solid phase (scheme 2.25). As discussed in section 2.3, difficulties were 
immediately encountered in the alkylation of immobilised lactone 118.
1. NaH, DMF, 0°C
118 2. Allyl bromide
Scheme 2.25
Our attention turned once again to the use of an analogous sulfur linker. It was felt that this 
might lead to a more facile method for allylation with the linking sulfur atom in the sulfone 
oxidation state. Whilst this did not occur satisfactorily with benzyl bromide as the 
electrophile (chapter 2.4), it was found that alkylation of sulfone 137 using allyl bromide 
and potassium carbonate was possible in good yield to give allylated lactone 159 (scheme 
2.26). We had therefore developed a way to successfully allylate our model system using 
milder conditions than those needed with the ether linker, which should be transferable to a 
solid phase synthesis.
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BnO BnO
& Allyl bromide, K2CO3, Kl, DMF 60 °C, (71 %)
137 159
Scheme 2.26
The next step in our route involved the opening of the lactone ring using trimethyl 
aluminium and 7V-methylallylamine (scheme 2.27).
BnO
O
X reagents
BnO.
HO
.R 1
X = O, S, S 0 2
Scheme 2.27
En Reaction conditions Linke Outcome
✓ /V-methylallylamine, AIMe3l tol., 50 0| O Desired product, 153, 77S
e
C /V-methylallylamine, AIMe3l tol., 50 0| S 0 2 Starting material, 159
r
V morpholine, AIMe3) tol., 50 °C S 0 2 Starting material, 159
1 A/-methylallylamine, AICI3, CH2CI2l R S 0 2 Cleavage of Bn, 162, 69 S
t
V A/-methylallylamine, tol., reflux S 0 2 Starting material, 159
i A/-methylallylamine, CH2CI2, reflux S 0 2 Unknown product
1 /V-methylallylamine, LiHMDS, THF, F S 0 2 Starting material, 159
I A/-methylallylamine, NaHMDS, THF, I S 0 2 Poor m ass balance of cruc
c morpholine, LiHMDS, THF, RT S 0 2 Poor m ass balance of cruc
1 /V-methylallylamine, AIMe3, tol., 50 °' S Starting material, 163
Table 2.2
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Unfortunately, all attempts to open up the lactone ring of sulfone 159 with amines met with 
failure (table 2.2). It was postulated that the nature of the amine may have an effect on the 
reaction and in order to simplify things in the NMR spectrum of products and by­
products, we opted for a symmetrical amine and employed morpholine (table 2.2, entry 3). 
However, once again no reaction occurred.
A search of the literature led us to attempt the reaction using trichloroaluminium as 
opposed to trimethyl aluminium. Shuto and co-workers had reported the opening of a 
lactone ring in a system extremely similar to ours. Butyrolactone 160 bearing a sulfone 
group at a quaternary centre a-to the carbonyl was opened using trichloroaluminium to 
afford amide 161 in excellent yield (scheme 2.28).106,107
Et2NH, AICI; NEt;
OH
161160
97 % yield 
98 % ee
Scheme 2.28
This time complete consumption of starting material was observed and phenol 162 was 
isolated in which the benzyl group had been removed (table 2.2, entry 4, and figure 2.5). 
The deprotection of benzyl ethers using a similar method has previously been reported.
HO.
162
Figure 2.5
We heated starting material 159 at reflux with the amine. With toluene (table 2.2, entry 5), 
this gave unreacted starting material. However when the same reaction was tried in
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refluxing dichloromethane (table 2 .2 , entry 6 ), the formation of an unknown product was 
observed.
Our attention then turned to the use of lithium or sodium hexamethyldisilazide and A/- 
methylallylamine in order to generate a reactive lithium or sodium amide (table 2 .2 , entries 
7 - 9 ) .  However none of the desired product was obtained and complete decomposition of 
the starting material was observed.
Our final attempt involved the ring opening of the lactone using our original conditions 
though this time on the corresponding sulfide substrate. It was believed that the sulfide 
substrate would have less of a tendency to sequester trimethyl aluminium (table 2 .2 , entry 
10). Alkylation of the sulfide was carried out via the conversion of 136, using the LDA 
conditions optimised for analogous ether lactone 120, into 163 in 80 % yield (scheme 
2.29). However, this substrate once again led to the formation of an unknown compound 
and unreacted starting material.
BnO.BnO.
1. LDA, THF,-45  °C
S 2. Allyl bromide (80 %)
136 163
Scheme 2.29
We decided to abandon this route at this stage and looked at developing an alternative route 
to the lactam motif which would be amenable to transfer onto solid phase. It was proposed 
to by-pass the problematic ring opening step by attaching amides such as 164 onto resin 
141 in the initial immobilisation step to give 165 (scheme 2.30). Oxidation of the linking 
sulfur atom in 165 to the sulfone oxidation state followed by allylation using potassium 
carbonate would lead us to the precursor for RCM as before. Formation of the lactam ring 
followed by a second alkylation would then lead to functionalised lactam 166. A final 
cleavage using the mild conditions afforded by SmL, should allow us access to a range of 
functionalised azepinones 167.
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Br-
N141 165
164 1. Oxidation
2. 1st Alkylation
3. RCM
4. 2nd Alkylation
R3 R2
O
Sml2
166 R3 R2167
Scheme 2.30
We chose to work with three amines for our solution phase studies. Firstly, reaction of N- 
methylallylamine with a-bromoacetyl bromide led to a-bromoamide 168 in 87 % yield 
(scheme 2.31). The same reaction was also completed using A-diallylamine and N- 
allylaniline, both of which led to their respective a-bromoamides 169 and 170 in near 
quantitative yields.
Treatment of thiol 135 with a-bromoamides 168, 169 and 170, under basic conditions, 
afforded the corresponding allyl amides 171, 172 and 173 in moderate yields (scheme 
2.32). The next step was oxidation of the sulfide to the sulfone which was initially 
attempted using mCPBA. This led to sulfones 174, 175 and 176 in yields of 53 -  70 %. A 
later attempt at the same transformation, this time using oxone gave sulfones 174, 175 and
168, R = Me, 87%
169, R = allyl, > 9 9 %
170, R = phenyl, > 99 %
Scheme 2.31
176 in much improved yields of 94 % and above. Finally, efficient alkylation at the op­
position to give diallyl amides 177, 178 and 179 using allyl bromide and potassium 
carbonate was accomplished. It was believed these conditions would be transferable to 
solid phase.
BnO
SH
135
BnO
168, 169 or 170, NEt3, DMF, RT
171, R = Me, 55%
172, R = allyl, 66 %
173, R = phenyl, 55 %
O
BnO.
oxone, DMF, 
H20 , RT
BnO
allyl bromide, 
K2C 0 3, Kl, DMF, 60 °C
177, R = Me, 89 %
178, R = allyl, 63%
179, R = phenyl, 91 %
174, R = Me, 99 %
175, R = allyl, 96 %
176, R = phenyl, 94 %
Scheme 2.32
In the case of A-methylallylamine-derived substrate 177, RCM was completed using 
Grubbs’ first generation catalyst, to give lactam 180 in reasonable yield (scheme 2.33). At 
this stage the second alkylation step was attempted, and pleasingly, it went in excellent 
yield with the use of potassium carbonate and benzyl bromide as the electrophile to give 
benzylated lactam 181. The final cleavage step using Sml2 was successful and gave desired 
lactam 182 in 81 % yield. Additives such as DMPU and HMPA are often added to Sml2 
reactions to increase the reduction potential of the reagent. The use of additives was 
necessary with the ether linker system but it is interesting to note that in the case of the 
sulfone the ‘cleavage’ worked well without the need for an additive.
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BnO.
177 CH2CI2, reflux, (76 %)
180
benzyl bromide, 
K2C 0 3, Kl, DMF, 
60 °C, (93 %)
BnO.
Bn Sml2, THF, MeOH,
RT, (81 %)
Bn
182 181
Scheme 2.33
Our main reason for attempting the sequence with diallyl amine was to see which product 
would result from RCM on 178 (scheme 2.34). As expected a mixture of both the five 
(183) and seven (184) -membered rings was obtained, in an approximately 3:1 ratio in 
favour of the seven-membered ring. It is possible these may be kinetic and thermodynamic 
products although there was insufficient time to pursue this.
178
PCy3
c l " R u = \  cr t ^ h
pcy3
CH2CI2, reflux
BnO.
2 0 %
o
183
Scheme 2.34
BnO.
+
57%
184
We were now at a stage to attempt RCM on substrate 179 (scheme 2.35). However, despite 
the presence of some of the expected product 185 present in the crude NMR spectrum, it 
was a messy reaction and none of the desired product was ever isolated. We believe this is
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due to 179 existing largely as the wrong rotamer normally, and even heating it in refluxing 
dichloromethane does not allow it to interconvert readily to the appropriate rotamer.
179
PCy3
CI"Ru=^v c r  i Ph 
 PCy_3____
CH2CI2, reflux
BnO.
,Ph
185
Scheme 2.35
Solid phase studies were then undertaken. Initially, the synthesis of azepinone 182 was 
attempted (scheme 2.36). However, although the IR spectra of intermediates in the 
sequence often looked satisfactory, no trace of product was obtained from the final 
cleavage step. Intermediate 186, obtained after the first alkylation step, was then cleaved 
from resin 187.
O
141
SH
1. 168, NEt3, DMF, 60 °C
2. oxone, DMF, H20 , RT
182
K
N'
Allyl bromide, K2C 0 3, 
Kl, DMF, 60 °C
Sml2, MeOH,
THF, RT
187
1. Benzylation
2. Cleavage
N'
RCM : 
t
/
Scheme 2.36
73
At this stage, amide 186 would be the expected product following cleavage from the resin. 
An authentic example of 186 was independently prepared to help monitor the cleavage 
reaction by TLC (scheme 2.37). Amide 186 however was not detected upon the attempted 
cleavage of 186 from 187. Suspicions once again turned to the nature of the thiol resin and 
in particular to the difficulties in deprotecting the trityl-protected thiol resin.
HN' 'Cl NEt3) CH2CI2i 
^  0 °C - RT, (94 %)
Scheme 2.37
In order to overcome this, the sequence was also followed using benzyl thiol resin 188 
(scheme 2.38).109 Sadly, no trace of the desired product 186 was found following the 
attempted cleavage from immobilised 189.
^ v ^ S H  1. 168, NEt3, DMF, 60 °C^ 
W  ‘ ~2. oxone" bMF, H20,'RT*"
N*
188
allyl bromide, K2C 0 3, 
Kl, DMF, 60 °C
Sml2, MeOH, 
"" THF,"RT ”
N'
189
Scheme 2.38
Following the attempted application of both ether and thiol linker sequences on solid phase, 
and the lack of a successful outcome, we turned our attention to the use of a soluble phase 
tag in place of an insoluble polymer tag. We chose to look at the use of a fluorous phase 
tag.
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2.6 Fluorous-phase synthesis
Whilst polymer supported chemistry has advanced greatly over the last fifty years, 
limitations on reaction scope and scale have limited further development. As a result, 
solution phase methods have once again become more popular, particularly fluorous-tagged 
synthesis. 110' 112 Initially pioneered by Curran in the mid 1990’s,113 fluorous phase synthesis 
has quickly become a useful tool for organic synthesis. One of its main advantages lies in 
the ease with which fluorinated components from a reaction can be separated from non- 
fluorinated organic molecules or reagents. Additionally, reactions can be monitored by 
more traditional methods such as TLC and lH NMR spectroscopy making development and 
optimisation of a given route much quicker than its solid phase equivalent. It also enables 
the characterisation of intermediates by !H and 13C NMR spectroscopy.
There are a number of ways in which fluorous phase synthesis can be employed. The first 
is in fluorous biphasic systems (FBS), where the immiscibility of fluorous solvents with 
conventional organic solvents is exploited. As an example, a fluorous catalyst may be 
present in the fluorous phase; whilst the substrate to be modified will be in the organic 
phase. Both fluorous and non-fluorous layers are allowed to combine upon heating to 
create a homogenous mixture thus allowing catalyst and substrate to come together. 
Separate layers are regained upon cooling allowing for easy separation and extraction. This 
affords the modified substrate in high purity from the organic phase whilst the catalyst can 
be isolated from the fluorous phase and then reused.
An example of such a system, reported by Bannwarth et al, is outlined below (scheme 
2.39) . 114 A fluorous bis-triphenylphosphine palladium complex was constructed and 
engaged for use in the palladium-catalysed Suzuki cross-coupling of aryl bromide 190 and 
phenyl boronic acid to yield biaryl 191. The reaction medium was a mixture of 
perfluoromethylcyclohexane (PFMC) and dimethoxyethane (DME), and the catalyst was 
recovered and reused up to six times without significant deterioration in the yield of the 
reaction.
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Br
L2PdCl2, PhB(OH)2, Na2C 0 3,
PFMC/DME, 75 °C, (95 %) >
190 191
Scheme 2.39
As a continuation, the separation of fluorous and non-fluorous molecules was carried out 
using a technique called fluorous-liquid, liquid extraction (FLLE). Fluorous alkenes, ethers 
and amines are generally immiscible in organic solvents. Fluorous reagents are soluble in 
fluorous solvents due to favourable fluorine-fluorine interactions. This property of fluorous 
solvents can be employed for the extraction of fluorous reaction components from an 
organic phase into a fluorous phase.
This system has been used to good effect by Curran and co-workers in the purification of 
allyl alcohols. 115 Aldehyde 192 was heated with a fluorous allylstannane reagent to give 
alcohol 193 (scheme 2.40). However, various tin by-products were also created during the 
reaction and FLLE was used to purify the product. Following the reaction, the crude 
mixture was partitioned between acetonitrile and perfluoroalkanes (FC-72), with the 
product being extracted into the acetonitrile layer and later isolated in high purity.
HCL
^ \^ S n (C H 2CH2C6F13)3 92 % yield 
85 % purityFLLE, 140°C
192 193
Scheme 2.40
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More recently, attention has switched to the use of a technique which allows separation of 
fluorous-tagged compounds from non-fluorous ones using fluorous reverse phase silica gel. 
It is known as fluorous solid phase extraction (FSPE) and involves loading a crude mixture 
onto a fluorous silica column. Elution with a fluorophobic solvent, commonly 80 % 
methanol/water, removes the non-fluorinated compounds from the mixture. Fluorous- 
tagged compounds remain on the column due to the strong fluorine-fluorine interactions 
with the fluorous silica and can later be removed using a fluorophilic solvent such as ( 1 0 0  
%) methanol.
Illustrated below is the use of fluorous phosphine in the Staudinger reaction on azide 194 
(scheme 2.41).116 Normally, the triphenylphosphine oxide generated as a by-product in this 
reaction is difficult to remove. Here it can be removed simply through FSPE to allow 
isolation of amine 195 in high purity.
PPh
NHN
, THF, RT
2. H20
FSPE
195194
88 % yield 
> 95 % purity
Scheme 2.41
2.7 Application of the linker system in a fluorous-phase
synthesis of azepinones
Various fluorous thiols with different length perfluoroalkyl chains are commercially 
available. These fluorous thiols consist of a perfluoroalkyl chain and a thiol functional 
group separated by a saturated two carbon spacer unit. The spacer unit ensures 
nucleophilicity at the sulfur is maintained by minimising the strong electron withdrawing 
effect of the perfluoroalkyl chain.
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Our studies began with the immobilisation of a-bromoamide 168 using perfluorodecyl thiol 
196 to give 197 in good yield (scheme 2.42). Oxidation of the sulfide with oxone led to 
formation of sulfone 198. However, problems were encountered isolating 198 using FSPE 
and the low yield of 198 following oxidation reflects this. Alkylation was attempted to 
construct diallyl amide 199 using allyl bromide and potassium carbonate. Whilst some 199 
was detected in the crude lH NMR spectrum, it was the minor product. This coupled with 
time constraints and the problems experienced in the extraction of fluorous-tagged 
compounds, led us to discontinue work into our fluorous linker system.
O O
NEt3, DMF, RT, (86 %)
FSPE N
k ^
196 168 197
oxone, DMF, 
H20 , RT, (33 %)
V °I /
' X X *
199 I]
allyl bromide, K2C 0 3,
Kl, DMF, 60 °C
198
N
k ^
Scheme 2.42
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2.8 Conclusions
In chapter 2 studies into the feasibility of phase-tag assisted routes to heterocycles using 
our linker system have been discussed. Initially, studies were made into the alkylation of 
various lactones and the reduction of the products using Sml2 . A simple lactone substrate 
was successfully cleaved from an ether linkage to a polymer tag using the reagent, though 
low overall yields were obtained (scheme 2.45).
BrY
127
Sm-'2' .  121
THF, MeOH 5%
over 5 steps from 125 
Scheme 2.45
A route toward simple azepinones that went via a key ring opening step as well as a crucial 
RCM step has been devised and carried out in solution phase studies into an ether-based 
link to a phase tag (scheme 2.46).
BnO.BnO.
TBDPSO
O
120 157
Scheme 2.46
TBDPSO.
158
In addition to this, after initial problems finding a route to azepinones whilst investigating 
the feasibility of a sulfone linker, we devised a route beginning from a-bromoamides that 
also utilised a key RCM step (scheme 2.47). Cleavage of the lactam from the resin model 
proceeded in an excellent 81 % yield, without the need for additives to increase the 
reduction potential of the reagent.
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Scheme 2.47
In summary, although my studies have failed to result in a solid or fluorous phase synthesis 
of azepinones using our linker system, several important observations have been made that 
highlight the strengths and weaknesses of the linker system. A future ring closing 
metathesis, solid phase route to functionalised azepinones based on my successful solution 
phase studies should be possible, but further optimisation is clearly needed.
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C hapter 3: Developing a cleavage-enantioselective protonation
strategy
3.1 Introduction
One o f  the goals o f  my PhD project was the developm ent o f  a new  strategy for the phase 
tag assisted synthesis o f  enantiom erically enriched carbonyl com pounds using our linker 
system. It was proposed that cleavage o f  the linker in the presence o f  a chiral protonating 
agent (CPA ) w ould allow  asym m etry to be introduced in the final step o f  a phase-tag 
assisted synthesis. This w ould release non-racem ic products from  the phase tag via the 
asym m etric protonation o f  the sam arium (III) enolate form ed upon cleavage o f  the substrate 
from the phase tag (schem e 3.1).
chiral proton 
source
X = O, S, S 02 enantiomerically
enriched
Scheme 3.1
3.2 Enantioselective protonation o f  sam arium (III) enolates
First introduced in 1976 as a m eans o f  deracem isation, the concept o f  enantioselective 
protonation o f  a prostereogenic centre is, in principle, a sim ple o n e .117 Since a prochiral 
enol derivative has two enantiotopic faces, the proton transfer from  a chiral, non-racem ic 
proton source to the enol derivative will be kinetically favoured from either the top or 
bottom  face, thus constructing enantiom erically enriched carbonyl com pounds (schem e 
3.2).
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o.0
o
R
X*-H - S/face 
4
I
X*-H - Re face
Scheme 3.2
With the increased knowledge of enolate structure and reactivity, and new methods for 
their regio- and stereoselective formation, enantioselective protonation has become a more
viable option for the production of enantiomerically enriched compounds. 118-120 An
additional advantage is that, upon normal aqueous work up of the reaction, reprotonation of 
the CPA occurs. This renders the CPA both recoverable and reusable.
During the last three years, we have been involved only in the generation of samarium(III) 
enolates and their enantioselective protonation. Our work has been inspired by the work of 
Takeuchi et al. which was covered in more detail in section 1.3.46 We were first attracted to 
the proton sources constructed by Takeuchi in his work on the reduction of a-hetero- 
substituted lactones. In the example shown, a-brominated lactone 200 is reduced in the 
presence of CPA 35 to give lactone 201 in good yield and in 72 % ee (scheme 3.3).
O
Sml2l THF, - 45 °C ___ ^ 0 ^ ^ Ph
Ph L J
200 201
88 % yield 
72 % ee
Scheme 3.3
OH
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Another example from Takeuchi’s work that bears a similarity to our proposed linker 
system is the reduction of a-methoxy cyclohexanone 202 in the presence of CPA 203 to 
give a-benzylated cyclohexanone 204 once again in good yield and this time in 81 % ee 
(scheme 3.4).
O
J-L^ OMeo
202
Sml2, T H F.-45 °C i r
204
72 % yield 
81 % ee
Scheme 3.4
We chose to adopt lactones of generic structure 205 as the model system for the 
development of a cleavage-asymmetric protonation sequence (scheme 3.5). Because of the 
similarity of the model system to Takeuchi’s substrates, we decided to begin our studies 
using proton sources used in his work in addition to other chiral proton sources.
Bn
Bn‘
121205
Scheme 3.5
3.3 Preparation of chiral protonating agents
A number of different CPA’s were used during our studies into the development of a 
sequential cleavage-enantioselective protonation strategy. As mentioned above, we focused 
initially on the use of CPA’s developed by Takeuchi and co-workers,40’ 41, 43, 44’ 46, 121
199  1 9 1although we also examined the use of related CPA’s reported by Pedrosa et al ’ in 
addition to some commercially available chiral alcohols (figure 3.1).
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camphorsultam (R)-(+)-BINOL (S)-(+)-pantolactone
O
OH
OH
" f t
Figure 3.1
Takeuchi and co-workers have prepared a number of C2 -symmetrical diol-based proton 
sources and we chose to synthesise the enantiomers of those that looked the most 
promising for our system, diols 35 and 203 (figure 3.2).
Takeuchis’ synthesis followed Stephenson’s method as far as alcohol 206.124 The route to 
206 began with the conversion of i?-(-)-mandelic acid 207 into i?-(-)-methyl mandelate, 
which was achieved in 78 % yield using thionyl chloride and methanol (scheme 3.6). The 
next step was to protect the secondary alcohol as a tetrahydropyranyl (THP) group, which 
is stable to basic conditions but which could later be deprotected easily under acidic 
conditions. This step afforded THP ether 208 in excellent yield. The methyl ester was then 
reduced using lithium aluminium hydride, to give 206 in 77 % yield. Primary alcohol 206 
was then converted into tosylate 209 using tosyl chloride and pyridine in 6 8  % yield.
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OH
C 0 2H
1. SOCI2, MeOH, -10 °C to RT, (78 %)
2. PPTS, dihydropy ran,
CH2CI2i 0 °C to RT, (97 %)
OTHP 
C 0 2Me
207 208
UAIH4, THF, 
0 °C to RT, (77 %)
OTHP
CH2° Ts p-TsCI, pyridine, RT, (68 %) 
209
Scheme 3.6
OTHP 
CH2OH
206
Our first two attempts to construct 210 failed to give yields close to the 78 % reported by 
Takeuchi. However, by leaving the reaction to stir for longer than reported in the literature, 
we were able to complete the synthesis of CPA 210 by first coupling tosylate 209 with 
catechol to give the THP-protected chiral ligand. Deprotection under acidic conditions then 
gave 210 in 76 % yield over two steps (scheme 3.7).
Ph
° H 1. C sC 03, 209, DMF, 8 0 ° C _
210 Ph
2. p-TSA, MeOH, RT 
(76 % over 2 steps)
OH
OH
Scheme 3.7
Tosylate 209 could also be used to prepare biaryl CPA 211. Coupling 209 with 2,2’- 
biphenol, followed by deprotection of the secondary alcohols led to CPA 211 in 6 8  % yield 
over two steps, marginally higher than that reported by Takeuchi (scheme 3.8).
85
1. C sC 03, 209, DMF, 80 °C
2. p-TSA, MeOH, RT 
(68 % over 2 steps)
Ph
OH
OH
211
Scheme 3.8
Proton source 212 was synthesised from o-xylenedibromide using a slightly different 
approach. Deprotonation of 206 using sodium hydride, followed by nucleophilic 
substitution of bromine in o-xylenedibromide, led to the formation of the protected diol. As 
before, deprotection was carried out under acidic conditions to give CPA 212 in 56 % yield 
over two steps (scheme 3.9)
1. NaH, o-xylenedibromide, THF, 0 °C - RT
2. p-TSA, MeOH, RT
(56 % over 2 steps)
Scheme 3.9
We also prepared Takeuchi’s protonating agent 213 from the ring opening of (R)-styrene 
oxide with AyV-diisopropylethylenediamine by heating in dimethylformamide and water at 
100 °C (scheme 3.10). In our hands, this reaction gave lower yields than the 52 % yield 
reported by Takeuchi,46 despite following the reported protocol exactly. Repeated attempts 
at optimisation failed to increase the yield beyond 32 %.
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213
Scheme 3.10
We also followed the work of Pedrosa and co-workers for the preparation of enantiopure 
C2-symmetrical ephedrine-derived alcohols 214 and 215.122 Pedrosa originally used the 
ligands for the enantioselective ethylation of aldehydes using diethyl zinc, however we saw 
the alcohols as potential CPA’s . 123 Synthesis of 214 began with the condensation of 
isophthaldialdehyde 216 and (-)-ephedrine to afford meta 6 /s-oxazolidine 216 (scheme 
3.11). Reduction using lithium aluminium hydride led to the final aminoalcohol ligand 214 
in 90 % yield over two steps, which reflected the good yields reported by Pedrosa.
PhPh
OH— O
UAIH4, THF, reflux,(-)-ephedrine,
(90 % over 2 steps)molecular sieves, 
= 0  CH2CI2, RT OH
216 "'Ph
214217
Scheme 3.11
Chiral proton source 215 was prepared in the same manner with the initial step being the 
condensation of phthaldialdehyde 218 with (-)-ephedrine to give ortho Ms-oxazolidine 219 
(scheme 3.12). The opening of the oxazolidine rings was once again achieved using lithium 
aluminium hydride to reach aminoalcohol 215 in reasonable yield.
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218
Ph
Ph OH(-)-ephedrine, UAIH4, THF, reflux,
molecular sieves, 
CH2CI2i RT
(66 % over 2 steps)
OHPh
"'Ph
219
Scheme 3.12
215
We had originally tried to construct CPA 215 via a more direct route. However the reaction 
of o-xylenedibromide and (-)-ephedrine in the presence of triethylamine failed to yield any 
of the desired product (scheme 3.13). The reaction was also attempted at elevated 
temperatures but with the same outcome.
y -f "«V
HN OH OH
Br \
Br NEt3l CH2CI2) RT „ QH
N. ,  . / p h
215
Scheme 3.13
3.4 Initial studies into the enantioselective protonation of
samarium(III) enolates
Work in the group has previously investigated the mechanism of reduction of a-oxygenated 
carbonyl compounds with Sml2. The work was concerned with the nature of the reactive 
species formed during the process.
In order to investigate the mechanism by which reduction initially occurs, a cyclopropyl 
group was used as a mechanistic probe. The rate of fragmentation of cyclopropylmethyl
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radical 220 is approximately 1.3 x 108 s' 1 and as the ring opens rapidly it is sometimes used 
as a radical clock (scheme 3.14).125 Tanko and co-workers have subsequently reported the 
rate of opening of cyclopropyl radical anion 2 2 1  as greater than 1 . 0  x 1 0 7 s' 1 and therefore 
not much different to the rate of ring opening of the neutral radical 220. Radical anions of 
this type should therefore also be useful radical clocks. 126 If a substrate, upon being treated 
with a single electron transfer reagent such as Sml2 , were to go via either radicals 2 2 0  or 
221, then opening of the cyclopropyl ring would be expected. Absence of any ring-opened 
product would indicate a different mechanistic pathway via an alternative radical.
221
Scheme 3.14
If the mechanism for the Sml2-induced reduction of the a-aryloxy group in our linker 
system proceeds via the generation of cyclopropylmethyl radical anion 2 2 2 , then 
fragmentation of the cyclopropyl ring would be expected to occur (scheme 3.15). However, 
if none of the ring opened product is obtained, it suggests the mechanism must proceed via 
direct reduction of the C-0 bond at the a-position to give a radical such as 223.
Scheme 3.15
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Work done earlier in the group concerned the use of a-aryloxy substituted cyclopropyl 
ketone 224 as a mechanistic probe (scheme 3.17). Careful titration of 224 with Sml2 led to 
the formation of cyclopropyl ketone 225 in 72 % yield (scheme 3.16). Interestingly, no 
trace of ring-opened product 226 was observed in the reaction. This suggested that the 
reaction was going directly through carbon-oxygen bond cleavage and not via the radical 
anion.
BnO.
224
O O
Sml2 , THF, +
0 °C - RT, 1.5 h
OTBDMS v OTBDMS
225 226
OTBDMS (72 %) (0 %)
Scheme 3.16
Ketone 227 is the immobilised version of solution model 224. Treatment of 227 with Sml2 
led to the cleavage of ketones 225 and 226 from the polymer backbone in an isolated yield 
of 18 % after 5 steps on resin and in a 6  : 1 ratio in favour of cyclopropyl ketone 225 
(scheme 3.17). This shows that fragmentation of cyclopropylketones does occur but in this 
case it is a result of over reduction of 225 by Sml2 .
227
OTBDMS
O O
Sml2, THF^ 
RT, 3 h
OTBDMS v OTBDMS 
225 226
6 : 1 ratio (18 %)
Scheme 3.17
In the next sequence of mechanistic studies, the nature of the reactive intermediate formed 
following cleavage was investigated. The reduction of a solution model substrate was 
carried out under various conditions, the aim being to ascertain whether it was radical
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intermediate 228, or enolate 229 that was the reactive species quenched at the end of the 
reaction (figure 3.3).
O OSrn111
228 229
Figure 3.3
To begin, the reduction of ketone 230 was carried out in the presence of deuterated 
methanol (MeOD). Complete deuterium incorporation a to the carbonyl group in the 
product 231 was observed (scheme 3.18). Whilst this implies the presence of an enolate 
intermediate, it is not inconceivable that the inclusion of MeOD could lead to an alteration
n
in the mechanistic course of the reaction.
BnO.
Sml2, MeOD, TBDMSO.
0°C, (100%)
231230
OTBDMS
Scheme 3.18
There is literature precedent for hydrogen atom abstraction from solvent when using THF 
in some Sml2 reactions. 127 This is a radical process and might occur if reactive intermediate 
228 was being formed. In order to assess the extent, if any, of hydrogen atom abstraction, 
the reduction of isopropyl ketone 232 was carried out in dg THF (scheme 3.19). Deuterium 
incorporation would have indicated that product formation occurs via quenching of an ex- 
radical intermediate. No deuterium incorporation was observed in 233, indicating once 
more the presence of an enolate as the reactive species.
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BnO
O
Sml2> d8 THF, RT, (96 %)
TBDMSO
233
OTBDMS
Scheme 3.19
My studies into cleavage of our linker and asymmetric protonation of the resulting 
samarium(III) enolate began by treatment of lactone 119, which had been prepared as in 
section 2.3, with Sml2 and chiral proton source 210 (scheme 3.20). The early results were
attempted at a number of different temperatures down as low as - 78 °C, with no effect on 
the enantioselectivity of the reduction. Also, as the temperature of the reaction was 
decreased, conversion decreased, leaving unreacted 119 which hindered purification.
Although we had not expected high enantioselectivities with CPA 210, we felt that the 
isolation of racemic 121 was significant. We felt there must be a mechanistic reason for the 
complete lack of selectivity observed. One possibility was that of achiral protonation 
during the reaction or during aqueous work up. As previous experiments in the group 
suggested that hydrogen atom abstraction from THF was not occurring, we concentrated on 
the possibility of achiral protonation of the enolate during work up. We devised some 
simple labelling experiments in order to verify at which stage the enolate was being 
protonated.
surprising and GC analysis indicated 0 % ee each time the reaction was attempted, despite 
altering the number of equivalents of both Smh  and 210. In addition, the reaction was
119 121
47 % yield, 
0 % ee
Scheme 3.20
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As in scheme 3.18, our initial foray into labelling was to determine whether we would 
witness deuterium incorporation upon reduction of 119 in the presence of MeOD (scheme 
3.21). Thankfully, we observed deuterium incorporation in lactone 234 at the a-position 
indicating that an enolate was indeed being protonated during the reaction and not during 
the subsequent aqueous work up.
BnO.
Bn"
119
O
Sml2, MeOD, THF, Bn.
0  - 20 °C, (21 %) Q
234
Scheme 3.21
O
We also carried out the reduction using benzyl alcohol as the proton source and this time 
used a D2O quench (scheme 3.22). No deuterium incorporation was observed and once 
again we felt confident that protonation was occurring during the reaction rather than on 
work up. Benzyl alcohol was used as it was more similar in size and pka to chiral proton 
source 2 1 0 .
BnO.
Bn
119
O
1. Sml2, BnOH, TH F,-2 0  °C ,r Bn U
2. D20  quench, (42 %)
121
Scheme 3.22
We were now relatively happy that the reaction was proceeding via the expected 
samarium(III) enolate. But why were we obtaining racemic 121 from the ‘cleavage’ 
reactions in the presence of CPA 210? In order to confront this problem we chose to assess 
the effect of the leaving group on the enantioselectivity of the reaction.
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3.5 Investigating the effect of the leaving group on
enantioselectivity in asymmetric protonations
In order to assess the effect of the leaving group on the enantioselectivity of the asymmetric 
protonation reaction, we chose to investigate the behaviour of a single enolate 235, 
generated from a range of substrates. Treatment of a variety of substituted butyrolactone 
substrates with Sml2 , would all generate 235 allowing us a means for direct comparison of 
the effect of the leaving group and maybe provide us with some mechanistic insights into 
the reaction (scheme 3.23). Initially, we concentrated on other a-oxygenated systems, 
before moving on to the reduction of sulfides and sulfones.
X = Leaving group 235 121
Scheme 3.23
how does the nature 
of the leaving group 
affect the ee?
Preparation of a-methoxy substrate 236 began by methylation of a-hydroxy-y- 
butyrolactone using silver oxide and methyl iodide to give 237 in 6 8  % yield (scheme 
3.24). Benzylation of 237 using LDA and benzyl bromide then gave 236 in an unoptimised 
35 % yield.
O O O  
H0 D Mel, Ag20 , DMF, > M e0 1  LDA, THF, BnBr, .  M e O ^ L  
\ _ J  RT, (6 8 %) \_ J  -4 5 °C , (35%)
237 236
Scheme 3.24
In the same manner, the analogous a-benzyloxy substrate was also prepared. After initially 
benzylating a-hydroxy-y-butyrolactone using silver oxide and benzyl bromide in 75 %
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yield, a-benzyloxy-y-butyrolactone 238 was alkylated on carbon using the conditions 
favoured above to give 239 in an unoptimised 39 % yield (scheme 3.25).
O O O  
H 0 U BnBr, Ag20 , DMF, Bn0 A  LDA, THF, BnBr, r Bn0 1
RT, (75% ) y j 1 -4 5 ° C ,(3 9 % ) b / L J 3
238 239
Scheme 3.25
a-Oxygenated compounds 236 and 239 were then reduced using Sml2 in the presence of 
C2-symmetric diol 210. We once again obtained a racemic mixture of lactone 121 from 
both substrates in poor yields (scheme 3.26). It is perhaps not surprising that alkoxy groups 
should be poorer leaving groups than aryloxy substituents and thus give lower yields in the 
reduction.
“ * , r
236 121
O O
H U 37%  yield
Sml2) 210, THF, - 20 °C BnV ^ O  0 % ee
239 121
Scheme 3.26
The next logical step was to investigate the effect of the linking heteroatom by exchanging 
oxygen for sulfide and sulfone moieties. To begin with, we chose to look at the proposed 
linker model and assemble the analogous sulfide and sulfone substrates. a-Arylsulfanyl-y- 
butyrolactone 136 was obtained according to the route described in chapter 2.4 (scheme 
2.15). Benzylation of 136 was achieved using LDA and benzyl bromide to give 240 in 81 
% yield (scheme 3.27).
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BnO. BnO.
LDA, THF, -4 5  °C,
S BnBr, (81 %)
Bn'
136 240
Scheme 3.27
Reduction of sulfide 240 gave a-benzyl-y-butyrolactone 121 in 46 % yield (scheme 3.28). 
Once again, however, chiral GC analysis indicated 0 % ee for lactone 121 obtained from 
the reduction of 240.
BnO.
Sml2, 210, THF, -20  °C
Bn
240
O
% yield
B n ^ A ,  4 6 'O 0 % ee
121
Scheme 3.28
Oxidation and benzylation were carried out according to the protocol described in chapter
2.4 (scheme 2.18) to afford 139 in 96 % yield (scheme 3.29).
B n O s y x  B n O ^ ^ s .
k J L i o  j? NaH, BnBr, DMF, .  fl
S C A Q ° ° C -RT- (96%)
137 139
Scheme 3.29
This time, upon reduction of sulfone 139 with Sml2 , we obtained lactone 121 in 76 % yield. 
This was the highest yield obtained in any reduction to date (scheme 3.30). More 
importantly however, was the fact that we obtained 121 in 13 % ee. This was a low, but 
reproducible enantiomeric excess, indicating that asymmetric protonation of the 
samarium(III) enolate was occurring at last. Why should the reduction of 121 give 13 % ee
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with CPA 210, while the reduction of the corresponding ether and sulfide lactones 119 and 
240, give racemic products with the same CPA?
BnO
Sml2, 210, THF, -20  °C
Bn'
139
_ j? 76 % yield 
BnV \ )  13 % ee
121
Scheme 3.30
Based on a Merrifield thiol resin used previously within the group to good effect, we next 
opted to construct a benzyl sulfide and sulfone in order to ascertain whether a similar trend 
was observed with other sulfide and sulfone substrates. Synthesis of benzyl sulfide 241 
began with the reaction of benzylmercaptan 242 with a-bromo-y-butyrolactone to give 243 
in reasonable yield (scheme 3.31). Benzylation of 243 using LDA and benzyl bromide 
yielded reduction substrate 241 in 97 % yield.
O
Br>rv A ,
C X SH^ -  °"sV S ,  - a
O
\__ / B n '\__ /RT, (78 %)
242 243 241
Scheme 3.31
Based on our observations for the reduction of 240, we expected the reduction of a- 
benzylsulfanyl lactone 241 to give benzylated lactone 121 in 0 % ee, and indeed this was 
found to be the case (scheme 3.32).
O O
Rn« u ________________  ^ Bn A  27%yie|d
b 'K u  Sml2’ 210’ THFi' 2 0 °c  " X Z ?0  0 % 00
241 121
Scheme 3.32
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Construction of the analogous benzylated sulfone began by oxidation of 243 with wCPBA 
to give 244 in 75% yield (scheme 3.33). Alkylation of 244 was possible using potassium 
carbonate and benzyl bromide to give benzylated sulfone 245 in 8 8  % yield.
O O O
B n S ^ X .  — D.9PBA' CH2CI2, „ B n O z S ^ J l   BnBr, K2C 0 3. Kl,  ^ Bn02S . A _
\ _ j °  RT, (75 %) \_ J  DMF- 6 0 °C ,(8 8 %) Br A _ J
243 244 245
Scheme 3.33
Reduction of the sulfone proceeded in reasonable yield to give lactone 121 in 13 % ee 
(scheme 3.34). This was an important result as it clarified our observation that altering the 
leaving group does indeed appear to have an effect on the enantioselectivity of the 
reduction-asymmetric protonation sequence.
O O
U 11 53 % yield
Sml2) 210, THF, -2 0 °C  /° 1 3 % e e
245 121
Scheme 3.34
All the experiments carried out in this section were completed under identical conditions 
using the same CPA 210 (table 3.1). This allowed for direct comparison between substrates 
as to the effect of the leaving group on the enantioselectivity of the reaction. The conditions 
were chosen as a balance between enantioselectivity and isolated yield. Whilst an increase 
in selectivity may have been observed at lower temperatures, reduction of all substrates 
was not feasible below - 20 °C, and this would have prevented direct comparisons from 
being made. In addition, we felt that in order to measure accurate enantioselectivities of the 
products, we required the reduction to yield at least 5 mg of 121.
The results are summarised in table 3.1. It is apparent from entries 1 - 4  and 6  (table 3.1) 
that for sulfides and ethers, we do not observe any enantioselectivity. However, it is also
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clear from entries 5 and 7 (table 3.1) that when the leaving group is a sulfone, be it aryl or 
alkyl, then we do obtain 1 2 1  with a small, but reproducible, enantiomeric excess.
entry Leaving group X % yield % ee
1 ArO-(119) 47 0
2 MeO- (236) 2 0 0
3 BnO- (239) 37 0
4 A rS-(240) 46 0
5 ArS(0)2- (139) 76 13 (-)
6 BnS- (241) 27 0
7 BnS(0)2- (245) 53 13 (-)
Ar =/?BnO-C6H4 -
Table 3.1
The explanation we propose for the discrepancies observed, concerns the nature of the 
leaving group, and its ability to interfere with the samarium(III) enolate. One possibility is 
that the expelled group acts as a ligand for the samarium of the enolate and thus modifies 
the reactivity and the asymmetry of protonation. As the expelled group is already co­
ordinated to a second samarium(III) ion, modification of the samarium(III) enolate is 
perhaps unlikely. We believe a more likely explanation is that rather than acting as a proton 
donor toward the enolate, the proton source was, in some cases, donating its proton to the 
leaving group expelled following the reduction (scheme 3.35).
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chiral proton 
source
RXSm111 +
Bn
Scheme 3.35
This would result in the generation of a competing achiral proton source in the reaction 
mixture, thus leading to a racemic lactone product. This would account for the dramatic 
‘switching on or o ff  of the asymmetric induction. In the case of a samarium(III) phenoxide 
or a samarium(III) thiophenoxide expelled group this would lead to an alcohol or thiol 
proton source respectively.
Why would samarium(III) alkoxides or thiolates be able to deprotonate the CPA? We 
believe multidentate chelation of the chiral proton source to the samarium(III) ion lowers 
the pka of the protons on the CPA by increasing the 5(+) on the hydroxyl protons and 
stabilising the conjugate base once the proton is lost (scheme 3.36). Also, as samarium is 
by nature very oxophilic, an additional driving force would be the formation a strong 
samarium-oxygen bond between the CPA and the samarium of the enolate.
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R = alkyl, aryl 
S = 0 , S
XR Smm
\
H -0" O'
ArXH + Smm
H -O ' O'
achiral proton 
source
Scheme 3.36
We believe there is a fine balance of pka’s in the system. Alkoxides and thiolates lead to 
achiral proton sources while samarium(III) sulfinates, generated by reduction of sulfones, 
are insufficiently basic. This is one possible explanation for the observation of asymmetric 
induction with the use of sulfones.
It was clear that the leaving group was having an effect on the enantioselectivity of our 
sequence. Takeuchi and co-workers have reported very little effect of the leaving group on 
the enantioselectivity of the reaction.46 Indeed, in section 1.3 (scheme 1.20), examples are 
shown where four cyclohexanone substrates bearing four different a-substituents 
underwent reduction-asymmetric protonation to give the ketone products with 
enantioselectivities between 82 and 91 %, a variation of only 9 % ee! In addition, in 
scheme 3.24 we outlined an example with a methoxy leaving group which gave rise to 
racemic product. Takeuchi and co-workers however have reported the reduction of cyclic 
ketones bearing a-methoxy substituents to give products with up to 94 % ee (scheme 3.37).
Ar
OMe
Sml2, TH F.-45 °C
O
33
Scheme 3.37
6 “
75 % yield 
94 % ee
To summarise, the reductions of a range of a-heterosubstituted lactones, giving rise to a 
common enolate intermediate, give different results in the presence of chiral proton source 
210. We originally thought that there should be no difference in the asymmetric induction 
obtained for each substrate as the proton source protonates the same enolate in each case. 
The only difference in the reactions summarised in table 3.1 is the nature of the expelled 
group. We therefore felt confident in stating that, at least for our system, the leaving group 
has an effect on the enantioselectivity of the reaction.
We chose to further investigate the effect of the leaving group. In order to do this, we chose 
to generate samarium(III) enolate 235 via an alternative method. Our proposal was that 
generation of 235 in the absence of an expelled group might aid us in understanding the 
influence of the leaving group on the enantioselectivities of the reaction. We aimed to 
generate enolate 235 by conjugate reduction of a,|3-unsaturated lactone 246 using Sml2 as 
opposed to the reduction of an a-heterosubstituted butyrolactone (scheme 3.38). 
Protonating agents in the reaction mixture would thus react with enolate 235 with no 
outside influence from a leaving group.
Ph Sml
246 235
CPA
121
Scheme 3.38
  X
Sm '2 Bn
O
X-SmMI present
Wittig reagent 247 was prepared from a-bromo-y-butyrolactone in two steps via the 
phosponium salt to obtain phosphorane 247 (scheme 3.39). This was converted to a,0-
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unsaturated lactone 246 via a Wittig reaction of 247 with benzaldehyde. This afforded 
unsaturated lactone 246 in excellent yield.
O 0 0
Rr. A  1. PPh3, DME, reflux, (61 %) Ph p j l  PhCHO, CH2CI2i ^ J|
" V  O 2. Na2C 0 3, MeOH, 3 O RT, (99 %) P I T ^ T  O
'— ' H20 , (45 %) '— ' '— '
247 246
Scheme 3.39
The general scheme for the conjugate reduction of a,p-unsaturated lactone 246 is outlined
in scheme 3.40. The CPA’s used for the reduction were a mixture of tetradentate ligands
bearing both oxygen and nitrogen co-ordinating atoms. Proton sources 210, 211, 212 and
213 were those taken from Takeuchi’s work, 46 whilst 214 and 215 were taken from the 
10 ')work of Pedrosa et al.
Bn
PIT ^  'O Sml2, CPA, THF, - 20 °C, __
246
O
121
OH
OH
Ph
210
Ph
OHN
OH
213
211
Ph
M
/— N OH
f = \  X
M /
' —  ^OH
Ph
214
Ph
r~ {
O CH
O OH 
Ph
212
OH
OH
N
215
Scheme 3.40
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The results obtained from the conjugate reduction-asymmetric protonation of a,p~ 
unsaturated lactone 246 are illustrated in table 3.2. All the reactions were carried out at 
least twice to ensure that the results were reproducible and an average of the two similar 
results was calculated for the table. Reasonable yields were obtained throughout with the 
isolated yield recorded in the table. It is important to add that in all cases no trace of 
starting material was apparent in the crude lH NMR spectrum. We believe some product 
was lost as a result of the small scale upon which our reactions were carried out. Our best 
result came from the reduction of 246 in the presence of xylene-derived proton source 212 
that gave lactone 121 with an ee of 41 % (table 3.2, entry 3).
Crucially, we obtained non-racemic 121 from the conjugate reduction-asymmetric 
protonation of 246 in all the reactions with selectivities ranging from 4 - 4 1  % ee. 
Evidently, there was some selective interaction between enolate 235 and the CPA. This 
emphasized the mechanistic significance of obtaining racemic products using ether and 
thioether-based substrates. This clearly suggests that the samarium(III) alkoxides or 
thiolates generated from the reduction of a-oxygenated and a-sulfanyl substrates were 
decreasing the enantioselectivity of the process, regardless of the mechanism by which that 
occurs.
entry CPA Isolated yield of 121 (% ) ee of 121 (% )
1 210 81 13 (-)
2 211 47 1 0 (-)
3 212 55 4 1 ( - )
4 213 43 7 (-)
5 214 69 4 (-)
6 215 62 6  (-)
Table 3.2
We were heartened by these results as we had obtained the same enantioselectivities for the 
reduction of a-heterosubstituted sulfones in the presence of proton source 210 (table 3.1,
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entries 5 and 7) as we did for the conjugate reduction of a,p-unsaturated lactone 246 in the 
presence of the same proton source (table 3.2, entry 1). We therefore expected to be able to 
apply our best proton source from the conjugate reduction studies to the reduction of a- 
heterosubstituted sulfone 139 and obtain 41 % ee! Consequently, we set out to screen the 
same set of proton sources in the reduction of sulfone 139 as well as trying the reaction in 
the presence of commercially available proton sources 248, 249 and 250.
The general conditions for the series of experiments are shown below. a-Heterosubstituted 
sulfone 139 was reduced in the presence of a range of CPA’s at - 20 °C (scheme 3.41). The 
conditions for the reduction are identical to those used for the reduction of a- 
heterosubstituted lactones in table 3.1 and a,p-unsaturated lactone 246 in table 3.2 (scheme 
3.40).
BnO.
Sml2l CPA, THF, - 20 °C,
139
Bn^Jy
121
Ph
^  O
0  0H y
 ^OH \— I
Ph
212 248 249
C
Ph 
N OH
 ^OH
Ph
213
OH
OHN
Ph
OH
OH
214 215 250
Scheme 3.41
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The outcome of screening different proton sources for the reduction of a-heterosubstituted 
sulfone 139 is illustrated in table 3.3. The initial result is that obtained previously during 
studies on the effect of the leaving group (table 3.3, entry 1). In this reaction we achieved 
13 % ee, and obtained the same selectivity during studies into the reduction of a,p- 
unsaturated lactone 246 using CPA 210 (table 3.2, entry 1). However, the reduction of 139 
in the presence of other proton sources failed to follow the trend. Using biphenol derived 
CPA 211 we saw selectivities drop from 10 % ee (unsaturated lactone 246) to an essentially 
racemic 1 % ee (sulfone 139, table 3.3, entry 2), whilst in the case of our most promising 
proton source, xylene-derived 212, we saw the enantiomeric excess drop from 41 % ee 
(246) to 16 % ee ( 139, table 3.3, entry 3). Attempting the reduction in the presence of (5)- 
(+)-pantolactone 248 and camphorsultam 249 resulted in racemic product (table 3.3, entries 
4 and 5). Conversely, the reduction of 139 in the presence of aminoalcohol-derived CPA’s 
213, 214 and 215 led to a rise in the enantioselectivity of the reaction with an increase from 
7 % ee, 6  % ee and 4 % ee (246) to 20 % ee, 19 % ee and 10 % ee ( 139)  respectively (table 
3.3, entries 6 , 7 and 8 ). In addition, there was a rather surprising switch in the sign of the 
optical rotation of the product indicating we were observing an opposite sense of 
asymmetric induction. Finally, the reaction was completed in the presence of commercially 
available BINOL 250 which led to 121 in 6  % ee and in low yield (table 3, entry 9).
entry CPA Isolated yield of 121 (% ) ee of 121 (% )
1 210 76 13 (-)
2 211 69 1 (-)
3 212 71 1 6 ( - )
4 248 8 6 0
5 249 77 0
6 213 62 2 0  (+)
7 214 67 19 (+)
8 215 71 1 0 (+)
9 250 29 6  (-)
Table 3.3
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The next question we asked was why the reduction-asymmetric protonation of 246 using 
Sml2 and a CPA gave different results to the reduction-asymmetric protonation of 139 
using the same conditions. In particular, why did reduction-asymmetric protonation of 246 
using CPA 212 give 121 in 41 % ee whilst reduction-asymmetric protonation of 139 using 
CPA 212 give 121 in only 16 % ee.
The main difference between those two processes, aside from the presence of an expelled 
group, is the number of protons needed for the transformation. Reduction of 139 requires 
only a single proton, while conjugate reduction of 246 requires two (scheme 3.42).
BnO.
Bn'
139
THF, - 2 0 °C P h ', .]  D
Sml2, CPA,
121
H O
P h ' THF- " 20 °c  Ph" H- 3
246 121
Scheme 3.42
As shown earlier, any protons in the reaction come from the chiral proton source (chapter 
3.4). The result is that during the conjugate reduction-asymmetric protonation sequence, 
the chiral proton source is modified by an initial protonation at the P-carbon leading to 
enolate A (figure 3.4). Reduction of sulfone 139 however may generate enolate B.
Ph' Ph'
B
Figure 3.4
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As the samarium(III) enolate is involved at the critical point of the reaction when 
enantioselectivity is introduced, it is conceivable that this minor difference in the enolate is 
leading to increased enantioselectivities in the cases of protonating agents 2 1 0 , 2 1 1  and 2 1 2  
and could possibly also lie behind the switch in the sense of induction in the cases where 
the protonating agents are 213, 214 and 215.
To summarise, we have made some interesting observations in the reduction-asymmetric 
protonation sequence. It is clear that using a tetradentate proton source leads to greater 
enantioselectivities than mono- or bidentate proton sources, presumably because 
multidentate proton sources better co-ordinate to samarium(III).
3.6 Investigating the effect of ring size on enantioselectivity
One major difference in the substrates investigated by Takeuchi and our model substrate is 
ring size. Whilst we have concentrated our efforts on five-membered lactones, Takeuchi’s 
examples are all on cyclic six-membered ketones and lactones. Ring size and type may be 
crucial in affecting the enantioselectivity of the reaction. In order to ascertain whether this 
was the case, we decided to prepare the analogous six-membered a,P-unsaturated lactone 
251 and carry out the conjugate reduction with Sml2 in the presence of chiral proton 
sources.
Our synthesis of a,p-unsaturated-5-valerolactone 251 began with the preparation of 
phosphonate 252 using LDA and diethyl chlorophosphonate in 39 % yield (scheme
190  1103.43). ’ The mechanism for the transformation is illustrated in scheme 3.44. First, one
equivalent of LDA deprotonates the lactone a-to the carbonyl to give enol 253 which reacts 
with diethyl chlorophosphonate leading to enolate 254. A second equivalent of LDA then 
abstracts a proton from the a-position in 254 to afford anion 255. The phosphonate group 
then migrates to the a-position to afford structure 256. Aqueous work up finally releases 
252.
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9 LDA, (Et0)2P(0)CI DMPU, THF, - 50 °C , (39 %)
(EIO)2P ^ A q
LDA
252
H+
P(OEt)2
©o
o
LDA
253 254
(EtO)2P ^
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Scheme 3.43
Phosphonate 252 was then converted to a,p-unsaturated-8 -valerolactone 251 via a Homer- 
Wadsworth-Emmons reaction with benzaldehyde. Unsaturated lactone 251 was obtained as 
a single isomer in 58 % yield (scheme 3.44).
O O O
(EtO)2P ^  PhCHO, K2CQ3i 18-crown-6, ;
T j  THF, RT(58% ) I  j
252 251
Scheme 3.44
We employed our standard conditions for the reduction and these are outlined below 
(scheme 3.45).
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251 257
Ph
OH
OH
Ph
210 211
Scheme 3.45
Two of Takeuchi’s proton sources; catechol-derived proton source 210 and biphenol- 
derived proton source 211 were used in the reduction of the 251 (figure 3.5). Conjugate 
reduction in the presence of chiral proton source 210 led to the saturated product 257 in 42 
% yield and in 7 % ee (table 3.4, entry 1). Reduction in the presence of biphenol-derived 
proton source 211 led to lactone 257 with slightly lower selectivity (table 3.4, entry 2). In 
both cases, reduction-asymmetric protonation of 251 gave rise to the product with R-
131 137configuration. ’ It should be pointed out that in the case of lactone product 257, 
enantiomeric excess was determined by optical rotation and comparison made with the 
literature rotation. As a result, there is a greater error associated with the 
enantioselectivities reported, particularly as the rotations were measured on small quantities 
(< 10 mg) of 257.
entry CPA Isolated yield of 257 (%) ee of 257 (%) Config.
1 2 1 0 42 7 R (+)
2 2 1 1 38 6 R (+)
Table 3.4
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These results seem to suggest that ring size, certainly a difference of one methylene unit, 
does not have an effect on the enantioselectivity of the sequence. However, we had also 
planned to attempt the conjugate reduction-asymmetric protonation of the analogous seven- 
membered unsaturated lactone 258. Synthesis began from s-caprolactone 259 which was 
converted to phosphonate 260 (scheme 3.46). Due to difficulties in removing DMPU from 
the crude mixture, 260 was used without further purification for the Homer-Wadsworth- 
Emmons reaction with benzaldehyde. This led to a,p-unsaturated-s-caprolactone 258 in a 
disappointingly low 7 % yield over the two steps.
o 0 0
LDA, ClP(0)0Et2, t (EtO)2Pv 
DMPU, THF, - 50 °C
PhCHO, K2C 0 3,
18-crown-6, THF, RT
259 260
Ph-
258
7 % over 2 steps
Scheme 3.46
Conjugate reduction of 258 was first carried out using methanol to obtain racemic 261 for 
the determination of chiral HPLC conditions. This led to a-benzyl-e-caprolactone 261 in an 
excellent 91 % (scheme 3.47). However, when the same transformation was carried out at - 
20 °C in the presence of chiral proton source 210, we failed to observe any of the reduced 
lactone, although starting material 258 was recovered. Unfortunately, we had insufficient 
time to repeat the reduction of this substrate.
O
Sml2, MeOH,
7 \ THF, RT, (91%)
258
O
Ph O
261
Scheme 3.47
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3.7 Phase-tag assisted synthesis
Having ascertained that a sequential cleavage-asymmetric protonation strategy should be 
feasible for use in sulfone linker systems, we sought to illustrate the concept in a phase tag- 
assisted synthesis. Having previously encountered many problems with solid phase 
synthesis, we opted to demonstrate our methodology in the cleavage of a fluorous phase tag 
from a simple butyrolactone substrate.
Synthesis of fluorous-tagged butyrolactone 262 began with the coupling of the fluorous 
thiol, C8F 17CH2CH2 SH 196, and a-bromo-y-butyrolactone using triethylamine to afford 
263 in 95 % yield (scheme 3.48). This was oxidised in 70 % yield using mCPBA to give 
sulfone 264. Benzylation was accomplished through the use of benzyl bromide and 
potassium carbonate and gave alkylated sulfone 262 in good yield. Fluorous solid phase 
extraction (FSPE) was used successfully throughout this synthesis for the purification of 
intermediates.
17 o
FSPE
196
C nF8r  17
NEt3l DMF, RT, (95 %) C8F17"
263
mCPBA, CH2CI2, 
RT, (70 %) FSPE
° w °  °\\S /
Bn
FSPE
0  BnBr, K2C 03, Kl, DMF, C8F17" 
60 °C, (85 %)
262
O O 0
264
O
Scheme 3.48
Reductive cleavage of the phase tag proceeded well under identical conditions to those 
used in previous reduction-asymmetric protonation studies. The cleavage was attempted in 
the presence of our better proton sources, and the general scheme for the reaction is 
illustrated below (scheme 3.49).
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The two proton sources employed for this reaction are illustrated above, with the results 
obtained shown in the table 3.5. Cleavage of fluorous-tagged lactone 262 in the presence of 
proton source 210 led to lactone 121 in 78 % yield and in 14 % ee (table 3.5, entry 1). 
Attempting the reduction with the best proton source 212 led to 121 this time in a yield of 
82 % and in 18 % ee (table 3.5, entry 2). Whilst these enantioselectivities are low, we 
believe this is the first instance of asymmetry being introduced in the final step of a phase- 
tag assisted synthesis and as such our results are significant and show the feasibility of the 
cleavage-asymmetric protonation strategy.
entry CPA Isolated yield of 121 (%) eeo f 1 2 1 (%)
1 2 1 0 78 14
2 2 1 2 82 18
Table 3.5
During our studies into the cleavage of a phase tag and our preceding investigations into 
the asymmetric protonation of samarium enolates, we often felt that the lack of selectivity 
encountered might simply be due to an unfortunate choice of model substrate for the 
development of our methodology. Accordingly, we decided to attempt the cleavage- 
asymmetric protonation on fluorous-tagged oxindole 265, which had been prepared by
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another member of the group (scheme 3.50).133 We first found chiral HPLC conditions for 
the separation of the two enantiomers of 266. The reduction-protonation proceeded in 
excellent yield, unfortunately, chiral HPLC analysis revealed 266 was isolated with an 
enantiomeric excess of only 6  %.
Br
Bn. ° V °
O
Bn
‘C«
N
265
Sml2, THF, 212, -20 °C
266
95 % yield 
6 % ee
Scheme 3.50
Whilst we have not achieved satisfactory selectivities in these reactions, we have 
demonstrated that cleavage of our linker in the presence of a CPA yields enantiomerically 
enriched carbonyl compounds after a phase tag assisted synthesis. Future screening of other 
proton sources as well as attempting the reduction on other fluorous-tagged carbonyl 
compounds might result in higher selectivities and a better understanding of the process.
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3.8 C onclusions
Whilst these studies have thrown up more questions than answers, some important points
leaving group does have an effect on the reduction-asymmetric protonation of a- 
substituted butyrolactones. We have advanced the theory that the isolation of racemic 
products is due to proton transfer from the CPA to the samarium(III) complex of the 
expelled group, leading to generation of an achiral proton source and non-selective 
protonation of the samarium(III) enolate.
Secondly, comparisons between the different proton sources employed gave insights into 
ligand design for this and similar processes. We obtained enantioselectivities of up to 41 % 
ee using tetradentate oxygen proton sources (scheme 3.51). Using aminoalcohol-derived 
proton sources with two oxygen and two nitrogen atoms available for co-ordination, led to 
enantioselectivities up to 20 % ee. However, the use of bidentate (i?)-(+)-BINOL led to a 
maximum enantiomeric excess of only 6  % ee, whilst attempts made using mono-dentate 
(5)-(+)-pantolactone and camphorsultam resulted in racemic product. This implies that the 
reaction relies upon a structured transition state in which maximum co-ordination between 
the protonating ligand and the samarium(III) enolate is necessary to give any 
enantioselectivity.
and conclusions can be drawn from the results. Firstly, it is apparent that the nature of the
O O
Ph
212
Scheme 3.51
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We have also proposed a theory as to why enantioselectivities obtained in the reduction of 
a-sulfonyl-y-butyrolactones such as 139 and 245 give different levels of enantioselectivity
again on the nature of the protonating species: In the conjugate reduction-asymmetric 
protonation of unsaturated lactone 246, the CPA is modified by an initial protonation of the 
substrate prior to the key protonation of the samarium(III) enolate. We believe the modified 
nature of the CPA leads to different enantioselectivities.
Finally, we have developed a strategy for the phase-tag assisted synthesis of 
enantiomerically enriched carbonyl compounds where asymmetry is introduced in the final 
cleavage step (scheme 3.52). Despite the low enantioselectivities observed, the 
methodology is still in its infancy and may yet prove advantageous for library synthesis.
compared to conjugate reduction of a,p-unsaturated lactone 246. This theory is based once
262
OH
OH 121
82 % yield 
18 % ee
Ph
212
Scheme 3.52
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Chapter 4: Future work
The nature o f  the project and the results obtained has left num erous directions that future 
w ork m ight take. In both chapters 2 and 3, we saw  studies tow ards the construction o f  
functionalised azepinones using our linker and phase tag m ethodology, as well as the 
potential for introducing chirality into a phase tag assisted synthesis. The ultimate aim for 
any future work w ould attem pt to encom pass both these d isciplines and apply them to 
create a small library o f  enantiom erically enriched pharm aceutically  im portant m olecules 
or building blocks. H ow ever, the realisation o f  this w ould require further exhaustive studies 
into the optim isation o f  either a solid or fluorous phase route to azepinones as well as the 
screening o f  a larger, m ore diverse array o f  chiral proton sources. In the short term , future 
aim s will involve responding to some o f  the m ore pressing questions throw n up by the 
research, particularly  regarding the cleavage-enantioselective protonation work.
Lim ited success has been achieved thus far on solid phase, and only w hen using an ether 
linker. The identification o f  thiol resins better suited to the reaction conditions em ployed in 
our synthesis o f  azepinones m ight provide more satisfactory results on solid phase.
One o f  the initial goals o f  this project was to investigate the potential for the alkylation o f 
substrates bound to a phase tag using our linker. A lthough we m ade som e progress towards 
our goal, we were generally unable to transfer prom ising solution studies to solid phase. 
We believe this was largely due to the reagents em ployed for the transform ation, and as 
such, further studies to identify a more ‘resin friendly’ m eans o f  alkylation is an area well 
worth investigating (schem e 4.1). Also, w ould using a selenium  linking atom offer any 
advantages in the transform ation?
reagents?
conditions?
X = O, S, S 02, Se?
Scheme 4.1
117
The work thus far undertaken into the construction of azepinones on solid phase has been 
fraught with complications, largely due to the nature of the starting resin as mentioned 
earlier. However, a number of solution phase routes towards such templates have been 
successful and attempting to perform these on other polymer backbones may afford a more 
positive outcome. At present a route utilising a fluorous tag appears the most promising. 
Although this route ultimately failed, a lack of time meant we were unable to optimise any 
of the reactions attempted. For instance, the use of wCPBA to change the oxidation state of 
the linking sulfur atom in 197 as opposed to oxone, could be investigated as previous 
experience showed that a more selective reaction can be obtained using mCPBA when the 
substrate also contains an alkene (scheme 4.2).
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Scheme 4.2
In the second part of my work, whilst screening a large number of diverse, tetradentate 
chiral proton sources may eventually yield a suitable proton source for the construction of 
enantiomerically enriched lactones, understanding the process is of more importance. 
Therefore, further mechanistic studies should take priority. In particular, the nature of the 
protonating species must be investigated. This would help us to explain the different 
selectivities observed in the reduction of 139 and 246 in the presence of the same CPA 
(scheme 4.3).
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An attempt should be made to independently prepare the protonating species that we 
believe is present in the reduction of a,p-unsaturated lactones. One such way would be to 
deprotonate the CPA initially using "butyllithium then displacing the lithium ion with the 
larger samarium ion (scheme 4.4). Would this lead to a similar CPA to that generated in the 
conjugate reduction of 246? Would this lead to enhanced enantioselectivities?
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Another interesting study would be to carry out the reduction of benzylated sulfoxide 140 
(scheme 4.5). Would the reduction of this lead to 0 % ee, as observed for the corresponding 
sulfide or 13 % ee, as observed for the corresponding sulfone?
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alkylation
138 140 121
Scheme 4.5
Introducing chirality at the final point in a phase tag assisted synthesis via a cleavage- 
enantioselective protonation strategy will allow access to enantiomerically enriched 
carbonyl compounds. When the final cleavage-enantioselective protonation sequence is 
optimised it will be applied to a range of immobilised (or tagged) substrates, thus allowing 
the asymmetric synthesis of libraries of pharmaceutically relevant classes.
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Chapter 5: Experimental section
5.1 General experimental
All experiments were carried out under an atmosphere of nitrogen or argon using 
anhydrous solvents unless otherwise stated. Reactions were carried out using oven-dried 
glassware. THF was distilled from sodium and benzophenone. CH2CI2 , toluene and 
diisopropylamine were distilled from CaH2 under Ar/N2 . NEt3 and DMSO were distilled 
from CaH2 and stored over KOH and under Ar/N2 . Reagents were purchased and used 
without purification unless stated. Distilled water was used throughout.
Samarium (II) iodide was prepared by the method of Imamoto134 with the modification that 
the samarium-iodine solution was heated at 60 °C rather than at reflux.
Column chromatography was carried out using Fischer Matrix silica gel 60 and 
FluoroFlash silica. Macherey-Nagel aluminium backed plates, pre-coated with silica gel 60 
(UV254), were used for thin layer chromatography and were visualized by illumination with 
UV light or staining with alkali KMnC>4 .
*H and 13C NMR spectra were recorded on both Varian 300 and Bruker DPX-400 and 
DPX-500 Fourier transform spectrometers with chemical shift values being reported in 
ppm relative to residual chloroform ( 8 h  = 7.27 or 8 c = 77.0) as an internal standard unless 
otherwise stated. NMR signals were assigned using DEPT 45, 90 and 135, HMQC and 
COSY spectra. All coupling constants are reported in Hertz (Hz). Rationalisation of 
coupling constants has been carried out where required. Peaks associated with the perfluoro 
chain in fluorous tagged compounds were not recorded as they were too weak to be visible 
in the 13C spectra.
IR spectra (KBr/NaCl) were recorded using a JASCO FT/IR 410 and Impact 400 
spectrometer. ATR IR spectra were recorded on a Bio-Rad Merlin Excaliber spectrometer. 
Mass Spectra were recorded at the University of Glasgow and the University of Manchester
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using a JEOL JMS-700 spectrometer. Melting points were recorded on Kofler hot stage 
apparatus and are uncorrected. GC analysis of 121 was carried out using a Supelco column 
p-dex 110. 50 °C to 230 °C at 1 °Cmin' 1 with a flow rate of 20 mis'1. Approximate 
retention times: 105.2 (- enantiomer), 106.8 (+ enantiomer).
Solid phase reactions were carried out in round bottom flasks and were performed with 
gentle stirring. In some cases reactions were performed in polypropylene bond elute 
cartridges which were placed in a carousel and rotated, such reactions are indicated within 
the experimental. Commercially available bromo-Wang resin with a loading of 1.40 
mmol/g was used. Solvents and soluble reagents were removed by high pressure water 
suction after transferral of the reaction suspension into polypropylene bond elute cartridges 
(25 ml or 50 ml fitted with a polyethylene porous disc), using approximately 50 ml solvent 
per gram of resin for each wash.
THF used for washing resin was distilled prior to use. The resin was washed with THF (30 
ml), THF:H20  (3:1) (3 x 30 ml), THF:H20  (1:1) (3 x 30 ml), THF:H20  (1:3) (3 x 30 ml), 
THF (2 x 30 ml), then alternate washings with CH2CI2 (3 x 30 ml) and MeOH (3 x 30 ml), 
finishing with THF ( 2 x 30 ml). The resin was then left to dry for 10 min under water 
pump pressure before being dried for at least 6  h under high vacuum.
Calculation of the theoretical loading of resins was carried out according to the equation:
S(th) - Theoretical substitution 
S(s) - Starting substitution mmol/g 
Wt - g/mol added to resin
_______ § ( S )_____
S(th) = A + / S(s)XAWt\
\  1000 /
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5.2 Experimental
3-(4-Benzyloxyphenoxy)dihydro-furan-2-one 11736
117
K2CO3 (3.45 g, 25.0 mmol) was added to a solution containing a-bromo-y-butyrolactone 
(1.85 ml, 20.0 mmol) and 4-benzyloxyphenol 115 (1.00 g, 4.99 mmol) in DMF (75 ml) and 
the mixture was stirred at room temperature for 48 h. The reaction mixture was quenched 
with aqueous saturated NH4CI (5 ml) followed by H2O (10 ml) and then extracted with 30 
% EtOAc/pet. ether (3 x 10 ml). The organic layers were then dried (MgS0 4 ) and 
concentrated. The crude mixture was purified by column chromatography (silica, 80 % 
EtOAc/pet. ether) to give 3-(4-benzyloxyphenoxy)dihydro-furan-2-one 117 (951 mg, 3.35 
mmol, 67 %).
*H NMR: 8 h (400 MHz, CDC13) 2.46 (1H, dt, J = 8.0, 13.3 Hz, C /^H BCH), 2.64-2.70 (1H, 
m, CUaHbCU), 4.34 (1H, m, C/^HbO), 4.52 (1H, dt, J = 8.0, 4.1, CHAHB0), 4.84 (1H, t, J 
= 8.0 Hz, CH), 5.04 (2H, s, PhCH2), 6.93 (2H, d, J = 6.9 Hz, 2 x ArH), 7.00 (2H, d, J = 6.9 
Hz, 2 x ArH), 7.44-7.31 (5H, m, ArH).
3-Benzyl-3-(4-benzyloxyphenoxy)dihydro-furan-2-one 119
119
To a solution of diisopropylamine (345 pi, 2.46 mmol), in THF (10 ml) that had been 
cooled to -45 °C was added "BuLi (985 pi, 2.46 mmol, 2.5 M in hexane). The reaction
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mixture was then stirred for 30 min. A solution of 117 (500 mg, 1.76 mmol) in THF (10 
ml) was then added dropwise by cannula and the reaction was stirred for a further 30 min. 
Finally, benzyl bromide (837 pi, 7.04 mmol) was added dropwise to the solution and the 
reaction mixture was allowed to warm slowly to -20 °C and stirred for 1.5 h. The reaction 
mixture was quenched with aqueous saturated NH4CI (3 ml) followed by H2 O (5 ml) and 
the aqueous layer extracted with 40 % EtOAc/pet. ether ( 3 x 5  ml). The organic layer was 
then dried (MgSCU), and concentrated. The crude mixture was purified by column 
chromatography (silica, 1 0 0  % CH2CI2) to give 3-benzyl-3-(4-benzyloxyphenoxy)dihydro- 
furan-2-one 119 as a white solid (461 mg, 1.20 mmol, 6 8  %).
‘H NMR: 5 h (400 MHz, CDCI3) 2.30-2.23 (1H, m, C//^HBCH2OC=0), 2.48-2.41 (1H, m, 
CHA//i)CH2 OC=0), 3.23 (1H, apparent d, J = 13.6 Hz, PhCH2C), 3.32 (1H, apparent d, J = 
13.6 Hz, PhCH2C), 3.80-3.74 (1H, m, 1 H from CH2OC=0), 4.11-4.05 (1H, m, 1 H from 
CH2 OC=0), 5.03 (2H, s, PhCH20), 7.01-6.87 (4H, m, 4  x ArH), 7.50-7.32 (10H, m, 10 x 
ArH).
13C NMR: 8 c (100 MHz, CDCI3) 30.2 (CH2CH20), 41.4 (PhCTfcC), 65.0 (CH2CH20), 70.4 
(PhCH20 ) 83.2 (ArC), 115.3 (2 x ArCH), 127.1 (2 x ArCH), 127.3 (2 x ArCH), 127.6 
(ArCH), 127.9 (2 x ArCH), 128.1 (ArCH), 130.2 (2 x ArCH), 130.4 (2 x ArCH), 134.5 
(OCC=0), 136.8 (ArC), 147.9 (ArCO), 155.6 (ArCO), 175.9 (C=0). 
vmax KBr/ cm ' 1 3529 br, 1776 m (C=0), 1504 s, 1454 s, 1379 s, 1207 br, 1025 m, 845 s, 
759 m.
MS (El): m/z 374 (M*, 16 %), 200,131,91 (Bn+, 100 %).
HRMS: Found 374.1517, C24H2 20 4, requires 374.1518.
MP: 83.8 -  85.2 °C.
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3-Allyl-3-(4-benzyloxyphenoxy)dihydro-furan-2-one 120
120
To a solution of diisopropylamine (69.0 pi, 0.49 mmol), in THF (2 ml) that had been 
cooled to -45 °C was added nBuLi (221 pi, 0.49 mmol, 2.5 M in hexane). The reaction 
mixture was then stirred for 30 min. A solution of 117 (100 mg, 0.35 mmol) in THF (3 ml) 
was then added dropwise via cannula and the reaction was stirred for a further 30 min. 
Finally, allyl bromide (152 pi, 1.76 mmol) was added dropwise to the solution and the 
reaction mixture was allowed to warm slowly to -20 °C and stirred for 1 h. The reaction 
mixture was quenched first with aqueous saturated NH4CI (3 ml) followed by H2O (5 ml) 
and the aqueous layer extracted with 40 % EtOAc/pet. ether ( 3 x 5  ml). The organic layer 
was then dried (MgSO,*), and concentrated. The crude mixture was purified by column 
chromatography (silica, 1 0 0  % CH2 CI2) to give 3-allyl-3-(4-benzyloxyphenoxy)dihydro- 
furan-2-one 120 as a clear oil (87 mg, 0.25 mmol, 73 %).
!H NMR: 5h (400 MHz, CDC13) 2.66-2.29 (1H, m, C i^ H BCH20 ), 2.59-2.49 (2H, m, 
Ctf2CH=CH2), 2.82-2.76 (1H, m, CHa//5 CH20 ), 4.28-4.19 (2H, m, CH20 ), 5.02 (2H, s, 
PhCH20), 5.14 (1H, dd, J = 1.5, 10.3 Hz, CH=Ctf„HB), 5.16 (1H, dd, J = 1.5, 15.5 Hz, 
CH=CHa/ /5), 5.94-5.84 ( 1H, m, CH= CH2), 7.01-6.88 (4H, m, 4 x ArH), 7.50-7.32 (5H, m, 
2 x ArH).
13C NMR: 8 C (100 MHz, CDC13) 31.2 (CH2CH20), 39.2 (CH2CH), 65.1 (CH2CH20), 70.3 
(PI1CH2O), 82.1 (ArC), 115.4 (2 x ArCH), 120.3 (CH=CH2), 123.0 (2 x ArCH), 127.2 (2 x 
ArCH), 127.7 (ArCH), 128.3 (2 x ArCH), 131.0 (CH=CH2), 136.8 (OCC=0), 147.8 
(ArCO), 155.6 (ArCO), 175.2 (C=0).
vmax KBr/ cm ' 1 3536 br, 2918 m, 1778 m (C=0), 1504 m, 1378 s, 1207 br, 1024 m, 843 s, 
741 s.
MS (El): m/z 324 (M+, 44 %), 200, 125, 91 (Bn+, 100 %).
HRMS: Found 324.1360, C20H20O4, requires 324.1362.
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3-Benzyldihydro-2(3//)-furanone 121
O
121
A solution of Sml2 (7.38 ml, 0.74 mmol, 0.1 M in THF), was added to a solution of 3- 
benzyl-3-(4-benzyloxyphenoxy)dihydro-furan-2-one 119 (115 mg, 0.31 mmol) in MeOH 
(2.5 ml) and THF (2.5 ml) that had been cooled to 0 °C. The mixture was then stirred 
before being allowed to warm to room temperature. After 1 h, a further 2.4 equivalents of 
Smh (7.38 ml, 0.74 mmol, 0.1 M in THF) was added and the reaction was allowed to stir 
for another 4 h. The reaction mixture was quenched first with aqueous saturated NH4CI (2 
ml) followed by H2O (2 ml) and the aqueous layer extracted with Et2 0  (3 x 20 ml). The 
organic layer was then dried (MgSCU), and concentrated. The crude mixture was purified 
by column chromatography (silica, 1 0 0  % CH2 CI2) to give 3-benzyldihydro-2(3//)- 
furanone 121 as a yellow oil (46 mg, 0.26 mmol, 84 %).
*H NMR: 5h (400 MHz, CDC13) 2.12-2.02 (1H, m, C /^H BCH20), 2.36-2.28 (1H, m, 
CHa// 5 CH20), 2.83 (1H, dd, J = 9.4, 13.6 Hz, PhC/fcHB), 2.96-2.88 (1H, m, CH) 3.19 
(1H, dd, J = 4.0, 13.6 Hz, PhCHA/75), 4.33-4.19 (2H, m, CH2 0), 7.40-7.29 (5H, m, 5 x 
ArH).
13C NMR: 6 C (100 MHz, CDC13) 27.0 (CH2 CH20), 35.1 (CH2Ph), 40.1 (CH), 65.5 (CH2 0), 
125.7 (ArCH), 127.7 (2 x ArCH), 127.9 (2 x ArCH), 137.4 (ArC), 177.7 (C=0). 
vmax KBr/ cm' 1 3510 br, 1774 m (C=0), 1497 s, 1454 s, 1375 s, 1149 m, 1022 m, 802 s, 
750 s, 702 s.
MS (El): m/z 176 (M+, 53 %), 148, 91 (Bn+, 100 %), 83.
HRMS: Found 176.0837, C11H 12O2 , requires 176.0837.
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3-AIlyldihydro-2(3i/)-fiiraiione 122
O
122
A solution of Sml2 (7.20 ml, 0.72 mmol, 0.1 M in THF), was added to a solution of 3-allyl-
3-(4-benzyloxyphenoxy)dihydro-furan-2-one 120 (97 mg, 0.28 mmol) and MeOH (2.3 ml) 
in THF (2.0 ml) that had been cooled to 0 °C. The mixture was then stirred before being 
allowed to warm to room temperature. After 1 h, a further 2.4 equivalents of Sml2 (7.20 ml, 
0.72 mmol, 0.1 M in THF) was added and the reaction was allowed to stir for another 4 h. 
The reaction mixture was quenched first with aqueous saturated N H 4 C I  (5 ml) then H20  
(10 ml) and the aqueous layer extracted with Et20  (3 x 20 ml). The organic layer was then 
dried (MgSC^), and concentrated. The crude mixture was purified by column 
chromatography (silica, 20 % pet. ether/CH2 Cl2) to give 3-allyldihydro-2(3/7)-furanone 122 
as a yellow oil (4 mg, 0.03 mmol, 9 %).
lU NMR: 5h (400 MHz, CDC13) 2.06-1.96 (1H, m, C//^HBCH2 0), 2.32-2.24 (1H, m, 
CHAtf5 CH2 0), 2.41-2.33 ( 1 H, m, CHC=0), 2.69-2.59 (2 H, m, CUCH2CH), 4.33-4.19 (2H, 
m, CH2 0), 5.14 (1H, dd, J = 1.5, 10.2 Hz, CH=C/^HB), 5.16 (1H, dd, J = 1.5, 15.3 Hz, 
CH=CHaHb), 5.80 (1H, m, Ctf=CH2).
13C NMR: 6 C (100 MHz, CDC13) 29.8 (CH2 CH20), 34.4 (CHCH2CH), 37.8 (CHC=0), 66.5 
(CH20), 117.8 (CH=CH2), 134.4 (CH=CH2), 178.8 (C=0).
vmax KBr/ cm' 1 3510 br, 1774 m (C=0), 1497 s, 1454 s, 1375 s, 1149 m, 1022 m, 802 s, 
750 s, 702 s.
MS (El): m/z 176 (M+, 53 %), 148, 91 (Bn+, 100 %), 83.
HRMS: Found 176.0837, CnHi20 2, requires 176.0837.
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O-te/T-Butyldimethylsilyl benzyloxyphenol 123
BnO
36
OTBDMS 
123
Imidazole (6.38 g, 93.6 mmol) and TBDMSC1 (9.03 g, 59.9 mmol) were added to a 
solution of benzyloxyphenol 115 (6.00 g, 30.0 mmol) in DMF (30 ml) at room temperature 
and the mixture was stirred for 4 h. The reaction was quenched with aqueous saturated 
NaHCC>3 (30 ml) and H2O (20 ml). The aqueous layer was extracted with 30 % EtOAc/pet. 
ether (3 x 50 ml). The organic layer was then dried (MgSO/j), and concentrated to give O- 
tert-butyldimethylsilyl benzyloxyphenol 123 as a white solid (8 . 6 6  g, 27.6 mmol, 92 %).
!H NMR: 5h (400 MHz, CDC13) 0.18 (6 H, s, (CH3)2 Si), 0.98 (9H, s, (CH3)3CSi), 5.00 (2H, 
s, PhCH20), 6.75-6.87 (4H, m, 4 x ArH), 7.30-7.52 (5H, m, 5 x ArH).
4-(te/*f-BtityldimethyIsilyIoxy)phenol 12436
HO.
'OTBDMS 
124
To a solution of 123 (8 . 6 6  g, 27.6 mmol) in EtOH (70 ml) was added 10 % Pd/C (1.30 g, 
15 % weight) under hydrogen (balloon) and the reaction was stirred at room temperature 
for 5 h. The reaction mixture was then poured onto a short column of silica gel and eluted 
with 40 % EtOAc/pet. ether, which upon concentration gave 4-(tert-
butyldimethylsilyloxy)phenol 124 as a white crystalline solid (6.11 g, 27.3 mmol, 99 %).
‘H NMR: 6 h (400 MHz, CDCI3) 0.17 (6 H, s, (CH3)2 Si), 0.98 (9H, s, (CH3)3CSi), 4.56 (1H, 
br s, OH), 6.74-6.68 (4H, apparent s, 4 x ArH).
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Wang-supported 4-(te/*/-butyldimethylsilanyloxy)-phenol 126
OTBDMS
4-(terf-Butyldimethylsilanyloxy)-phenol 124 (13.4 g, 59.5 mmol) was added to a flask 
containing a suspension of bromo-Wang resin 125 (1.40 mmol/g, 8.50g, 11.9 mmol) which 
had been pre-swollen in DMF (80 ml) for 20 min. NaH (1.43 g, 59.5 mmol) was added and 
the mixture was stirred slowly at room temperature. After 12 h, the resin was filtered, 
washed and dried according to the standard washing procedure to give Wang-supported 4- 
(tert-butyldimethylsilanyloxy)-phenol 126. 
vmax KBr/cm' 1 3029 w, 2918 w, 1601 m, 1509 s, 1218 s (C-O).
Wang-supported hydroquinone 116
116
Wang-supported 4-(tert-butyldimethylsilanyloxy)-phenol 126 (1.17 mmol/g, 8.50 g, 9.95 
nmol) was swollen in THF (100 ml) for 20 min. TBAF (59.7 ml, 59.7 mmol, 1.0 M in 
THF) was then added and the mixture was rotated at room temperature. After 24 h, the 
esin was filtered, washed and dried according to the standard washing procedure to give 
Wang-supported hydroquinone 116.
•W  KBr/cm-1 3027 w (OH), 2915 w, 1600 m, 1506 s, 1218 m (C-O).
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Wang-supported 3-(4-hydroxy-phenoxy)dihydro-furan-2-one 118
118
Wang-supported hydroquinone 116 (1.35 mmol/g, 0.96 g, 1.30 mmol) was swollen in DMF 
(35 ml) for 20 min. a-Bromo-y-butyrolactone (1.92 ml, 20.8 mmol) was then added 
followed by K2CO3 (1.80 g, 13.0 mmol), and the reaction mixture was stirred slowly at 60 
°C. After 36 h, the resin was filtered, washed and dried according to the standard washing 
procedure to give Wang-supported 3-(4-hydroxy-phenoxy)dihydro-furan-2-one 118. 
vmax KBr/cm ' 1 3025 w, 2917 w, 1788 s (C=0), 1611 s, 1507 s, 1217 s (C-O).
Wang-supported 3-benzyl-3-(4-hydroxy-phenoxy)dihydro-furan-2-one 127
Bn
127
"BuLi (2.11 ml, 5.86 mmol, 2.8 M in hexane) was added dropwise to a solution of 
diisopropylamine (821 pi, 5.86 mmol), in THF (4 ml) that had been cooled to -45 °C and 
the solution was stirred for 30 min. Wang-supported 3-(4-hydroxy-phenoxy)dihydro-furan-
2-one 118 (1.22 mmol/g, 600 mg, 0.73 mmol) that had been pre-swollen in THF (10 ml) 
was then added dropwise by cannula to the LDA. After 30 min, benzyl bromide (697 pi, 
5.86 mmol) was added dropwise to the solution and the reaction mixture was allowed to 
warm slowly to -20 °C and stirred for a further 1.5 h. The reaction mixture was first 
quenched with H2 O ( 2 0  ml), before being filtered, washed and dried according to the 
standard washing procedure to give Wang-supported 3-benzyl-3-(4-hydroxy- 
phenoxy)dihydro-furan-2-one 127.
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vmax KBr/cm'1 3023 m, 2920 m, 1783 s (C=0), 1599 s, 1493 m, 1221 (C-O).
3-BenzyIdihydro-2(3//)-furanone 121 cleaved from Wang-supported 3-benzyl-3-(4- 
hydroxy-phenoxy)dihydro-furan-2-one 127
O
121
A solution of MeOH (5.42 ml) and Sml2 (15.7 ml, 1.57 mmol, 0.1 M in THF) was added to 
a solution of Wang-supported 3-benzyl-3-(4-hydroxy-phenoxy)dihydro-furan-2-one 127 
(1.09 mmol/g, 600 mg, 0.65 mmol) in THF (6.00 ml) and the reaction mixture was stirred 
slowly at room temperature for 1 h. A further 2.4 equivalents o f SmH (15.7 ml, 1.57 mmol, 
0.1 M in THF) were then added and the reaction mixture was stirred for a further 2 h. The 
resin was drained, washed with THF (3 x 100 ml) and then concentrated. The crude 
mixture was purified by column chromatography (silica, 100 % CH2CI2) to give 3- 
benzyldihydro-2(3/7)-furanone 121 as a yellow oil (6 mg, 0.03 mmol, 5 % over 5 steps). 
Spectroscopic data corresponded to that reported earlier in this section.
3-(4-Hydroxyphenoxy)dihydro-furan-2-one 128 and 3-benzyl-3-(4-hydroxyphenoxy) 
dihydro-furan-2-one 129
128 129
Wang-supported 3-benzyl-3-(4-hydroxy-phenoxy)dihydro-furan-2-one 127 (1.09 mmol/g, 
600 mg, 0.65 mmol) was swollen in CH2CI2 (6 ml) for 20 min. TFA (6 ml) was then added 
and the mixture was stirred slowly at room temperature for 24 h. The suspension was then 
filtered and the resin washed with CH2CI2 (3 x 20 ml) and the washings were collected and
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concentrated. The crude product was purified by column chromatography (silica, 60 % 
EtOAc/pet. ether) to give a mixture of 3-(4-hydroxyphenoxy)dihydro-furan-2-one 128 as a 
light brown oil (23 mg, 0.03 mmol, 5 %) and 3-benzyl-3-(4-hydroxyphenoxy)dihydro- 
furan-2-one 129 as a brown solid (48 mg, 0.12 mmol, 18 %).
For 128: 5H (400 MHz, CDC13) 2.46 (1H, apparent dq, J = 8.1, 13.2 Hz, C /^H BCHO), 
2.72-2.64 (1H, m, CH a^CH O ), 4.34 (1H, ddd, J = 6 .8 , 8.1, 15.2 Hz, C/frHB0), 4.52 (1H, 
ddd, J = 4.0, 8 .6 , 15.2 Hz, CUaHbO), 4.83 (1H, apparent t, J = 7.8 Hz, CHC=0), 7.01-6.76 
(4H, m, 4 x ArH).
For 129: 5H (400 MHz, CDC13) 2.25 (1H, ddd, J = 5.9, 7.9, 14.0 Hz, C/frHBCH20), 2.43 
(1H, ddd, J = 6.0, 7.9, 14.0 Hz, CHA// 5 CH20), 3.21 (1H, d, J = 13.6 Hz, Ph CHAHB), 3.30 
(1H, d, J = 13.6 Hz, Ph CHAHB\  3.78 (1H, dt, J = 6.0, 8.5 Hz, CHaUbO), 4.08 (1H, dt, J = 
5.9, 8.5 Hz, CUaHbO), 4.99 (1H, br s, OH), 6.75 (2H, d, J = 8.9 Hz, 2 x ArH), 6.92 (2H, d, 
J = 8.9 Hz, 2 x ArH), 7.35-7.29 (5H, m, 2 x ArH).
4-Tritylsulfanyl phenol 13399
133
Trityl chloride (4.42 g, 15.9 mmol) was added to a solution of 4-mercaptophenol 132 (2.00 
g, 15.9 mmol) and pyridine (1.28 ml, 15.9 mmol) in CH2 CI2 (10 ml) and the reaction 
mixture was stirred at room temperature for 4 h. The crude mixture concentrated then 
purified by column chromatography (60 % EtOAc/pet. ether) to give 4-tritylsulfanyl phenol 
133 as a white solid (14.2 g, 15.6 mmol, 98 %).
]H NMR: 5h (400 MHz, CDC13) 4.72 (1H, br, OH), 6.50 (2H, d, J = 8.4 Hz, 2 x ArH), 6.87 
(2H, d, J = 8.4 Hz, 2 x ArH), 7.28-7.18 (9H, m, 9 x ArH), 7.44-7.42 (6 H, m, 6  x ArH).
132
l-BenzyIoxy-4-tritylsulfanyl-benzene 134
134
Sodium hydride (548 mg, 22.8 mmol) was added to a solution of 4-tritylsulfanyl phenol 
133 (4.21 g, 11.4 mmol) in THF (30 ml) that had been cooled to 0 °C. TBAI (84.0 mg, 0.23 
mmol) and benzyl bromide (2.72 ml, 22.8 mmol) were then added and the reaction mixture 
was stirred at room temperature for 2 h. The reaction mixture was quenched with aqueous 
saturated N H 4 C I  (5 ml), then H2O (10 ml), the organic layer was then extracted with 30 % 
EtOAc/pet. ether (3 x 10 ml), dried (MgS0 4 ) and concentrated. The crude mixture was 
purified by recrystalisation from pet. ether/C^Ch to give l-benzyloxy-4-tritylsulfanyl- 
benzene 134 as a white solid (4.43 g, 9.69 mmol, 85 %).
‘H NMR: SH (400 MHz, CDCI3) 4.99 (2H, s, CH2), 6.62 (2H, d, J = 8.9 Hz, 2 x ArH), 6.90 
(2H, d, J = 8.9 Hz, 2 x ArH), 7.43-7.18 (20H, m, 20 x ArH).
13C NMR: 5c (100 MHz, CDCI3) 69.8 (CH2), 70.8 (CPh3), 114.6 (2 x ArCH), 124.6 (ArC),
126.5 (3 x ArCH), 127.4 (2 x ArCH), 127.5 (ArCH), 127.9 ( 6  x ArCH), 128.0 (ArCH),
130.0 (ArCH), 132.5 ( 6  x ArCH), 136.6 (3 x ArC), 137.7 (2 x ArCH), 144.7 (ArCO),
159.2 (ArCS).
vmax KBr/cm ' 1 3450 br, 3054 s, 1589 m, 1491 m,1250 m, 1026 m, 831 s, 700 s.
MP: 129.5-132.6 °C.
4-Benzyloxy-benzenethiol 135
135
TFA (1 ml) was added to a solution of l-benzyloxy-4-tritylsulfanyl-benzene 134 (190 mg, 
0.41 mmol) and triethylsilane (132 pi, 0.83 mmol) in CH2CI2 (1 ml) and the reaction
133
mixture was stirred at room temperature for 1 h. The reaction mixture was quenched with 
aqueous saturated NH4CI (2 ml), then H20  (5 ml), the organic layer was then extracted with 
30 % EtOAc/pet. ether ( 3 x 5  ml). The organic layers were then dried (MgS0 4 ) and 
concentrated. The crude mixture was purified by column chromatography (silica, 5 % 
EtOAc/pet. ether) to give 4-benzyloxy-benzenethiol 135 as a yellow oil (60.0 mg, 0.27 
mmol, 67 %).
'H NMR: 8 h (400 MHz, CDC13) 4.96 (2H, s, CH2), 6.80 (2H, d, J = 9.8, 2 x ArH), 7.27- 
7.14 (5H, m, 5  x ArH), 7.35-7.29 (2H, m, 2  x ArH).
13C NMR: 8 c (100 MHz, CDCI3) 70.1 (CH2), 115.7 (2 x ArCH), 132.3 (2 x ArCH), 128.0 
(ArCH), 128.3 (2 x ArCH), 128.6 (2 x ArCH), 133.9 (ArC), 136.7 (ArCO), 157.7 (ArCS). 
vmax KBr/cm' 1 3345 br, 2557 s (S-H), 1222 m, 819 m.
3-(4-Benzyloxy-benzenesulfanyl)dihydro-furaii-2-one 136
BnO.
136
a-Bromo-y-butyrolactone (87.0 pi, 0.94 mmol) was added to a solution of 4-benzyloxy- 
benzenethiol 135 (51.0 mg, 0.24 mmol) and NEt3 (99.0 pi, 0.71 mmol) in DMF (2 ml), and 
the reaction mixture was stirred at room temperature for 1.5 h. The reaction mixture was 
quenched with H20  (2 ml) and the aqueous layer was extracted with 30 % EtOAc/pet. ether 
( 3 x 5  ml). The organic layer was then dried (MgS0 4 ) and concentrated. The crude mixture 
was purified by kugelrohr distillation to remove excess a-bromo-y-butyrolactone and gave 
3-(4-benzyloxy-benzenesulfanyl)dihydro-furan-2-one 136 as a clear oil (47.0 mg, 0.16 
mmol, 6 6  %).
NMR: 5h (400 MHz, CDC13) 2.30-2.22 (1H, m, C7^HBCH2 0), 2.68-2.59 (1H, m, 
CUaHbCH20 ), 3.72 (1H, dd, J = 5.9, 8.7 Hz, CH), 4.26-4.11 (2H, m, CU2CH20), 5.07 (2H, 
s, PhCH2 0), 6.96 (2H, d, J = 8 . 8  Hz, 2 x ArH), 7.44-7.29 (5H, m, 5  x ArH), 7.53 (2H, d, J 
= 8 . 8  Hz, 2 x ArH).
134
13C NMR: 5C (100 MHz, CDC13) 29.5 (CH2CH20), 45.0 (CH), 66.4 (CH2 CH20), 70.1
(PhCH20), 115.7 (2 x ArCH), 121.8 (ArC), 127.5 (2 x ArCH), 128.1 (2 x ArCH), 128.6
(ArCH), 136.4 (ArCO), 136.9 (2 x ArCH), 159.9 (ArCS), 175.1 (C=0). 
vmax KBr/cm ' 1 3462 br, 1781 s (C=0), 1220 m, 830 m.
MS (El): m/z 300 (M+, 50 %), 91 (Bn+, 100 %).
HRMS: Found 300.0821, C17H 16O3S, requires 300.0820.
MP: 85.9 -  87.1 °C.
3-(4-Benzyloxy-benzenesulfonyl)dihydro-furan-2-one 137
137
mCPBA (1.15 g, 6 . 6 6  mmol) was added to a solution of 3-(4-benzyloxy- 
benzenesulfanyl)dihydro-furan-2-one 136 (500 mg, 1.67 mmol) in CH2 C12 (15 ml) and the 
reaction mixture was stirred at room temperature for 1.5 h. The reaction mixture was 
quenched with aqueous saturated NaHCC>3 (5 ml), and then H20  (5 ml) and the aqueous 
layer was then washed with CH2C12 (3 x 10 ml). The organic layers were then dried 
(MgSO^, and concentrated. The crude mixture was purified by column chromatography 
(silica, 40 % EtOAc/pet. ether) to give 3-(4-benzyloxy-benzenesulfonyl)dihydro-furan-2- 
one 137 as a white solid (511 mg, 1.54 mmol, 92 %).
'H NMR: 8 h (400 MHz, CDC13) 2.79-2.68 (1H, m, C% H BCH20), 3.08-3.00 (1H, m, 
CHaHbCH20), 4.01 (1H, dd, J = 4.3, 10.0, Hz, CH), 4.39 (1H, dt, J = 4.0, 8.3 Hz, 
C% HbO), 4.50 (1H, apparent q, J = 8.3 Hz, CHAHaO), 5.16 (2H, s, PhCH2 0), 7.05 (2H, d, 
J = 9.0 Hz, 2 x ArH), 7.45-7.35 (5H, m, 5 x ArH), 7.88 (2H, d, J = 9.0 Hz, 2  x ArH).
13C NMR: 8 c (100 MHz, CDC13) 24.1 (CH2CH20), 63.7 (CH), 67.1 (CH20), 70.5 
(PhCH20), 115.3 (2 x ArCH), 127.6 (2 x ArCH), 128.1 (ArC), 128.5 (2 x ArCH), 128.8 
(ArCH), 131.7 (2 x ArCH), 163.8 (ArCS), 165.5 (ArCO), 168.5 (C=0). 
vmax KBr/cm" 1 3442 br, 1764 m (C=0), 1591 s, 1497 s, 831 m.
135
MS (El): m/z 332 (M+, 6  %), 91 (Bn+, 100 %).
HRMS: Found 332.0720, Ci7H 160 5S, requires 332.0718. 
MP: 110.4-112.5 °C.
3-(4-Benzyloxy-benzenesulfinyl)dihydro-furan-2-one 138
138
H2O2 (46.0 pi, 0.41 mmol) was added to a solution of the 3-(4-benzyloxy- 
benzenesulfanyl)dihydro-furan-2 -one 136 (30.0 mg, 0 . 1 0  mmol) in CH2CI2 (1 ml) and 
HFIP (0.5 ml) and the reaction mixture was stirred at room temperature for 18 h. The 
reaction mixture was quenched with H2 O ( 2  ml) and the organic layer was then extracted 
with CH2 CI2 ( 3 x 5  ml). The organic layers were then dried (MgSCT*) and concentrated. The 
crude mixture was purified by column chromatography (silica, 50 % EtOAc/pet. ether) to 
give 3-(4-benzyloxy-benzenesulfinyl)dihydro-furan-2-one 138 as a white solid (22.0 mg, 
0.07 mmol, 70 %).
Approx. 1:1 mixture of diastereoisomers; !H NMR: Sh (400 MHz, C D C I 3 )  2.18-2.02 (1H, 
m, C/frHBCH20 , one diastereoisomer), 2.60-2.50 ( 1 H, m, C /^H bC ^O , one 
diastereoisomer), 2.74-2.66 (1H, m, CHaT/aCTEO, one diastereoisomer), 2.90-2.81 (1H, m, 
CHAT/flCH2 0 , one diastereoisomer), 3.44 (1H, apparent q, J = 8.4 Hz, CH, one 
diastereoisomer), 3.64 (1H, dd, J = 7.2, 9.6 Hz, CH, one diastereoisomer), 4.13 (1H, dd, J = 
38, 10.0 Hz, C^CT^HbO, one diastereoisomer), 4.20 (1H, dt, J = 3.8, 9.6 Hz, 
Q^CHaT/sO, one diastereoisomer), 4.32 (1H, dd, J = 8 .8 , 15.3 Hz, CRiCHaRqO, one 
diastereoisomer), 4.43 (1H, dt, J = 5.3, 8 . 8  Hz, C^CHa/Z^O, one diastereoisomer), 5.12 
(4H, s, PI1CH2 , both diastereoisomers), 7.14 (4H, d, J = 8.7 Hz, 4 x ArH, both 
dastereoisomers), 7.43-7.36 (10H, m, 1 0  x ArH, both diastereoisomers), 7.61 (4H, d, J = 
92 Hz, 4 x ArH, both diastereoisomers).
136
I3C NMR: 5 h  (100 MHz, CDC13) 18.9 (CH2CH20 , one diastereoisomer), 20.8 (CH2CH20 , 
one diastereoisomer), 62.3 (CH, one diastereoisomer), 63.9 (CH, one diastereoisomer),
67.5 (CH2CH2O, one diastereoisomer), 67.6 (CH2 CH2O, one diastereoisomer), 70.3 (2 x 
PhCH2 0 , both diastereoisomers), 115.8 (2 x ArCH, one diastereoisomer), 115.9 (2 x 
ArCH, one diastereoisomer), 125.8 (4 x ArCH both diastereoisomers), 127.5 (4 x ArCH 
both diastereoisomers), 127.6 (2 x ArCH both diastereoisomers), 128.7 (4 x ArCH both 
diastereoisomers), 129.6 (2 x ArC, both diastereoisomers), 135.9 (ArCO, one 
diastereoisomer), 135.9 (ArCO, one diastereoisomer), 161.6 (ArCS, one diastereoisomer),
162.1 (ArCS, one diastereoisomer), 170.4 (C=0, one diastereoisomer), 171.7 (C=0, one 
diastereoisomer).
vmax KBr/cm" 1 3446 br, 1770 m (C=0), 1592 s, 1497 s, 1242 m, 835 m.
MS (El): m/z 316 (M+, 1 %), 91 (Bn+, 100 %).
HRMS: Found 316.0770, Ci7Hi60 4 S, requires 316.0769.
MP: 106.1 -  108.7 °C.
3-BenzyI-3-(4-benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139
139
3-(4-Benzyloxy-benzenesulfonyl)dihydro-furan-2-one 137 (100 mg, 0.30 mmol) was added 
to a solution of NaH (14.0 mg, 0.60 mmol) in DMF (2 ml) that had been cooled to 0 °C, 
and the reaction mixture was stirred for 15 min. Benzyl bromide (72.0 pi, 0.60 mmol) was 
then added dropwise and the reaction mixture was stirred at room temperature for 3 h. The 
reaction mixture was quenched with acetic acid (1 ml), then H2O (3 ml), and then extracted 
with Et2 0  ( 3 x 5  ml). The organic layers were then combined, dried (MgS0 4 ) and 
concentrated. The crude mixture was purified by column chromatography (silica, 20 % 
EtOAc/pet. ether) to give 3-benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro-furan-2-one 
139 as a white solid (122 mg, 0.29 mmol, 96 %).
137
'H NMR: 6 h (400 MHz, CDC13) 2.36 (1H, dd, J = 8.0, 9.0, Hz, C i^H BCH20), 3.02-2.95 
(1H, m, CHa/ / sCH20), 3.02 (1H, d, AB system, J = 13.1 Hz, CCH2Ph), 3.18 (1H, d, AB 
system, J = 13.1 Hz, CCH2Ph), 3.61 (1H, dt, J = 3.9, 9.0 Hz, CH2 C /^H B0), 4.21 (1H, m, 
CH2CHa//£0), 5.09 (2H, s, PhCH2 0), 7.04-7.01 (2H, m, 2 x ArH), 7.09-7.05 (2H, m, 2  x 
ArH), 7.38-7.17 (8 H, m, 8  x ArH), 7.84-7.80 (2H, m, 2 x ArH).
13C NMR: 5c (100 MHz, CDCI3) 25.9 (CH2CH2 0), 37.6 (CCH2Ph), 65.9 (CH2 CH20), 70.5 
(PhCH20), 72.6 (CC=0), 115.0 (2 x ArCH), 125.6 (ArCS), 127.6 (2 x ArCH), 127.9 
(ArCH), 128.5 (2 x ArCH), 128.8 (2 x ArCH), 129.0 (2 x ArCH), 130.2 (2 x ArCH), 133.3 
(ArCH), 135.5 (2 x ArC), 163.9 (ArCO), 172.0 (C=0).
vmax KBr/cm ' 1 3435 br, 1761 m (C=0), 1591 m, 1319 s (S02), 1261 m, 1140 m (S02), 831 
s, 704 s.
MS (El): m/z 422 (M+, 3 %), 91 (Bn+, 100 %).
HRMS: Found 422.1187, C24H2 2O5S, requires 422.1188.
MP: 154.2- 157.1 °C.
3-Benzyldihydro-2(3//)-furanone 121 from 3-benzyl-3-(4-benzyloxy-
benzenesulfonyl)dihydro-furan-2-one 139
O
121
A solution of Sml2 (3.90 ml, 0.39 mmol, 0.1 M in THF), was added to a solution of 3- 
benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 (69.0 mg, 0.16 mmol) in 
MeOH (1.1 ml) and THF (0.5 ml) that had been cooled to 0 °C. The mixture was then 
allowed to warm to room temperature and stirred for 1 h. The reaction mixture was 
quenched first with aqueous saturated N H 4 C I  (2 ml) followed by H2 O (2 ml) and the 
aqueous layer extracted with 40 % EtOAc/pet. ether (3 x 10 ml). The organic layer was 
then dried (MgS0 4 ), and concentrated. The crude mixture was purified by column
138
chromatography (silica, 20 % EtOAc/pet. ether) to give 3-benzyldihydro-2(3//)-furanone 
121 as a yellow oil (15 mg, 0.08 mmol, 52 %).
Spectroscopic data corresponded to that reported earlier in this section.
Wang-supported protected thiol 142
142
Bromo-Wang resin 125 (2.00 g, 1.40 mmol/g, 2.80 mmol) was swollen in DMF (25 ml) for 
20 min. 4-Tritylsulfanyl phenol 133 (5.16 g, 14.0 mmol) was then added followed by NaH 
(336 mg, 14.0 mmol) and the reaction mixture was stirred at room temperature. After 24 h, 
the resin was filtered, washed and dried according to the standard washing procedure to 
give Wang-supported protected thiol 142.
vmax KBr/cm' 1 3442 br, 2922 br, 1589 m, 1491 s, 1223 m, 1005 br, 822 m.
Wang-supported thiol 141
141
Wang-supported protected thiol 142 (1.90 g, 1.00 mmol/g, 1.90 mmol) was swollen in 
CH2CI2 (10 ml) for 20 min. Then triethylsilane (1 ml) and TFA (9 ml) were added and the 
leaction mixture was stirred at room temperature. After 1 h, the resin was filtered, washed 
aid dried according to the standard washing procedure to give Wang-supported thiol 141. 
w  KBr/cm ' 1 3529 br, 2922 br, 2599 s (S-H), 1599 br, 1493 s, 1221 m, 1014 s, 822 m, 758 
n.
139
Wang-supported lactone 143
143
Wang-supported thiol 141 (1.90 g, 1.32 mmol/g, 2.51 mmol) was swollen in DMF (20 ml) 
for 20 min. a-Bromo-y-butyrolactone (3.71 ml, 40.1 mmol) was added to the solution, 
followed by NEt3 (3.52 ml, 25.1 mmol) and the reaction mixture was heated to 60 °C. After 
24 h, the resin was filtered, washed and dried according to the standard washing procedure 
to give Wang-supported lactone 143.
vmax KBr/cm ' 1 3417 br, 2920 br, 1787 br (C=0), 1601 m, 1493 s, 1223 br, 824 m, 758 m. 
Wang-supported sulfone 144
144
Wang-supported lactone 143 (2.00 g, 1.19 mmol/g, 2.38 mmol) was swollen in CH2CI2 (20 
ml) for 20 min. mCPBA (1.64 g, 9.52 mmol) was added and the solution was stirred at 
room temperature. After 17 h, the resin was filtered, washed and dried according to the 
standard washing procedure to give Wang-supported sulfone 144.
Vmax KBr/cm-' 3435 br, 3024 m, 2922 s, 1788 s (C=0), 1603 m, 1452 s, 1146 w (S02), 758 
m.
140
Wang-supported benzylated sulfone 145
145
NaH (166 mg, 6.90 mmol) was added dropwise via cannula to a solution of Wang- 
supported sulfone 144 (600 mg, 1.15 mmol/g, 0.69 mmol) that had been pre-swollen in 
DMF ( 6  ml) for 20 min, at 0 °C. After 1 h, benzyl bromide (821 pi, 6.90 mmol) was added 
dropwise and the mixture was allowed to warm to room temperature. After 24 h, the resin 
was filtered, washed and dried according to the standard washing procedure to give resin 
145.
vmax KBr/cm' 1 3433 br, 3025 w, 2922 m, 1788 m (C=0), 1493 m, 1320 w (SO2), 1148 w 
(S02), 699 s.
2-(4-Benzyloxyphenoxy)-2-(2-hydroxyethyl)-pent-4-enoic acid-/V-allyl-/V-methyl amide 
153
AlMe3 (1.69 ml, 3.39 mmol, 2.0 M in hexane) was added to a solution of N- 
methylallylamine (1.30 ml, 13.5 mmol) in toluene (2.5 ml) at room temperature and the 
mixture was stirred for 20 min. A solution of 3-allyl-3-(4-benzyloxyphenoxy)dihydro- 
furan-2-one 120 (366 mg, 1.13 mmol) in toluene (10 ml) was then added dropwise via 
cannula and the reaction mixture was stirred for 24 h. The reaction mixture was quenched 
with HC1 (2 ml, 1.0 M) then H2 O (5 ml) dropwise before being extracted with CH2CI2 (3 x
141
20 ml). The organic layers were then dried (MgSCU), and concentrated. The crude mixture 
was purified by column chromatography (silica, 40 % EtOAc/pet. ether) to give the 2-(4- 
benzyloxyphenoxy)-2-(2-hydroxyethyl)-pent-4-enoic acid-TV-allyl-TV-methyl amide 153 as a 
clear oil (343 mg, 0.87 mmol, 77 %).
Approx 3:1 mixture of rotamers; !H NMR: 8 h (400 MHz, C D C I 3 )  1.58 (2H, br, CH2 O#, 
both rotamers), 2.21 (2H, dt, J = 5.6, 14.7 Hz, C i^H BCH2 OH, both rotamers), 2.41-2.31 
(2H, m, CHa//sCH2 0 H, both rotamers), 2.87-2.79 (4H, m, CC//2CH=CH2 , both rotamers), 
2.91 (3H, s, NMe, one rotamer), 3.19 (3H, s, NMe, one rotamer), 3.80-3.71 (4H, m, 
C7 / 2OH, both rotamers), 4.01 (2H, d, J = 4.8 Hz, NC/Z^Hb, one rotamer), 4.39 (2H, d, J = 
5.3 Hz, NCHaHb> one rotamer), 5.01 (4H, s, PhCH20 , both rotamers), 5.20-5.10 (8 H, m, 
CCH2CH=CZZ2, NCH2CH=CZZ2, both rotamers), 5.57-5.48 (2H, m, CCH2CZZ=CH2, both 
rotamers), 5.75-5.70 (2H, m, NCH2CZZ=CH2, both rotamers), 6.78 (4H, dd, J = 7.8, 9.0 Hz, 
4 x ArH, both rotamers), 6.89-6.84 (4H, m, 4 x ArH, both rotamers), 7.44-7.32 (10H, m, 10 
x ArH, both rotamers).
Approx 3:1 mixture of rotamers; 13C NMR: 5c (100 MHz, CDCI3) 34.8 (NMe, one 
rotamer), 35.0 (NMe, one rotamer), 37.3 (CH2CH2OH, one rotamer), 37.2 (CH2CH2OH, 
one rotamer), 38.4 (CH2 CH=CH2 , one rotamer), 38.7 (CH2CH=CH2 , one rotamer), 52.1 
(NCH2, one rotamer), 52.6 (NCH2, one rotamer), 58.3 (2 x CH2 OH, both rotamers), 70.5 ( 2  
x PhCH2 0 , both rotamers), 84.2 (2 x CC=0, both rotamers), 115.7 (4 x ArCH, both 
rotamers), 118.1 (2 x CR2=CH, both rotamers), 118.4 (4 x ArCH, both rotamers), 118.9 (4 
x ArCH, both rotamers), 119.2 (2 x CH2=CH, both rotamers), 127.5 (2 x ArCH, both 
rotamers), 128.6 (4 x ArCH, both rotamers), 132.1 (2 x NCH2CH=CH2 , both rotamers),
132.2 (2 x CCH2CH=CH2 , both rotamers), 137.0 (2 x ArC, both rotamers), 148.5 (2 x 
ArCO, both rotamers), 153.8 (2 x ArCO, both rotamers), 172.9 (2 x C=0, both rotamers). 
vmax KBr/ cm' 1 3454 br, 1620 s (tertiary amide), 1506 s, 1207 s, 1080 m, 829 m, 700 s.
MS (El): m/z 395 (M+, 22 %), 196, 166, 91 (Bn+, 100 %).
HRMS: Found 395.2097, C 2 4 H 2 9 O 4 N ,  requires 395.2097.
142
3-(4-BenzyIoxyphenoxy)-3-(2-hydroxyethyl)-l-methyl-l,3»4,7-tetrahydro-azepin-2-one
154
BnO.
HO
154
Grubbs 1st generation catalyst ((PCy3)2Cl2Ru=CHPh, 31 mg, 0.04 mmol) was added to a 
solution of 2-(4-benzyloxyphenoxy)-2-(2-hydroxyethyl)-pent-4-enoic acid-A-allyl-A- 
methyl amide 153 (151 mg, 0.38 mmol) in CH2CI2 (5 ml) at room temperature and the 
solution was heated at reflux for 48 h. The reaction mixture was purified by filtration 
(silica, 60 % EtOAc/pet. ether) and concentrated. The reaction mixture was further 
purified by column chromatography (silica, 60 % EtOAc/pet. ether) to give 3-(4- 
benzyloxyphenoxy)-3-(2-hydroxyethyl)-l-methyl-l,3,4,7-tetrahydro-azepin-2-one 154 as a 
brown oil ( 8 6  mg, 0.24 mmol, 62 %).
*H NMR: 8 h (400 MHz, CDC13) 2.02-1.96 (1H, m, C /^H BCH=CH ), 2.60-2.52 (1H, m, 
CHa// 5 CH=CH), 2.67-2.63 (2H, m, CH2CU20), 3.10 (3H, s, NMe), 3.30 (1H, dd, J = 7.4,
17.4 Hz, CJfcHsN), 3.81-3.71 (2H, m, CH2OH), 4.01 (1H, br s, OH), 4.66-4.68 (1H, m, 
CUaHbN), 4.93 (2H, s, PhCH20 ) 5.74-5.68 (1H, m, Ci/=CH), 5.87-5.81 (1H, m, CH=CH), 
6.70-6.81 (4H, m, 4 x ArH), 7.44-7.32 (5H, m, 5 x ArH).
13C NMR: 8 C (100 MHz, CDC13) 35.2 (CH2CH2OH), 38.6 (NMe), 38.8 (CCH2CH=CH),
49.1 (NCH2), 58.0 (CH2OH), 70.5 (PhCH20), 83.7 (ArC), 115.7 (2 x ArCH), 119.4 
(CH=CH), 124.6 (2 x ArCH), 127.1 (ArCH), 127.5 (2 x ArCH), 127.9 (CH=CH), 128.6 
(2 x ArCH), 137 (OCC=0), 148.3 (ArCO), 154.2 (ArCO), 173.7 (C=0). 
vmax KBr/ cm' 1 3433 br, 2927 br, 1627 m (tertiary amide), 1504 s, 1207 m, 735 s.
MS (El): m/z 367 (M+, 49 %), 200, 168, 150, 138, 91 (Bn+, 100 %).
HRMS: Found 367.1782, C 2 2 H 2 5 O 4 N ,  requires 367.1784.
143
2-(4-Benzyloxyphenoxy)-2-[2-(te/*/-butyldiphenyIsilanyIoxy)ethyl]-pent-4-enoic acid-A-
allyk/V-methyl-amide 156
BnO
TBDPSO'
N'
156
TBDPSC1 (132 pi, 0.51 mmol) and imidazole (69.0 mg, 1.01 mmol) were added to a 
solution of 2-(4-benzyloxyphenoxy)-2-(2-hydroxyethyl)-pent-4-enoic acid-A-allyl-vV- 
methyl amide 153 (100 mg, 0.25 mmol) in DMF (1 ml) and the reaction mixture was 
allowed to stir at room temperature for 3 h. The reaction mixture was quenched first with 
aqueous saturated NH4CI (2 ml), then H2O (2 ml), the organic layer was then extracted with 
30 % EtOAc/pet. ether (3 x 10 ml). The organic layers were then dried (MgS0 4 ) and 
concentrated. The crude mixture was purified by column chromatography (silica, 40 % 
EtOAc/pet. ether) to give 2-(4-benzyloxyphenoxy)-2-[2-(tert-butyldiphenylsilanyloxy) 
ethyl]-pent-4-enoic acid-A-allyl-A-methyl-amide 156 as a clear oil (114 mg, 0.18 mmol, 71 
%).
Approx 3:1 mixture of rotamers; NMR: 6 r  (400 MHz, C D C I 3 )  1.02 (18H, s, 2 x 
C(CH3)3 , both rotamers), 2.38-2.30 (2H, m, 2 x CT/^HBC^OSi, both rotamers), 2.48-2.46 
(2H, m, 2 x CHA/ZflCTbOSi, both rotamers), 2.69 (2H, dd, J = 8.1, 14.9 Hz, 2 x 
CC/^HbCH=CH2 , both rotamers), 2.83 (3H, s, NMe, one rotamer), 2.95-2.91 (2H, m, 2 x 
CCHa7 /5 CH=CH2 , both rotamers), 3.07 (3H, s, NMe, one rotamer), 3.77 (4H, t, J = 7.1 Hz, 
2 x CH2 0 Si, both rotamers), 3.84 (2H, AB system, J = 6.3, 14.5 Hz, NCT/^Hb, both 
rotamers), 4.01 (2H, AB system, J = 6.3, 14.5 Hz, NCHaF/a, both rotamers), 4.99 (4H, s, 2 
x PhCH20 , both rotamers), 5.12-5.92 (8 H, m, 2 x CCH2CH=C/72, 2 x NCH2 CH=C//2, both 
rotamers), 5.48-5.37 (2H, m, 2 x CCH2 C//=CH2 , both rotamers), 5.70-5.62 (2H, m, 2 x 
NCH2 C7 /=CH2 , both rotamers), 6.74-6.70 (4H, m, 4 x ArH, both rotamers), 6.82-6.79 (4H,
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m, 2  x ArH, both rotamers), 7.44-7.31 (20H, m, 20 x ArH, both rotamers), 7.67-7.61 (8 H, 
m, 8  x ArH, both rotamers), 7.74-7.72 (2H, m, 2 x ArH, both rotamers).
Approx 3:1 mixture of rotamers; 13C NMR: 5c (100 MHz, CDCI3) 19.1 (2 x C(CH3)3, both 
rotamers), 26.6 (3 x C(CH3)3 , one rotamer), 26.8 (3 x C(CH3)3 , one rotamer), 34.5 (NMe, 
one rotamer), 34.6 (NMe, one rotamer), 35.6 (CH2CH2 OH, one rotamer), 36.1 
(CH2 CH2OH, one rotamer), 37.7 (CH2CH=CH2, one rotamer), 37.8 (CH2CH=CH2, one 
rotamer), 51.6 (NCH2 , one rotamer), 52.3 (NCH2 , one rotamer), 59.6 ( 2  x CH2 0 Si, both 
rotamers), 70.5 (2 x PI1CH2O, both rotamers), 83.6 (2 x CC=0, both rotamers), 115.6 (4 x 
ArCH, both rotamers), 117.8 (2 x CCH2 CH=CH2 , both rotamers), 117.9 (4 x ArCH, both 
rotamers), 118.1 (2 x ArCH, both rotamers), 118.9 (2 x NCH2CH=CH2 , both rotamers),
127.5 (4 x ArCH, both rotamers), 127.6 (4 x ArCH, both rotamers), 127.7 (4 x ArCH, both 
rotamers), 127.9 (4 x ArCH, both rotamers), 128.6 (2 x ArCH, both rotamers), 129.5 (4 x 
ArCH, both rotamers), 129.7 (2 x ArCH, both rotamers), 132.3 (2 x CCH2CH=CH2 , both 
rotamers), 132.5 (2 x NCH2 CH=CH2 , both rotamers), 133.6 (2 x ArC, both rotamers),
134.8 (2 x ArC, both rotamers), 135.6 (4 x ArCH, both rotamers), 136.6 (2 x ArC, both 
rotamers), 149.3 (2 x ArCO, both rotamers), 153.6 (2 x ArCO, both rotamers), 173.1 (2 x 
C=0, both rotamers).
Vmax NaCl/ cm ' 1 3436 br, 1633 m (tertiary amide), 1504 s, 1207 m, 1111 s, 737 m, 702 m. 
MS (El): m/z 633 (M+, 3 %), 356, 135, 91 (Bn+, 100 %).
HRMS: Found 633.3270, C ^ H ^ N S i ,  requires 633.3274.
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3-(4-Benzyloxyphenoxy)-3-[2-(tert-butyldiphenyIsilanyloxy)ethyl]-l-methyl-l,3,4,7-
tetrahydro-azepin-2-one 157
BnO.
TBDPSO
157
Grubbs 1st generation catalyst ((PCy3)2Cl2Ru=CHPh, 27.0 mg, 0.03 mmol) was added to a 
solution of 2-(4-benzyloxyphenoxy)-2- [2-(tert-butyldiphenylsilanyloxy)ethyl]-pent-4-enoic 
acid allyl-methyl-amide 156 (104 mg, 0.16 mmol) in CH2CI2 (3.5 ml) at room temperature 
and the solution was heated at reflux for 24 h. The reaction mixture was purified by column 
chromatography (silica, 15 % EtOAc/pet. ether) to give 3-(4-benzyloxyphenoxy)-3-[2- 
(tert-butyldiphenylsilanyloxy)ethyl]-l-methyl-1,3,4,7-tetrahydro-azepin-2-one 157 as a 
dark grey oil (83 mg, 0.13 mmol, 84 %).
]H NMR: 5h (400 MHz, CDC13) 1.00 (9H, s, C(CH3)3), 2.34-2.27 (1H, m, CHAHBCH), 
2.44-2.38 (1H, m, C/^HbCHzO), 2.68-2.61 (1H, m, CHA/feCH), 2.96-2.91 (1H, m, 
CHa// 5 CH2 0 ), 3.03 (3H, s, NMe), 3.13 ( 1 H, dd, J = 7.5, 17.3 Hz, C/frHaN), 3.69-3.64 
(1H, m, CH2C /^H bO), 3.87-3.81 (1H, m, CH2CHa//5 0), 4.37 (1H, dt, J = 2.8, 17.3 Hz, 
CHa/^N), 5.06 (2H, s, PhCH20), 5.63-5.59 (1H, m, C//=CH), 5.80-5.75 (1H, m, 
CH=CH), 6.76 (2H, d, J = 9.3 Hz, 2 x ArH), 6.81 (2H, d, J = 9.3 Hz, 2 x ArH), 7.45-7.30 
(11H, m, 11 x ArH), 7.57 (2H, d, J = 8.0 Hz, 2 x ArH), 7.64 (2H, d, J = 7.9 Hz, 2 x ArH). 
13C NMR: 6 C ( 1 0 0  MHz, CDCI3) 19.1 (C(CH3)3), 26.8 (3 x C(CH3)3), 36.4 (CH2 CH2 0 ),
36.5 (CCH2 CH), 38.3 (NMe), 48.6 (NCH2), 59.5 (CH2OSi), 70.5 (PhCH2 0), 82.3 (ArC),
115.6 (2 x ArCH), 117.8 (2 x ArCH), 124.4 (CH C H ), 127.5 (2 x ArCH), 127.5 (4 x 
ArCH), 127.6 (ArCH), 127.9 (CH=CH), 128.6 (4 x ArCH), 129.5 (2 x ArCH), 133.6 
(ArC), 133.9 (ArC), 135.6 (2 x ArCH), 137.2 (OCC=0), 149.0 (ArCO), 153.5 (ArCO),
172.9 (C=0).
vmax KBr/cm' 1 3450 br, 2929 m, 1643 s (tertiary amide), 1504 m, 1209 m 823 s.
MS (El): m/z 605 (M+, 11 %), 548,406, 328, 261, 197, 150, 91 (Bn+, 95 %).
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HRMS: Found 605.2962, C38H43N04Si, requires 605.2961.
3-[2-(ter/-ButyldiphenylsiIanyIoxy)ethyl]-l,3,4,7-tetrahydro-azepiii-2-oiie 158
TBDPSO
A solution of Sml2 (4.00 ml, 0.40 mmol, 0.1 M in THF) was added to a solution of 3-(4- 
benzyloxyphenoxy)-3-[2-(tert-butyldiphenylsilanyloxy)ethyl]-1 -methyl-1,3,4,7-tetrahydro- 
azepin-2-one 157 (82.0 mg, 0.14 mmol) and DMPU (261 pi, 2.16 mmol) in THF (1.1 ml) 
at room temperature and the reaction mixture was stirred for 12 h. The reaction mixture 
was quenched first with aqueous saturated NH4 C1 (2 ml) followed by H2 O (2 ml) and the 
aqueous layer was extracted with CH2CI2 (3 x 10 ml). The organic layer was then dried 
(Na2 S0 4), and concentrated. The crude mixture was purified by column chromatography 
(silica, 15 % EtOAc/pet. ether) to give 3-[2-(tert-butyldiphenylsilanyloxy)ethyl]-l,3,4,7- 
tetrahydro-azepin-2-one 158 as an orange oil (26.0 mg, 0.07 mmol, 47 %).
*H NMR: 5h (400 MHz, CDC13) 1.06 (9H, s, C(CH3)3), 1.58-1.54 (1H, m, CHAUBCU20% 
2.22-2.17 (3H, m, CHCH2CH, CUAHBCU20), 3.02 (3H, s, NMe), 3.18 (1H, dd, J = 7.5,
17.4 Hz, NC/^Hb), 3.43-3.42 (1H, m, CHC=0), 3.79-3.76 (2H, m, CH20), 4.45 (1H, d, J =
17.4 Hz, NCHaHb% 5.78-5.73 (2H, m, CH=CH), 7.42-7.38 (6 H, m, 6  x ArH), 7.67-7.64 
(4H, m, 4 x ArH).
13C NMR: 5c (100 MHz, CDC13) 19.3 (C(CH3)3), 26.9 (3 x C(CH3)3), 32.1 (CHCH2CH),
34.4 (CH2CH2 O), 35.9 (NMe), 36.3 (CH), 47.4 (CH2N), 61.8 (CH20), 124.1 (CH=CH),
127.6 (2 x ArCH), 129.5 (4 x ArCH), 131.7 (CH=CH), 133.9 (ArC), 134.0 (ArC), 135.5 (4 
x ArCH), 175.5 (C=0).
Vmax ATR/ cm ' 1 2929 w, 1643 s (tertiary amide), 1427 m, 1096 s, 814 m.
MS (Cl): m/z 408 ((M+H)+, 100 %), 350, 199.
HRMS: Found 408.2358, C2 5H34 0 2NSi, requires 408.2353.
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3-Allyl-3-(4-benzyIoxybenzenesulfonyl)dihydro-furan-2-oiie 159
159
Allyl bromide (82.0 pi, 0.95 mmol) was added to a solution of 3-(4- 
benzyloxybenzenesulfonyl)dihydro-furan-2-one 137 (79.0 mg, 0.24 mmol), K 2 C O 3  (165 
mg, 1.19 mmol) and KI (8.00 mg, 0.05 mmol) in DMF (1 ml). The reaction mixture was 
then heated to 60 °C for 3 h. The reaction mixture was quenched with aqueous saturated 
NH4CI (2 ml) followed by H2 O (2 ml) and then extracted with 40 % EtOAc/pet. ether (3 x 
10 ml). The organic layers were then dried (MgS0 4 ) and concentrated. The crude mixture 
was purified by column chromatography (silica, 30 % EtO Ac/pet. ether) to give 3-ally 1-3- 
(4-benzyloxy-benzenesulfonyl)dihydro-furan-2-one 159 as a white solid (63.0 mg, 0.17 
mmol, 71 %).
*H NMR: 8 h (400 MHz, CDC13) 2.65-2.57 (3H, m, CH2CH, C//„HBCH20), 3.09 (1H, ddd, 
J = 2.9, 7.9, 14.8 Hz, CHAHBCH20), 4.31 (1H, dt, J = 2.9, 8.9 Hz, CH2C ^ H bO), 4.47 (1H, 
dd, J = 8.9, 14.8 Hz, CH2CHA// 5 0), 5.16 (2H, s, PhCH2 0), 5.13 (1H, dd, J = 1.6, 15.7 Hz, 
CH=C/^Hb), 5.15 (1H, dd, J = 1.6, 10.3 Hz, CH=CHAHB), 5.60-5.50 (1H, m, CH2=CH), 
7.12 (2H, d, J = 9.0 Hz, 2 x ArH), 7.45-7.35 (5H, m, 5 x ArH), 7.83 (2H, d, J = 9.0 Hz, 2 x 
ArH).
13C NMR: 8 C (100 MHz, CDC13) 26.6 (CH2CH20), 36.5 (CH2CH), 66.3 (CH20), 70.5 
(PhCH20), 70.9 (ArC), 115.0 (2 x ArCH), 122.2 (CH2=CH), 125.4 (ArCS), 127.6 (2 x 
ArCH), 128.5 (2 x ArCH), 128.8 (CH2=CH), 129.7 (ArCH), 133.1 (2 x ArCH), 135.5 
(ArCO), 163.9 (CC=0), 171.6 (C=0).
vmax KBr/cm ' 1 3483 br, 2939 s, 1756 m (C=0), 1591 s, 1495 s, 1321 (S02), 1146 (S02), 
831 m.
MS (El): m/z 372 (M+, 6  %), 91 (Bn+, 95 %).
Acc. Mass: Found 372.1031, Csg^M IUSi requires 372.1031.
MP: 107.9-110.1 °C.
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3-(4-Hydroxybenzenesulfonyl)-3-alIyl-dihydrofuran-2(3H)-one 162
HO
162
TV-Methylallylamine (254 pi, 2.64 mmol) was added dropwise to a solution of 3-allyl-3-(4- 
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 159 (82.0 mg, 0.22 mmol) and AICI3 (176 
mg, 1.32 mmol) in CH2CI2 (3 ml) that had been cooled to 0 °C. The reaction mixture was 
then allowed to warm to room temperature and stirred for 6  h. The reaction mixture was 
quenched first with 1M HC1 (2 ml) and then H2O (2 ml), and the aqueous layer was then 
extracted with CH2 CI2 (3 x 10 ml). The organic layers were then dried (MgSCU) and 
concentrated. The crude mixture was purified by column chromatography (silica, 30 % 
EtOAc/pet. ether) to give 3-(4-hydroxybenzenesulfonyl)-3-allyl-dihydrofuran-2(3H)-one 
162 as a clear oil (43 mg, 0.15 mmol, 69 %).
‘H NMR: 8 h (400 MHz, CDCI3) 2.68-2.55 (3H, m, C //2 CH=CH2, C /^H BCH2 0), 3.10 (1H, 
ddd, J = 2.8, 7.9, 14.8 Hz, CHA//fiCH20), 4.36 (1H, dt, J = 2.8, 8 . 8  Hz, C/^HbO), 4.51 
(1 H, dd, J = 8 .8 , 17.1 Hz, CHAtfB0), 5.21 ( 1 H, dd, J = 1.3, 15.6 Hz, CH=Ctf,HB), 5.29 
(1H, dd, J = 1.3, 9.6 Hz, CH=CHA//B), 5.60-5.49 (1H, m, Ctf=CH2), 6.93 (2H, d, J = 8.5 
Hz, 2 x ArH), 7.72 (2H, d, J = 8.5 Hz, 2  x ArH).
3-Allyl-3-(4-benzyloxy-benzenesulfanyl)dihydro-furan-2-one 163
BnO
163
To a solution of diisopropylamine (196 pi, 1.40 mmol), in THF (1 ml) that had been cooled 
to -45 °C was added "BuLi (633 pi, 1.40 mmol, 2.21 M in hexane). The reaction mixture
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was then stirred for 30 min. A solution of 3-(4-benzyloxy-benzenesulfanyl)dihydro-furan- 
2-one 136 (300 mg, 1.00 mmol) in THF (4 ml) was then added dropwise by cannula and 
the reaction was stirred for a further 30 min. Finally allyl bromide (432 pi, 4.99 mmol) was 
added dropwise to the solution and the reaction mixture was stirred for 7 h. The reaction 
mixture was quenched first with aqueous saturated N H 4 C I  (5 ml) followed by H2O (5 ml) 
and the aqueous layer was extracted with 40 % EtO Ac/pet. ether ( 3 x 1 0  ml). The organic 
layer was then dried (MgS0 4 ), and concentrated. The crude mixture was purified by 
column chromatography (silica, 10 % EtO Ac/pet. ether) to give 3-Allyl-3-(4-benzyloxy- 
benzenesulfanyl)dihydro-furan-2-one 163 as a clear oil (271 mg, 0.80 mmol, 80 %).
*H NMR: 5h (400 MHz, CDC13) 2.21-2.15 (1H, m, C /^H BCH2 0), 2.57-2.47 (3H, m, 
CHA//fiCH20 , CH2CH), 4.27 (2H, apparent dd, J = 8.9, 10.4 Hz, CU2CH20), 5.08 (2H, s, 
PhCH20), 5.24-5.18 (2H, m, CH2=CU), 5.87-5.77 (1H, m, CH2=C//), 6.97 (2H, d, J = 8 . 8  
Hz, 2 x ArH), 7.46-7.34 (5H, m, 5  x ArH), 7.49 (2H, d, J = 8 . 8  Hz, 2 x ArH).
,3C NMR: 6 C (100 MHz, CDC13) 33.2 (CH2CH20), 39.2 (CH2CH), 52.8 (CC=0), 65.0 
(CH20), 70.1 (PhCH2 0), 115.4 (2 x ArCH), 119.9 (ArCS), 120.0 (CH2=CH), 127.6 (2 x 
ArCH), 128.2 (ArCH), 128.7 (CH2=CH), 132.2 (2 x ArCH), 136.4 (ArC), 138.9 (2 x 
ArCH), 160.5 (ArCO), 175.7 (C=0).
vmax ATR cm’ 1 2903 br, 2330 w, 1759 s (C=0), 1578 m, 996 m, 679 s.
MS (El): m/z 340 (M+, 36 %), 91 (Bn+, 100 %).
Acc. Mass: Found 340.1132, C2oH2o0 3 S, requires 340.1133.
MP: 87.8 -  89.9 °C.
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A-Allyl-2-bromo-A-iiiethyl-acetamide 168
O
Br- - Vs
168
To a solution of A-methylallylamine (675 |ji, 7.03 mmol) in CH2 CI2 (10 ml) that had been 
cooled to 0 °C was added NEt3 (1.19 ml, 8.44 mmol) and bromoacetylbromide (737 pi, 
8.44 mmol). The reaction mixture was allowed to warm to room temperature and stirred for 
2 h. The reaction mixture was quenched with aqueous saturated N H 4 C I  (5 ml), then H 2 O  (5 
ml) and then extracted with C H 2 C I 2  ( 3 x 1 0  ml). The organic layers were then combined, 
dried ( M g S C > 4 )  and concentrated. The crude mixture was purified by column 
chromatography (silica, 30 % EtO Ac/pet. ether) to give A-allyl-2-bromo-A-methyl- 
acetamide 168 as a yellow oil (1.18 g, 6.12 mmol, 87 %).
Approx. 1:1 mixture of rotamers; JH NMR: 8 h (400 MHz, CDCI3) 2.97 (3H, s, CH3 , one 
rotamer), 3.06 (3H, s, CH3 , one rotamer), 3.84 (2H, s, CH2Br, one rotamer), 3.88 (2H, s, 
CH2Br, one rotamer), 4.02-4.00 (4H, m, 2 x CH2N, both rotamers), 5.31-5.18 (4H, m, 2 x 
CH2=CH, both rotamers), 5.90-5.72 (2H, m, 2 x CH2=CH, both rotamers).
Approx. 1:1 mixture of rotamers; 13C NMR: 8 c (100 MHz, CDCI3) 25.5 (CTEBr, one 
rotamer), 26.0 (CH2Br, one rotamer), 34.1 (CH3, one rotamer), 35.5 (CH3, one rotamer),
50.4 (CH2N, one rotamer), 52.3 (CH2N, one rotamer), 117.4 (CH2=CH, one rotamer), 117.8 
(CH2=CH, one rotamer), 130.9 (CH2=CH, one rotamer), 131.7 (CH2=CH, one rotamer),
167.0 (C=0, one rotamer), 167.4 (C=0, one rotamer).
Vmax NaCl cm' 1 3449 br, 2934 br, 1727 s, 1650 s (tertiary amide), 1405 m, 1280 m, 1090 m, 
929 m, 633 w.
MS (Cl): m/z 192 (M+, 50 %), 154 (31).
HRMS: Found 192.0019 192 C6HnONBr requires.0019.
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AyV-DialIyl-2-bromoacetamide 169
O
169
To a solution of diallylamine (634 pi, 5.15 mmol) in CH2CI2 (10 ml) that had been cooled 
to 0 °C was added NEt3 ( 8 6 8  pi, 6.18 mmol) and bromoacetylbromide (540 pi, 6.18 mmol). 
The reaction mixture was allowed to warm to room temperature and stirred for 2 h. The 
reaction mixture was quenched with aqueous saturated N H 4 C I  (5 ml), then H 2 O  (5 ml) and 
tien extracted with C H 2 C I 2  (3 x  10 ml). The organic layers were then combined, dried 
(MgSCU) and concentrated to give AfiV-diallyl-2-bromoacetamide 169 as a brown oil (1.09 
g 5.10 mmol, 99 %).
b  NMR: 6 h (400 MHz, CDCI3) 3.85 (2H, s CH2Br), 3.99 (4H, apparent dt, J = 1.5, 3.3 Hz, 
: x CH2N), 5.27-5.17 (4H, m, 2  x C /fcCH ), 5.88-5.72 (2H, m, CH).
BC NMR: 8 C (100 MHz, CDC13) 26.1 (CH2Br), 48.4 (NCH2), 50.0 (NCH2), 117.1 
(CH2=CH), 117.6 (CH2=CH), 132.1 (CH), 132.6 (CH), 166.8 ( C = 0) .
W  NaCl/cm'1: 3494 w, 2983 w, 1656 s (tertiary amide), 1415 s, 1210 m, 928 s, 617 w.
MS (El): m/z 217 (M+, 9 %), 138 (100), 41 (44).
HRMS: Found 217.0103, C8Hi2ONBr requires 217.0102.
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TV-AIlyl^-bromo-TV-phenyl-acetamide 170
O
Br^ V Phs
170
To a solution of Anally laniline (509 pi, 3.75 mmol) in CH2 CI2 (10 ml) that had been cooled 
to 0 °C was added NEt3 (633 pi, 4.51 mmol) and bromoacetylbromide (394 pi, 4.51 mmol). 
The reaction mixture was allowed to warm to room temperature and stirred for 2 h. The 
reaction mixture was quenched with aqueous saturated N H 4 C I  (5 ml), then H 2 O  (5 ml) and 
then extracted with C H 2 C I 2  (3 x  1 0  ml). The organic layers were then combined, dried 
(MgSCU) and concentrated. The crude mixture was then purified by column 
chromatography (10 % EtO Ac/pet. ether) to give A^-allyl-2-bromo-Ar-phenyl-acetamide 170 
as an orange oil (935 mg, 3.71 mmol, 99 %).
'H NMR: 8 h (400 MHz, CDCI3) 3.68 (2H, s, CH2Br), 4.32 (2H, d, J = 6.4 Hz, CH2N), 5.12 
(1H, dd, J = 1.4, 10.3 Hz, CH=Cfl^HB), 5.18 ( 1 H, dd, J = 1.4, 15.9 Hz, CH=CHAfla), 5.93-
5.83 (1H, m, CH2=CH), 7.28-7.21 (2H, m, 2 x  ArH), 7.49-7.37 (3H, m, 3 x  ArH).
,3C NMR: 5c (100 MHz, CDCI3) 27.0 (CH2Br), 52.9 (CH2N), 118.7 (CH2=CH), 128.0 (2 x  
ArCH), 128.7 (ArCH), 129.8 (2 x ArCH), 132.0 (CH2=CH), 141.3 (ArCN), 166.3 (C=0). 
vmax NaCl/cm"1: 3062 br, 1668 s (tertiary amide), 1210 m, 928 m, 700 s.
MS (Cl): m/z 254 ((M+H)+, 82 %), 176 (100).
HRMS: Found 254.0180, Cn Hr2ONBr requires 254.0181.
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7V-AUyl-2-(4-benzyloxyphenylsulfanyl)-7V-methyI-acetamide 171
./V-Allyl^-bromo-N-methyl-acetamide 168 ( 8 8 8  mg, 4.62 mmol) was added to a solution of
4-benzyloxybenzenethiol 135 (200 mg, 0.93 mmol) and NEt3 (650 pi, 4.62 mmol) in DMF 
(4 ml) and the reaction mixture was stirred at room temperature for 12 h. The reaction 
mixture was quenched with aqueous saturated NH4 CI (2 ml), then H2 O (2 ml) and then 
extracted with CH2CI2 ( 3 x 1 0  ml). The organic layers were then combined, dried (MgSCU) 
and concentrated. The crude mixture was purified by column chromatography (silica, 20 % 
EtOAc/pet. ether) to give jV-allyl-2 -(4 -benzyloxyphenylsulfanyl)-7V-methyl-acetamide 171 
as a green/yellow oil (168 mg, 0.51 mmol, 55 %).
Approx. 1:1 mixture of rotamers; NMR: §h (400 MHz, CDCI3) 2.93 (3H, s, CH3 , one 
rotamer), 2.95 (3H, s, CH3 , one rotamer), 3.63 (2H, s, CH2 S, one rotamer), 3.67 (2H, s, 
CH2 S, one rotamer), 3.90 (2H, m, CH2N, one rotamer), 3.98 (2H, m, CH2N, one rotamer),
5.06 (4H, s, 2  x CH2O, both rotamers), 5.24-5.12 (4H, m, 2 x C//2=CH, both rotamers), 
5.81-5.70 (2H, m, 2 x CH2=CH, both rotamers), 6.92 (4H, apparent dd J = 2.1, 5.2 Hz, 4 x 
ArH, both rotamers), 6.94 (4H, apparent dd J = 2.1, 5.2 Hz, 4 x ArH, both rotamers), 7.48- 
7.32 (10H, m, 10 x ArH, both rotamers).
Approx. 1:1 mixture of rotamers; 13C NMR: 6 c (100 MHz, CDCI3) 33.8 (CH3, one 
rotamer), 35.1 (CH3 , one rotamer), 38.2 (CH2 S, one rotamer), 38.5 (CH2 S, one rotamer),
50.2 (CH2N, one rotamer), 52.6 (CH2N, one rotamer), 70.0 (2 x CH2 O, both rotamers),
115.3 ( 8  x ArCH, both rotamers), 116.9 (CH2=CH, one rotamer), 117.4 (CH2=CH, one 
rotamer), 125.2 (ArCS, one rotamer), 125.3 (ArCS, one rotamer), 127.4 (4 x ArCH, both 
rotamers), 128.1 (4 x ArCH, both rotamers), 128.5 (2 x ArCH, both rotamers), 132.4 
(CH2=CH, one rotamer), 132.6 (CH2=CH, one rotamer), 134.1 (ArCO, one rotamer), 134.2
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(ArCO, one rotamer), 136.6 (2 x ArC, both rotamers), 168.4, (C=0, one rotamer), 168.8 
(C=0, one rotamer).
Vmax NaCl/cm'1: 2926 br, 1648 s (tertiary amide), 1492 m, 1242 m, 1008 m, 828 m.
MS (El): m/z 327 (M+, 6 6  %), 236 (27), 112 (43), 91 (Bn+, 100).
HRMS: Found 327.1292, Ci9H2 i0 2NS requires 327.1293.
AyV-Dially l-2-(4-benzyloxy pheny lsulfany l)-acetamide 172
A^/V-Diallyl-2-bromoacetamide 169 (2.15 g, 9.85 mmol) was added to a solution of 4- 
benzyloxybenzenethiol 135 (1.42 g, 6.54 mmol) and NEt3 (1.38 ml, 9.85 mmol) in DMF 
(15 ml) and the reaction mixture was stirred at room temperature for 12 h. The reaction 
mixture was quenched with aqueous saturated NH4 CI (5 ml), then H20  (5 ml) and then 
extracted with CH2C12 (3 x 20 ml). The organic layers were then combined, dried (MgSCU) 
and concentrated. The crude mixture was purified by kugelrohr distillation to remove 
excess amide. This gave A^V-diallyl-2-(4-benzyloxyphenylsulfanyl)-acetamide 172 as a 
yellow oil (1.53 g, 4.32 mmol, 6 6  %).
*H NMR: 5h (400 MHz, CDC13) 3.63 (2H, s, CH2 S), 3.90 (2H, d, J = 5.7 Hz, CH2N), 3.99 
(2H, d, J = 5.7 Hz, CH2N), 5.06 (2H, s, CH20), 5.27-5.13 (4H, m, 2 x C //2=CH), 5.83-5.69 
(2H, m, 2 x CH2=C//), 6.93 (2H, dd, J = 1.8, 6 . 8  Hz, 2 x ArH), 7.43-7.30 (5H, m, 5 x 
ArH), 7.45 (2H, dd, J = 1.8, 6 . 8  Hz, 2 x ArH).
13C NMR: 5c (100 MHz, CDC13) 38.3 (CH2 S), 48.0 (CH2N), 49.5 (CH2N), 70.0 (PhCH20),
115.5 (2 x ArCH), 116.8 (CH2=CH), 117.4 (CH2=CH), 125.2 (ArCS), 127.4 (2 x ArCH),
128.0 (ArCH), 128.5 (2 x ArCH), 132.7 (CH2=CH), 132.8 (CH2=CH) 134.2 (2 x ArCH),
136.6 (ArC), 158.7 (ArCO), 168.7 (C=0).
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Vmax NaCl/cm'1: 3450 w, 2923 w, 1651 s (tertiary amide), 1493 s, 1454 m, 1243 s, 996 m, 
827 m.
MS (El): m/z 353 (M+, 52 %), 262 (23), 138 (52), 91 (Bn+, 100).
HRMS: Found 353.1451, C21H2 3O2NS requires 353.1450.
A^Allyl-2-(4-benzyloxyphenyIsulfanyl)-A^-phenyl-acetamide 173
Af-Allyl-2-bromo-Af-phenyl-acetamide 170 (2.50 g, 9.85 mmol) was added to a solution of
4-benzyloxybenzenethiol 135 (1.42 g, 6.54 mmol) and NEt3 (1.38 ml, 9.85 mmol) in DMF 
(15 ml) and the reaction mixture was stirred at room temperature for 12 h. The reaction 
mixture was quenched with aqueous saturated NH4 CI (5 ml), then H2O (5 ml) and then 
extracted with CH2CI2 (3 x 2 0  ml). The organic layers were then combined, dried (MgSCU) 
and concentrated. The crude mixture was purified by kugelrohr distillation to remove 
excess amide. This gave Ar-allyl-2-(4-benzyloxyphenylsulfanyl)-A^-phenyl-acetamide 173 
as a yellow oil (1.41 g, 3.60 mmol, 55 %).
’H NMR: 5h (400 MHz, CDC13) 3.40 (2H, s, CH2 S), 4.29 (2H, d, J = 6.3 Hz, CH2N), 5.07 
(2H, s, CH20), 5.08 (1H, dd, J = 1.3, 15.9 Hz, CH=C//„HB), 5.12 (1H, dd, J = 1.3, 10.4 Hz, 
CH=CHA//5), 5.90-5.80 (1H, m, CH2=CH), 6.90 (2H, dd, J = 5.0, 6.9 Hz, 2 x ArH), 7.07-
7.05 (2H, m, 2  x ArH), 7.45-7.31 (10H, m, 10 x ArH).
13C NMR: 5C (100 MHz, CDCI3) 38.9 (CH2 S), 52.6 (CH2N), 70.0 (CH20), 115.4 (2 x 
ArCH), 118.1 (CH2=CH), 125.8 (ArCH), 127.4 (ArCS), 128.0 (2 x ArCH), 128.1 (ArCH),
128.3 (2 x ArCH), 128.6 (2 x ArCH), 129.6 (2 x ArCH), 132.7 (CH2=CH), 134.2 (2 x 
ArCH), 136.7 (ArC), 141.8 (ArCN), 158.6 (ArCO), 168.5 (C=0).
VmaxNaCl/cm'1: 3062 br, 1656 s (tertiary amide), 1494 s, 1240 s, 1007 m, 827 m.
MS (El): m/z 389 (M+, 8 8  %), 298 (45), 91 (Bn+, 100).
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HRMS: Found 389.1451, C24H2 3O2NS requires 389.1450.
7V-Allyl-2-(4-benzyloxyphenylsulfonyl)-Ar-methyl-acetamide 174
174
Oxone (796 mg, 1.22 mmol) was added to a solution of N-allyl-2-(4- 
benzyloxyphenylsulfanyl)-Af-methyl-acetamide 171 (106 mg, 0.31 mmol) in DMF (2 ml) 
and H2 O (0.5 ml) and the reaction mixture was stirred at room temperature for 3 h. The 
reaction mixture was quenched with aqueous saturated NH4 CI (1 ml), then H2 O (1 ml) and 
then extracted with CH2 CI2 ( 3 x 5  ml). The organic layers were then combined, dried 
(MgSCU) and concentrated. The crude mixture was purified by kugelrohr distillation to 
remove DMF. This gave A/r-allyl-2-(4-benzyloxyphenylsulfonyl)-A^-methyl-acetamide 174 
as a brown oil (115 mg, 0.31 mmol, 99 %).
Approx. 1:1 mixture of rotamers; !H NMR: 8 h (400 MHz, C D C I 3 )  2.95 (3H, s, C H 3 ,  one 
rotamer), 3.14 (3H, s, C H 3 ,  one rotamer), 3.99 (2H, d, J = 5.8 Hz, C H 2 N ,  one rotamer), 4.13 
(2H, d, J = 4.8 Hz, C H 2 N ,  one rotamer), 4.18 (2H, s, C H 2 S ,  one rotamer), 4.25 (2H, s, 
C H 2 S ,  one rotamer), 5.15 (4H, s, 2  x C H 2 O ,  both rotamers), 5.29-5.18 (4H, m, 2 x 
CF/2=CH, both rotamers), 5.89-5.68 (2H, m, 2 x CH2=CH, both rotamers), 7.11 (4H, dd, J 
= 2.0, 9.0 Hz, 4 x ArH, both rotamers), 7.45-7.35 (10H, m, 10 x ArH, both rotamers), 7.89-
7.84 (4H, m, 2  x ArH, both rotamers).
Approx. 1:1 mixture of rotamers; 13C NMR: 8 c (100 MHz, CDCI3) 34.3 (CH3 , one 
rotamer), 36.2 (CH3 , one rotamer), 50.5 (CH2N, one rotamer), 53.1 (CH2N, one rotamer),
59.9 (CH2 S, one rotamer), 60.2 (CH2 S, one rotamer), 70.4 (2 x CH2O, both rotamers),
115.1 (4 x ArCH, both rotamers), 117.2 (CH2=CH, one rotamer), 117.8 (CH2=CH, one 
rotamer), 127.5 (2 x ArCH, both rotamers), 128.4 (4 x ArCH, both rotamers), 128.7 (4 x
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ArCH, both rotamers), 130.5 (ArCO, one rotamer), 130.6 (ArCO, one rotamer), 130.8 (4 x 
ArCH, both rotamers), 131.8 (CH2=CH, one rotamer), 132.0 (CH2=CH, one rotamer),
135.7 (2 x ArC, both rotamers), 161.4 (C=0, one rotamer), 161.8 (C=0, one rotamer),
163.2 (2 x ArCS, both rotamers).
vmax KBr/cm'1: 3429 w, 1648 s (tertiary amide), 1262 m, 1084 m, 1013 w, 934 w, 725 m. 
MS (El): m/z 359 (M+, 10 %), 295 (24), 112 (84), 91 (Bn+, 100).
HRMS: Found 359.1193, C 1 9 H 2 1 O 4 N S  requires 359.1191.
A,A-DiallyI-2-(4-benzyloxyphenylsulfonyl)-acetamide 175
175
Oxone (779 mg, 1.27 mmol) was added to a solution of AyV-diallyl-2-(4- 
benzyloxyphenylsulfanyl)-acetamide 172 (112 mg, 0.32 mmol) in DMF (2 ml) and H2O 
(0.5 ml) and the reaction mixture was stirred at room temperature for 3 h. The reaction 
mixture was quenched with aqueous saturated NH4 CI (2 ml), then H2O (2 ml) and then 
extracted with CH2CI2 ( 3x10  ml). The organic layers were then combined, dried (MgS04) 
and concentrated. The crude mixture was purified by kugelrohr distillation to remove 
DMF. This gave AyV-diallyl-2-(4-benzyloxyphenylsulfonyl)-acetamide 175 as a white solid 
(117 mg, 0.31 mmol, 96 %).
]H NMR: 5h (400 MHz, CDCI3) 3.99 (2H, d, J = 5.5 Hz, C/frHBN), 4.16-4.13 (2H, m, 
CUaHbM), 4.19 (2H, s, CH2 S), 5.15 (2H, s, CH2 0), 2.30-5.19 (4H, m, 2 x C tfjC H ), 5.88- 
5.70 (2H, m, 2  x CH2=CH), 7.10 (2H, d, J = 9.0 Hz, 2 x ArH), 7.45-7.36 (5H, m, 5 x ArH),
7.85 (2H, d, J = 9.0 Hz, 2 x ArH).
13C NMR: 8 C (100 MHz, CDCI3) 48.5 (CH2N), 50.1 (CH2N), 60.1 (CH2 S), 70.4 (CH20),
115.1 (2 x ArCH), 117.1 (CH2=CH), 117.6 (CH2=CH), 127.6 (2 x ArCH), 128.4 (2 x
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ArCH), 128.7 (ArCH), 130.4 (ArCO), 130.9 (2 x ArCH), 132.0 (CH2=CH), 132.3 
(CH2=CH), 135.7 (ArC), 161.8 (C=0), 163.5 (ArCS).
vmax KBr/cm'1: 3431 w, 1649 s (tertiary amide), 1450 m, 1144 s, 925 m, 733 m.
MS (El): m/z 385 (M+, 13 %), 138 (71), 91 (Bn+, 100).
HRMS: Found 385.1346, C2 iH2 30 4NS requires 385.1348.
MP: 84.5 -86.1  °C.
7V-AIlyl-2-(4-benzyloxyphenylsulfonyl)-A-pheiiyI-acetamide 176
176
Oxone (644 mg, 1.05 mmol) was added to a solution of A-allyl-2-(4- 
benzyloxyphenylsulfanyl)-A-phenyl-acetamide 173 (102 mg, 0.26 mmol) in DMF (2 ml) 
and H20  (0.5 ml) and the reaction mixture was stirred at room temperature for 3 h. The 
reaction mixture was quenched with aqueous saturated NH4 C1 (2 ml), then H20  (2 ml) and 
then extracted with CH2C12 (3 x 10 ml). The organic layers were then combined, dried 
(MgS04) and concentrated. The crude mixture was purified by kugelrohr distillation to 
remove DMF. This gave A-allyl-2-(4-benzyloxyphenylsulfonyl)-A-phenyl-acetamide 176 
as a yellow oil (103 mg, 0.24 mmol, 94%).
'H NMR: 6h (400 MHz, CDC13) 3.97 (2H, s, CH20), 4.28 (2H, d, J = 6.2 Hz, CH2N), 5.12 
(1H, dd, J = 1.7, 9.9 Hz, C H =C ^H B), 5.15 ( 1 H, dd, J = 1.7, 15.0 Hz, CH=CHA% ), 5.16 
(2H, s, CH2 S), 5.87-5.77 (1H, m, CH2=CH), 7.11 (2H, dd, J = 2.0, 7.0 Hz, 2 x ArH), 7.19-
7.16 (2H, m, 2  x ArH), 7.46-7.38 (8 H, m, 8  x ArH), 7.85 (2H, dd, J = 2.0, 7.0 Hz, 2 x 
ArH).
13C NMR: 8 C (100 MHz, CDCI3) 52.6 (CHjN), 59.4 (CH2 0), 70.4 (CH2 S), 114.9 (2 x 
ArCH), 118.5 (CH2=CH), 126.3 (ArCH), 127.5 (2 x ArCH), 128.4 (ArCO), 128.4 (2 x
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ArCH), 128.8 (2 x ArCH), 130.0 (2 x ArCH), 130.9 (ArCH), 131.1 (2 x ArCH), 131.9 
(CH2=CH), 135.7 (ArC), 141.2 (ArCN), 161.3 (C=0), 163.1 (ArCS).
Vmax ATR/cm ' 1 3682 br, 2904 m, 1655 s (tertiary amide), 1586 m, 1492 m, 1306 m, 1150 
m, 1000 w, 689 s.
MS (El): m/z 421 (M+, 9 %), 174 (100), 91 (Bn+, 100).
HRMS: Found 421.1350, C24H2 3O4NS requires 421.1348.
2-(4-Benzyloxybenzenesulfonyl)-pent-4-enoic acid-TV-allyl-N-methyl-amide 177
Allyl bromide (333 jul, 3.85 mmol) was added to a solution of A-allyl-2-(4- 
benzyloxyphenylsulfonyl)-A-methyl-acetamide 174 (346 mg, 0.96 mmol), K2 CO3 (665 mg, 
4.81 mmol) and KI (32.0 mg, 0.19 mmol) in DMF (10 ml) and the reaction mixture was 
stirred at room temperature for 12 h. The reaction mixture was quenched with aqueous 
saturated NH4C1 (5 ml), then H20  (5 ml) and then extracted with CH2CI2 (3 x 20 ml). The 
organic layers were then combined, dried (MgSCU) and concentrated. The crude mixture 
was purified by kugelrohr distillation to remove excess allyl bromide. This gave 2-(4- 
benzyloxybenzenesulfonyl)-pent-4-enoic acid-TV-allyl-A-methyl-amide 177 as a white solid 
(254 mg, 0.85 mmol, 89 %).
Approx. 1:1 mixture of rotamers; *H NMR: 5H (400 MHz, CDCI3) 2.72-2.56 (4H, m, 2 x 
C//2 CHC=0 , both rotamers), 2.97 (3H, s, CH3 , one rotamer), 3.13 (3H, s, CH3 , one 
rotamer), 3.80 ( 1 H, dd, J = 4.4, 13.0 Hz, NC/fcHB, one rotamer), 3.97 ( 1 H, dd, J = 5.5, 15.3 
Hz, NC/Z^Hb, one rotamer), 4.08 (1H, dd, J = 5.5, 15.3 Hz, NCHa//#, one rotamer), 4.24 
(1H, t, J = 10.8 Hz, CHC=0, one rotamer), 4.39 (1H, t, J = 10.8 Hz, CHC=0, one rotamer),
4.52-4.46 ( 1 H, m, NCHA/fe, one rotamer), 5.08-5.03 (4H, m, 2 x CHCH2CH=C//2, both 
rotamers), 5.09 (4H, s, 2  x CH20 , both rotamers), 5.27-5.13 (4H, m, 2 x NCH2CH=C//2,
177
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both rotamers), 5.59-5.53 (2H, m, 2 x CHCH2C//=CH2 , both rotamers), 5.83-5.67 (2H, m, 
2 x NCH2CT/M3 H2 , both rotamers), 7.09 (4H, dd, J = 2.8, 8.9 Hz, 4 x ArH, both rotamers),
7.45-7.35 (10H, m, 10 x ArH, both rotamers), 7.80-7.76 (4H, m, 4 x ArH, both rotamers). 
Approx. 1:1 mixture of rotamers; 13C NMR: 8c (100 MHz, CDCI3) 32.6 (CH2CHC=0 , one 
rotamer), 32.9 (CH2CHC=0 , one rotamer), 34.6, (CH3 , one rotamer), 35.9 (CH3 , one 
rotamer), 50.9 (CH2N, one rotamer), 52.6 (CH2N, one rotamer), 66.0 (2 x CHC=0, both 
rotamers), 70.4 (2 x CH2 O, both rotamers), 114.7 (2 x ArCH, one rotamer), 114.8 (2 x 
ArCH, one rotamer), 117.3 (2 x CHCH2CH=CH2, both rotamers), 118.8 (NCH2CH=CH2, 
one rotamer), 119.0 (NCH2CH=CH2 , one rotamer), 127.6 (2 x ArCH, both rotamers), 128.8 
(4 x ArCH, both rotamers), 132.1 (4 x ArCH, both rotamers), 132.2 (2 x CHCH2 CH=CH2 , 
both rotamers), 132.2 (4 x ArCH, both rotamers), 132.4 (2 x NCH2 CH=CH2 , both 
rotamers) 135.7 (2 x ArC, both rotamers), 138.2 (2 x ArCO, both rotamers), 163.3 (2 x 
ArCS, both rotamers), 164.6 (C=0, one rotamer), 165.5 (C=0, one rotamer). 
vmax KBr/cm'1: 3438 w, 2925 m, 1659 m (tertiary amide), 1251 m, 1144 s, 1007 m, 727 m. 
MS (El): m/z 399 (M*, 6  %), 152 (46), 91 (Bn+, 100).
HRMS: Found 399.1505, C 2 2 H 2 5 O 4 N S  requires 399.1504.
MP: 106.3- 108.2 °C.
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2-(4-BenzyIoxybenzenesuIfonyl)-pent-4-enoic acid-TV^V-diallylamide 178
BnO.
N'
178
Allyl bromide (260 pi, 3.00 mmol) was added to a solution of A,A-diallyl-2-(4- 
benzyloxyphenylsulfonyl)-acetamide 175 (289 mg, 0.75 mmol), K 2 C O 3  (518 mg, 3.75 
mmol) and KI (25.0 mg, 0.15 mmol) in DMF (10 ml) and the reaction mixture was stirred 
at room temperature for 24 h. The reaction mixture was quenched with aqueous saturated 
N H 4 C I  (2 ml), then H 2 O  (2 ml) and then extracted with C H 2 C I 2  (3 x  20 ml). The organic 
layers were then combined, dried (MgSOzj) and concentrated. The crude mixture was 
purified by kugelrohr distillation to remove excess allyl bromide. This gave 2-(4- 
benzyloxybenzenesulfonyl)-pent-4-enoic acid-A-jV-diallylamide 178 as a clear oil (201 mg, 
0.47 mmol, 63 %).
*H NMR: 5h (400 MHz, CDC13) 2.60-2.52 (1H, m, C//„HBCHC=0), 2.70-2.64 (1H, m, 
CHAtfz?CHC=0), 3.64 (1H, dd, J = 5.9, 15.6 Hz, N C /^H B), 3.84 (1H, apparent dt, J = 2.4,
18.3 Hz, NC/frHs), 4.26 (1H, dd, J = 3.7, 10.9 Hz, CHC=0), 4.35 (1H, apparent dt, J =
2.0, 15.6 Hz, NCHa//s), 4.49 (1H, apparent dt, J = 2.0, 18.3 Hz, NCHAtf5), 5.14-5.04 (2H, 
m, CUCH2CH=CH2), 5.15 (2H, s, PhCH20), 5.33-5.17 (4H, m, NCH2 CH=C7fr), 5.62-5.52 
(1H, m, CHCH2 C//=CH2), 5.84-5.72 (2H, m, NCH2 C//=CH2), 7.09 (2H, dd, J = 2.0, 7.1 
Hz, 2 x ArH), 7.44-7.35 (5H, m, 5 x ArH), 7.76 (2H, dd, J = 2.0, 7.1 Hz, 2 x ArH).
13C NMR: 5C (100 MHz, CDC13) 33.0 (CH2CHC=0), 48.8 (CH2N), 49.7 (CH2N), 66.2 
(CHC=0), 70.4 (PhCH20), 114.7 (2 x ArCH), 117.3 (NCH2 CH=CH2), 117.3 
(NCH2CH=CH2), 119.1 (CHCH2 CH=CH2), 127.6 ( 2  x ArCH), 128.4 ( 2  x ArCH), 128.7 
(ArCH), 130.4 (ArCO), 132.2 (2 x NCH2 CH=CH2), 132.3 (CHCH2 CH=CH2), 132.6 (2 x 
ArCH), 135.7 (ArC), 163.4 (ArCS), 164.6 (C=0).
Vmax NaCl/cm'1: 3628 w, 3080 m, 1654 s (tertiary amide), 1316 s, 1146 s, 925 m, 700 m.
MS (El): m/z 425 (M*, 6  %), 210 (20), 178 (81), 91 (Bn+, 100).
162
HRMS: Found 425.1660, C 2 4 H 2 7 O 4 N S  requires 425.1661.
2-(4-BenzyloxybenzenesulfonyI)-pent-4-enoic acid-N-allyl-TV-phenyl-amide 179
Allyl bromide (278 pi, 3.21 mmol) was added to a solution of A-allyl-2-(4- 
benzyloxyphenylsulfonyl)-A-phenyl-acetamide 176 (338 mg, 0.80 mmol), K2CO3 (554 mg, 
4.01 mmol) and KI (27.0 mg, 0.16 mmol) in DMF (10 ml) and the reaction mixture was 
stirred at room temperature for 7 h. The reaction mixture was quenched with aqueous 
saturated NH4 CI (3 ml), then H2O (3 ml) and then extracted with CH2 CI2 (3 x 20 ml). The 
organic layers were then combined, dried (MgS0 4 ) and concentrated. The crude mixture 
was purified by kugelrohr distillation to remove excess allyl bromide. This gave 2-(4- 
benzyloxybenzenesulfonyl)-pent-4-enoic acid-TV-allyl-Af-pheny 1-amide 179 as a yellow oil 
(335 mg, 0.73 mmol, 91 %).
!H NMR: 5h (400 MHz, CDC13) 2.58-2.51 (2H, m, C//2 CHC=0), 4.03 (1H, dd, J = 5.9, 9.2 
Hz, CHC=0), 4.29 (2H, dd, J = 2.1, 5.1 Hz, CH2N), 5.18-5.08 (4H, m, C//2=CHCH2CH, 
C//2=CHCH2N), 5.17 (2H, s, PhCH20), 5.59-5.48 (1H, m, CH2=C/7CH2CH), 5.89-5.79 
(1H, m, CH2=C//CH2N), 7.10 (2H, dd, J = 2.0, 7.0 Hz, 2 x ArH), 7.47-7.36 (10H, m, 10 x 
ArH), 7.77 (2H, dd, J = 2.0, 7.0 Hz, 2 x ArH).
,3C NMR: 6 C (100 MHz, CDC13) 33.2 (CH2CHC=0), 52.9 (CH2N), 66.2 (CHC=0), 70.4 
(PhCH20), 114.6 (2 x ArCH), 118.3 (CH2=CHCH2N), 119.4 (CH2=CHCH2CH), 127.5 (3 x 
ArCH), 128.4 (2 x ArCH), 128.6 (2 x ArCH), 128.8 (3 x ArCH), 129.7 (ArCO), 131.8 
(CH2=CHCH2N), 132.2 (CH2=CHCH2 CH), 132.4 (2 x ArCH), 135.7 (ArC), 141.1 (ArCN),
163.2 (ArCS), 164.2(C=0).
Vmax NaCl/cm'1: 3066 br, 1661 s (tertiary amide), 1495 s, 1259 s, 1146 s, 834 m, 701 m.
MS (El): m/z 461 (M+, 7 %), 214 (6 6 ), 91 (Bn+, 100).
179
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HRMS: Found 461.1662, C2 7H2 7O4NS requires 461.1661.
3-(4-Benzyloxybenzenesulfonyl)-l-methyl-l,3j4,7-tetrahydro-azepiii-2-oiie 180
BnO.
180
Grubbs 1st generation catalyst ((PCy3)2Cl2Ru=CHPh, 50.0 mg, 0.06 mmol), was added to a 
solution of 2-(4-benzyloxybenzenesulfonyl)-pent-4-enoic acid-W-allyl-A-methyl-amide 177 
(244 mg, 0.61 mmol) in CH2CI2 (5 ml) and the reaction mixture was heated to reflux for 24 
h. The reaction mixture was purified by filtration (silica, 100 % CH2CI2). The crude 
mixture was then purified by column chromatography (silica, 20 % EtOAc/pet. ether) to 
give 3-(4-benzyloxybenzenesulfonyl)-l-methyl-l,3,4,7-tetrahydro-azepin-2-one 180 as a 
brown oil (171 mg, 0.46 mmol, 76 %).
*H NMR: 5h (400 MHz, CDC13) 2.54-2.46 (1H, m, Ctf„HBCHC=0), 2.99 (3H, s, CH3), 
3.04-3.00 (1H, m, CHA/f5 CHC=0), 3.43-3.37 (1H, m, N C /^H B), 4.42-4.37 (1H, m, 
NCHa/ /5), 4.67 (1H, dd, J = 3.3, 13.0 Hz, CHC=0), 5.15 (2H, s, CH20), 5.81 (2H, m, 
CH=CH), 7.10 (2H, d, J = 9.0 Hz, 2 x ArH), 7.45-7.37 (5H, m, 5  x ArH), 8.05 (2H, d, J = 
9.0 Hz, 2 x ArH).
,3C NMR: 5C (100 MHz, CDC13) 27.3 (CH2CHC=0), 36.0 (CH3), 47.3 (CH2N), 66.2 
(CHC=0), 70.4 (PhCH20), 114.6 (2 x ArCH), 124.4 (CH=CH), 127.5 (3 x ArCH), 128.4 
(CH=CH), 128.7 (2 x ArCH), 129.4 (ArCO), 132.9 (2 x ArCH), 135.8 (ArC), 163.1 
(ArCS), 167.0 (C=0).
Vmax ATR/cm ' 1 2922 br, 1652 s (tertiary amide), 1587 m, 1491 w, 1250 m, 1128 m, 996 w, 
829 w.
MS (El): m/z 372 (M+, 100 %), 152 (65).
HRMS: Found 372.1270, C 2 0 H 2 2 O 4 N S  requires 372.1270.
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3-BenzyI-3-(4-benzyIoxybenzenesuIfonyl)-l-methyl-l,3j4,7-tetrahydro-azepm-2-one
181
BnO.
181
LiHMDS (0.11 ml, 0.11 mmol), was added to solution of 180 (20.0 mg, 0.05 mmol) in 
THF (0.5 ml) that had been cooled to -78 °C and the reaction mixture was stirred for 30 
min. Benzyl bromide (26.0 pi, 0.22 mmol) was then added dropwise and the reaction 
mixture was stirred at -78 °C for 16 h. The reaction mixture was quenched first with 
aqueous saturated NH4CI (2 ml) followed by H2O (2 ml) and the aqueous layer extracted 
with CH2CI2 ( 3 x 1 0  ml). The organic layers were then dried (MgS0 4 ), and concentrated. 
The crude mixture was purified by column chromatography (silica, 30 % EtO Ac/pet. ether) 
to give 3-benzyl-3-(4-benzyloxybenzenesulfonyl)-1 -methyl-1,3,4,7-tetrahydro-azepin-2- 
one 181 as a clear oil (23.0 mg, 0.05 mmol, 93 %).
JH NMR: 5h (400 MHz, CDC13) 2.73 (1H, dd, J = 6.9, 15.2 Hz, CC/^H BCH=CH), 2.81 
(1H, d, J = 12.4 Hz, PhC/frHnC), 3.08 (3H, s, NMe), 3.27 (1H, dd, J = 6.5, 15.2 Hz, 
CCHA// 5 CH=CH), 3.36 (1H, dd, J = 6.9, 15.2 Hz, NCH2), 3.67 (1H, d, J = 12.4 Hz, 
PhCHA//z?C), 3.87 (1H, dd, J = 7.0, 15.2 Hz, NCH2), 5.14 (2H, s, PhCH2 0), 5.63 (1H, dt, J 
= 6.5, 9.2 Hz, CCH2 C//=CH), 5.92 (1H, dt, J = 6.9, 9.2 Hz, NCH2C//=CH), 7.12-7.07 (4H, 
m, 4 x ArH), 7.25-7.19 (3H, m, 3 x ArH), 7.45-7.34 (5H, m, 5  x ArH), 7.88-7.84 (2H, m, 2 
x ArH).
,3C NMR: 5C (100 MHz, CDC13) 27.7 (CCH2CH=CH), 39.4 (NMe), 42.9 (PhCH2C), 46.5 
(NCH2), 70.3 (PhCH2 0), 79.1 (CC=0), 114.2 (2 x ArCH), 126.2 (ArC), 127.2 (ArCH),
127.6 (2 x ArCH), 128.3 (2 x ArCH), 128.4 (2 x ArCH), 128.7 (2 x ArCH), 129.5 (ArCH),
130.4 (CH=CH), 131.3 (ArC), 132.4 (CH=CH), 133.2 (2 x ArCH), 135.4 (ArCO), 135.8 
(ArCS), 163.0 (C=0).
Vmax ATR/cm ' 1 3666 br, 2925 br, 1650 s (tertiary amide), 1249 m, 1130 m, 714s.
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MS (Cl): m/z 372 ((M+H)+, 54 %), 231 (33), 214 (38), 124 (100). 
HRMS: Found 462.1735, C2 7H2 8O4NS requires 462.1734.
3-BenzyI-l-m ethyl-1,3,4,7-tetrahydro-azepin-2-one 182
O
182
A solution of Sml2 (2.59 ml, 0.26 mmol, 0.1 M in THF), was added to a solution of 3- 
benzyl-3-(4-benzyloxybenzenesulfonyl)-1 -methyl-1,3,4,7-tetrahydro-azepin-2-one 181
(50.0 mg, 0.11 mmol) and MeOH (0.8 ml) in THF (0.4 ml) that had been cooled to 0 °C. 
The mixture was then allowed to warm to room temperature and stirred for 1 h. The 
reaction mixture was quenched first with aqueous saturated NH4CI (2 ml) followed by H20  
(2 ml) and the aqueous layer extracted with CH2 C12 ( 3 x 5  ml) dried (MgS04), and 
concentrated. The crude mixture was purified by column chromatography (silica, 30 % 
EtO Ac/pet. ether) to give 3-benzyl-l-methyl-1,3,4,7-tetrahydro-azepin-2-one 182 as a 
yellow oil (19.0 mg, 0.09 mmol, 81 %).
!H NMR: 5h (400 MHz, CDC13) 2.21-2.05 (2H, m, PhCH2), 2.52 (1H, apparent dd, J = 7.6,
13.6 Hz, CHC=0), 2.95 (3H, s, NMe), 3.28-3.19 (3H, m, CHCTftC, CHC7^HBN), 4.41-
4.36 (1H, m, CHCHa/^N ), 5.68-5.58 (2H, m, C tfC fl) , 7.23-6.91 (5H, m, 5 x ArH).
13C NMR: 5C (100 MHz, CDC13) 31.4 (CHCH2 CH), 36.1 (NMe), 37.6 (CH2Ph), 42.4 (CH),
47.4 (NCH2), 124.0 (CH=CH), 126.0 (2 x ArCH), 128.3 (ArCH), 129.3 (CH=CH), 131.6 (2 
x ArCH), 140.4 (ArC), 162.3 (C=0).
vmax KBr/cm ' 1 2929 br, 1644 m (tertiary amide), 1490 w, 1219 w, 804 w, 342 m.
MS (Cl): m/z 216 ((M+H)+, 100 %), 124 (100), 91 (92).
HRMS: Found 216.1380, Ci4Hi8ON, requires 216.1383.
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2-(4-Benzyloxyphenylsulfonyl)-l-(2H-pyrrol-l(5H)-yl)pent-4-en-l-one 183 and 3-(4- 
benzyloxyphenylsulfonyI)-l-allyl-3,4-dihydro-lH-azepin-2(7H)-one 184
Grubbs 1st generation catalyst ((PCy3)2Cl2Ru=CHPh, 6.00 mg, 0.01 mmol), was added to a 
solution of 2-(4-benzyloxybenzenesulfonyl)-pent-4-enoic acid-AyV-diallylamide 178 (30.0 
mg, 0.07 mmol) in CH2CI2 (2 ml) and the reaction mixture was heated at reflux for 2 h. The 
reaction mixture was purified by filtration (silica, 1 0 0  % CH2CI2). The crude mixture was 
then purified by column chromatography (silica, 20 % EtO Ac/pet. ether) to give a mixture 
of 2-(4-benzyloxyphenylsulfonyl)-l-(2H-pyrrol-l(5H)-yl)pent-4-en-l-one 183 as a dark 
grey oil (5.57 mg, 0.01 mmol, 20 %) and 3-(4-benzyloxyphenylsulfonyl)-l-ally 1-3,4- 
dihydro- lH-azepin-2(7H)-one 184 as a brown oil (15.9 mg, 0.04 mmol, 57 %).
For 183: *H NMR: 8 H (400 MHz, CDC13) 2.72-2.57 (2H, m, CH2CHC=0), 4.13 (1H, dd, J 
= 3.9, 11.0 Hz, CHC=0), 4.32-4.22 (3H, m, NCH2, NC/GHB), 4.67-4.61 (1H, m, 
NCHaHb), 5.07 (2H, apparent dd, J = 1.2, 10.1, CH=CH2\  5.15 (2H, s, CH20), 5.70-5.59 
(1H, m, CH=CU2), 5.81-5.78 (1H, m, Ctf=CH), 5.88-5.86 (1H, m, CH=CH), 7.07 (2H, dd, 
J = 2.0, 6.9 Hz, 2 x ArH), 7.45-7.36 (5H, m, 5 x ArH), 7.81 (2H, dd, J = 2.0, 6.9 Hz, 2 x
13C NMR: 8 C (100 MHz, CDC13) 32.3 (CH2 CHC=0), 53.5 (NCH2), 54.0 (NCH2), 68.3 
(CHC=0), 70.4 (CH20), 114.7 (2 x ArCH), 118.9 (CH=CH2), 124.8 (CH=CH), 125.8 
(CH=CH), 127.6 (2 x ArCH), 127.8 (ArCO), 128.4 (2 x ArCH), 128.6 (CH=CH2), 128.8 
(ArCH), 132.2 (2 x ArCH), 135.7 (ArC), 162.6 (ArCS), 163.4 (C=0). 
vmax KBr/cm'1: 3431 w, 2923 w, 1659 s (tertiary amide), 1437 m, 1145 m, 1002 m, 737 m. 
MS (El): m/z 397 (M+, 1 %), 150 (100), 91 (Bn+, 87), 6 8  (46).
HRMS: Found 397.1350, C 2 2 H 2 3 O 4 N S  requires 397.1348.
183 184
ArH).
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For 184: lU NMR: 5H (400 MHz, CDC13) 2.49-2.56 (1H, m, C /^H BCHC=0), 3.03 (1H, dd, 
J = 3.2, 17.8 Hz, CHA/75 CHC=0), 3.42 (1H, dd, J = 5.5, 17.5 Hz, NC/^HbCH), 3.86 (1H, 
dd, J = 6.3, 15.4 Hz, NC/frHBCH=CH2), 4.16 (1H, dd, J = 5.5, 15.4 Hz, 
NCHAT7flCH=CH2), 4.27-4.22 (1H, m, NCHA// 5 CH), 4.67 (1H, dd, J = 3.2, 13.0 Hz, 
CHC=0), 5.15 (2H, s, CH20), 5.17-5.13 (2H, m, CH2 =CR), 5.67-5.63 (1H, m, CH2=CH), 
5.82-5.76 (2H, m, CH=CH), 7.02 (2H, dd, J = 2.1, 7.0 Hz, 2 x ArH), 7.45-7.38 (5H, 5 x 
ArH), 8.04 (2H, dd, J = 2.1, 7.0 Hz, 2 x ArH).
,3C NMR: 5C (100 MHz, CDC13) 27.3 (CHCH2CH), 44.3 (NCH2 CH=CH2), 50.2 
(NCH2CH=CH), 66.3 (CH), 70.3 (PhCH20), 114.6 (2 x ArCH), 118.1 (CH=CH2), 125.0 
(CH=CH), 127.5 (2 x ArCH), 127.9 (ArCO), 128.4 (2 x ArCH), 128.5 (CH=CH), 128.7 
(ArCH), 132.7 (CH=CH2), 132.8 (2 x ArCH), 133.8 (ArC), 159.3 (ArCS), 161.9 (C=0). 
vmax KBr/cm'1: 2922 br, 1655 s (tertiary amide), 1465 w, 1249 m, 997 m, 727 m.
MS (Cl): m/z 398 ((M+H)+, 22 %), 164 (100), 150 (46), 91 (Bn+, 100).
HRMS: Found 398.1422, C22H2 40 4NS requires 398.1421.
A-Allyl-Ar-methylpent-4-enamide 186
O
186
NEt3 (461 pi, 4.55 mmol) and 4-pentenoyl chloride (503 pi, 4.55 mmol) were added to a 
solution of Af-methylallylamine (270 pi, 3.80 mmol) in CH2C12 (10 ml) that had been 
cooled to 0 °C. The mixture was then allowed to warm to room temperature and stirred for 
12 h. The reaction mixture was quenched with aqueous saturated NFLjCl (5 ml) then H20  (5 
ml). The aqueous layer was then extracted with CH2C12 (3 x 10 ml). The organic layers 
were then dried (Na2 S 04) and concentrated to give A-allyl-A-methylpent-4-enamide 186 as 
a brown oil (547 mg, 3.57 mmol, 94 %)
Approx. 1:1 mixture of rotamers; *H NMR: 5h (500 MHz, CDCI3) 2.43-2.17 (8 H, m, 2 x 
CH2CH2 C=0, both rotamers), 2.93 (3H, s, NMe, one rotamer), 2.95 (3H, s, NMe, one
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rotamer), 3.90 (2H, d, J = 6.0 Hz, NCH2, one rotamer), 4.00 (2H, d, J = 6.0 Hz, NCH2, one 
rotamer), 5.22-5.03 (8 H, m, 2 x CH2CH2CH=C//2, 2 x NCH2CH=C//2, both rotamers), 
5.88-5.75 (4H, m, 2 x CH2CH2C//=CH2, 2 x NCH2 C/7=CH2, both rotamers).
2-(3,3j4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecylsulfanyl)-ALallyl-Ar-
methylacetamide 197
O
197
Af-Allyl-2-bromo-7V-methyl-acetamide 168 (2.45 g, 12.8 mmol) was added via cannula to a 
solution of 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecane-l-thiol 196 (2.49 ml, 
8.50 mmol) and NEt3 (1.80 ml, 12.8 mmol) in DMF (20 ml) and the reaction mixture was 
stirred at room temperature for 16 h. The reaction mixture was quenched with aqueous 
saturated NH4CI (5 ml) then H20  (5 ml). The aqueous layer was then extracted with 
CH2 C12 (3 x 20 ml). The organic layers were then dried (Na2 SC>4) and then concentrated. 
The crude product was then purified using fluorous silica (eluting with 80 % MeCN/H20  
then MeCN) to give 2-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfanyl)- 
N-allyl-Af-methylacetamide 197 as a white solid (4.32 g, 7.31 mmol, 8 6  %).
Approx. 1:1 mixture of rotamers; ]H NMR: 8 h (500 MHz, CDCI3) 2.51-2.45 (4H, m, 2 x 
CH2CF2, both rotamers), 2.92-2.89 (4H, m, 2 x C//2 CH2 CF2, both rotamers), 2.95 (3H, s, 
NMe, one rotamer), 3.03 (3H, s, NMe, one rotamer), 3.32 (2H, s, CH2 C=0, one rotamer),
3.36 (2H, s, CH2C=0, one rotamer), 4.01-3.97 (4H, m, 2 x NCH2, both rotamers), 5.28-
5.16 (4H, m, 2  x CH=C//2, both rotamers), 5.87-5.70 (2H, m, 2 x CH= CH2, both rotamers). 
Approx. 1:1 mixture of rotamers; 13C NMR: 8 c (75 MHz, CDCI3) 22.6 (2 x CH2 CH2CF2, 
both rotamers), 31.4 (2 x CH2CF2, both rotamers), 32.7 (CH2 C=0, one rotamer), 33.1 
(CH2C=0, one rotamer), 33.7 (NCH3, one rotamer), 35.1 (NCH3 , one rotamer), 50.0 
(NCH2, one rotamer), 52.4 (NCH2, one rotamer), 116.7 (CH=CH2, one rotamer), 117.1
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(CH=CH2 , one rotamer), 132.1 (CH=CH2 , one rotamer), 132.2 (CH=CH2 , one rotamer),
168.2 (C=0, one rotamer), 168.7 (C=0, one rotamer).
Vmax ATR/cm'1: 2930 br, 1650 s (tertiary amide), 1489 m, 1241 m, 996 m, 823 m.
Oxone (8.32 g, 13.5 mmol) was added to a solution of 2-(3,3,4,4,5,5, 
6 ,6 ,7,7,8 ,8 ,9,9,10,10,1O-heptadecafluorodecylsulfanyO-A-allyl-jV-methylacetamide 197
(2.00 g, 3.38 mmol) in DMF (22 ml) and H2 O (5.5 ml) and the reaction mixture was stirred 
at room temperature for 2 h. The reaction mixture was diluted with H2O (10 ml) and the 
aqueous layer was extracted with CH2CI2 (3 x 2 0  ml). The organic layers were then dried 
(Na2 S0 4) and then concentrated. The crude product was then purified using fluorous silica 
(eluting with 80 % MeCN/H20  then MeCN) to give 2-(3,3,4,4,5,5,6 ,6 ,7,7,8 ,8 ,9,9,10,10,10- 
heptadecafluorodecylsulfonyl)-7V-allyl-iV-methylacetamide 198 as a white solid (695 mg,
1.16 mmol, 33 %).
Approx. 1:1 mixture of rotamers; NMR: 8 h (500 MHz, CDCI3) 2.74-2.70 (4H, m, 2  x 
CH2CF2 , both rotamers), 3.03 (3H, s, NMe, one rotamer), 3.14 (3H, s, NMe, one rotamer), 
3.63-3.58 (4H, m, 2  x C//2 CH2CF2 , both rotamers), 4.09-4.06 (6 H, m, CH2C=0 , one 
rotamer and 2  x NCH2 , both rotamers), 4.15 (2 H, m, CH2 C=0 , one rotamer), 5.33-5.18 
(4H, m, 2 x CH=CH2 , both rotamers), 5.87-5.73 (2H, m, 2 x CH=CH2 , both rotamers). 
Approx. 1:1 mixture of rotamers; 13C NMR: 5c (75 MHz, CDCI3) 24.5 (2 x CH2CF2 , both 
rotamers), 34.5 (NCH3, one rotamer), 36.3 (NCH3, one rotamer), 45.6 (2 x CH2CH2CF2 , 
both rotamers), 50.7 (NCH2 , one rotamer), 53.1 (NCH2 , one rotamer), 56.4 (CH2C=0 , one 
rotamer), 56.7 (CH2CK), one rotamer), 117.6 (CH=CH2 , one rotamer), 118.1 (CH=CH2 ,
Z -P^^ ^SjS^^^T jSjS^^lO jlO JO -H eptadecafluorodecylsuIfonyty-A ^ally l-A f-
methylacetamide 198
O
198
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one rotamer), 131.3 (CH=CH2 , one rotamer), 131.5 (CH=CH2 , one rotamer), 161.5 (C=0, 
one rotamer), 162.0 (C=0, one rotamer).
Vmix ATR/cm'1: 2929 br, 1644 s (tertiary amide), 1487 m, 1239 m, 996 m, 819 m. 
J?-(-)-Methyl mandelate 267124
OH
CO2M©
267
^-(-)-Mandelic acid 207 (10.0 g, 65.7 mmol), was dissolved in MeOH (70 ml), and the 
mixture was cooled to -10 °C before thionyl chloride (5.28 ml, 72.3 mmol) was added 
dropwise. The reaction was then allowed to warm to room temperature and stirred for 3 h. 
The solvent was then evaporated and the reaction mixture was diluted with iced H2O (60 
ml) and Et2 0  (100 ml). The organic layer was then extracted with H2 O (3 x 20 ml), dried 
(MgS04 ), and concentrated to give /?-(-)-methyl mandelate 267 as a white solid (8.50 g,
51.3 mmol, 78 %).
'HNMR: 8 h (400 MHz, CDC13) 3.44 (1H, d, J = 6.5 Hz, OH), 3.78 (3H, s, CH3), 5.19 (1H, 
d, J = 6.5 Hz, CH), 7.45-7.32 (5H, m, 5  x ArH).
R-(-)-!YIe thy I-2-plienyl-2-(tetrahyd ropy ranyloxy) acetate 208124
OTHP
C 0 2Me
208
To a solution containing i?-(-)-methyl mandelate 267 (12.9 g, 77.4 mmol) and dihydropyran 
(29.7 ml, 354 mmol) in CH2 CI2 (200 ml) at 0 °C, was added pyridinium p-toluene sulfonate 
(2.26 g). The reaction was stirred at 0 °C for 10 min before being stirred for a further 43 h
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at room temperature. The reaction mixture was quenched with aqueous saturated NH4 CI 
(10 ml) then H2O (40 ml). The aqueous layer was then extracted with CH2 CI2 (3 x 40 ml). 
The organic layers were then dried (Na2 S0 4 ) and concentrated. The crude product was 
purified by column chromatography (silica, 30 % EtOAc/pet. ether) to give i?-(-)-methyl-2- 
phenyl-2-(tetrahydropyranyloxy) acetate 208 as a clear oil (18.8 g, 75.1 mmol, 97 %). 
Approx. 1:1 mixture of diastereoisomers; !H NMR: 8 h (400 MHz, CDCI3) 1.95-1.47 (12H, 
m, 3  x CH2 of THP, both diastereoisomers), 3.54-3.48 (4H, m, 2 x CH2O, both 
diastereoisomers), 3.72 (6 H, s, 2  x CH3 , both diastereoisomers), 4.59 (1H, t, J = 3.5 Hz, 
OCHO, one diastereoisomer), 4.97-4.82 (1H, m, OCHO, one diastereoisomer), 5.25 (1H, s, 
CHC=0, one diastereoisomer), 5.34 (1H, s, CHC=0, one diastereoisomer), 7.51-7.31 (10H, 
m, 10 x ArH, both diastereoisomers).
/?-(-)-2-Phenyl-2-(tetrahydropyranyloxy) ethanol 206124
OTHP
206
A solution of i?-(-)-methyl-2-phenyl-2-(tetrahydropyranyloxy) acetate 208 (6.76 g, 27.0 
mmol) in THF (70 ml) was added dropwise to a stirred suspension of LiAUTj (2.05 g, 54.0 
mmol) in THF (70 ml) at 0 °C. The reaction mixture was stirred at 0 °C for 30 min before 
being allowed to warm to room temperature and stirred for a further 2 h. The reaction 
mixture was then cooled and quenched with the consecutive addition of aqueous saturated 
NH4CI (10 ml), 10 % aqueous NaOH (10 ml), and H2 O (10 ml). The resulting white 
precipitate was then filtered and extracted with THF (2 x 50 ml). The organic layer was 
then dried (MgS0 4 ), and concentrated. The crude mixture was purified by column 
chromatography (silica, 40 % EtOAc/pet. ether) to give Z?-(-)-2-phenyl-2-
(tetrahydropyranyloxy) ethanol 206 as a clear oil (4.64 g, 20.8 mmol, 77 %).
Approx. 1:1 mixture of diastereoisomers; *H NMR: 5h (400 MHz, CDCI3) 1.91-1.44 (12H, 
m, 3 x CH2 of THP, both diastereoisomers), 2.40 (1H, broad, OH, one diastereoisomer),
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3.13 (1H, broad, OH, one diastereoisomer), 3.33-3.28 (2H, m, 2 x CT/^HbOH, both 
dias:ereoisomers), 3.62-3.53 (2H, m, 2  x CHaT/aOH, both diastereoisomers), 4.08-4.01 
(2H. m, 2 x C//^HbOC, both diastereoisomers), 4.54 (1H, apparent q, J = 2.8 Hz, OCHO, 
one diastereoisomer), 4.76-4.73 (2H, m, 2 x CHaT/sOC, both diastereoisomers), 4.85-4.82 
(2H. m, C//CH2 O, both diastereoisomers), 4.93 (1H, t, J = 3.6 Hz, OCHO, one 
diasiereoisomer), 7.42-7.28 (10H, m, 10 x ArH, both diastereoisomers).
/?-(-)-2-Phenyl-2-(tetrahydropyranyloxy)-l-/?-toluenesulfonyloxyethane 20946
/?-TsCl (8.85 g, 46.4 mmol) was added to a solution containing i?-(-)-2-phenyl-2- 
(tetrahydropyranyloxy) ethanol 206 (9.38 g, 42.2 mmol), in pyridine (28.9 ml). The 
mixture was stirred at room temperature for 7 h. The reaction mixture was quenched first 
with aqueous saturated NaCl (10 ml) and then with H2O (20 ml) and the organic layer 
extracted with CHCI3 (3 x 20 ml). The organic layer was then further washed with aqueous 
saturated CUSO4 (0.5 M, 5 x 20 ml) to remove excess pyridine. The organic layer was then 
dried (MgS0 4 ), and concentrated. The crude mixture was purified by recrystallisation from 
pet. ether/CH2Cl2 to give i?-(-)-2 -phenyl-2 -(tetrahydropyranyloxy)-l-p-toluenesulfonyloxy 
ethane 209 as white crystals (10.9 g, 28.7 mmol, 6 8  %).
Approx. 1:1 mixture of diastereoisomers; !H NMR: §h (400 MHz, CDCI3) 1.88-1.49 (12H, 
m, 3  x CH2 of THP, both diastereoisomers), 2.45 (6 H, s, 2  x CH3 , both diastereoisomers),
3.52-3.50 (1H, m, OCHPh, one diastereoisomer), 3.98 (1H, dt, J = 3.1, 10.5, OCHO, one 
diastereoisomer), 4.16-4.07 (4H, m, 2 x CH2 OC, both diastereoisomers), 4.22 (1H, dd, J =
8.0,10.5, OCHPh, one diastereoisomer), 4.50 (1H, t, J = 3.1, OCHO, one diastereoisomer),
4.96-4.87 (4H, m, 2 x CH2OS, both diastereoisomers), 7.32-7.24 (14H, m, 14 x ArH, both 
diastereoisomers), 7.75 (4H, dd, J = 2.7, 8.4 Hz, 4 x ArH, both diastereoisomers).
OTHP
209
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l,2-Di[(*S)-2-hydroxy-2-phenylethoxy] benzene 21046
Ph
OH
OH
Ph
210
To a suspension of CS2 CO3 (1.50 g, 4.60 mmol), in DMF (2.5 ml) was added catechol (0.23 
g, 2.09 mmol) and the reaction mixture was stirred vigorously for 30 min. ^-(-)-2-Phenyl-
2-(tetrahydropyranyloxy)-l-p-toluenesulfonyloxy ethane 209 (1.73 g, 4.60 mmol) was then 
added to the suspension which was then heated to 80 °C and stirred for 23 h. After cooling 
the reaction mixture was diluted with Et2 0  (50 ml) and then washed with aqueous saturated 
NaCl (10 ml), and H2O (2 x 10 ml). The organic layer was then dried (MgS0 4 ), 
concentrated and used without further purification.
A solution of the residue and p-toluenesulfonic acid (0.14 g, 0.73 mmol) in MeOH (15 ml) 
was stirred at room temperature for a further 2.5 h. The MeOH was then removed in the 
presence of NaHC0 3  (1.00 g), and the resulting residue was diluted with Et2 0  (50 ml), the 
solids filtered off, and the filtrate concentrated. The crude mixture was purified by column 
chromatography (silica, 30 % EtOAc/pet. ether), and then further purified by 
recrystallisation from pet. ether/CH2 Cl2 to give l , 2 -di[(iS)-2 -hydroxy-2 -phenylethoxy] 
benzene 210 as off white crystals (580 mg, 1.59 mmol, 76 %).
‘H NMR: SH (400 MHz, CDCU) 3.81 (2H, s, OH), 4.08 (2H, m, C/^HbO), 4.18 (2H, dd, J 
= 3.0, 10.0, CHaHsO), 5.13 (2H, dd, J = 3.0, 8.9, CHO), 6.98 (4H, s, 4 x ArH), 7.42 (10H, 
m, 1 0  x ArH).
[<x]D = -  86.1°, Lit. value = + 85.7° ^-isomer (CHCI3).
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2,2’-Di[(S)-2-hydroxy-2-phenylethoxy]-l,l’-biphenyl 21146
According to the procedure described for 210, 2,2’-diphenol (1.50 g, 8.06 mmol) and 
tosylate 209 (6.67 g, 17.7 mmol) were reacted with CS2CO3 (6.36 g, 17.7 mmol) in DMF 
(20 ml) for 15 h at 80 °C. The crude mixture was purified by column chromatography 
(silica, 20 % EtOAc/pet. ether), to give 2,2’-di[(S)-2-hydroxy-2-phenylethoxy]-l,r- 
biphenyl 211 as an orange oil (2.33 g, 5.48 mmol, 6 8  %).
!H NMR: 8 h (400 MHz, CDCI3) 3.73 (2H, broad singlet, OH), 4.05 (2H, apparent t, J = 9.3 
Hz, CT^HbO), 4.17-4.13 (2H, m, CUaHbO), 4.92 (2H, d, J = 8.9 Hz, CM)H), 7.04 (2H, d, 
J = 8.3 Hz, ArCH), 7.16 (2H, t, J = 7.6 Hz, 2 x ArCH), 7.35-7.30 (14H, m, 14 x ArH).
[a]D = -  40.5°, Lit. value = + 40.1° /?-isomer (CHCI3).
l , l ’-Di [(S)-2-hydroxy-2-phenylethyl]-0-xylenedioxide 21240
Ph
° H
OHv_y
Ph
212
7?-(-)-2-Phenyl-2-(tetrahydropyranyloxy) ethanol 206 (8.58 g, 0.04 mmol) was added to a 
suspension of NaH (0.94 g, 0.04 mmol) in THF (140 ml) that had been cooled to 0 °C, and 
the reaction mixture was stirred for 30 min. 1,1’-o-Xylenedibromide (4.63 g, 0.02 mmol) 
was then added and the reaction mixture was allowed to warm to room temperature before 
being stirred for 17 h. The reaction mixture was quenched with acetic acid (10 ml), then
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H2O before being extracted with Et2 0  (3 x 20 ml). The organic layers were then dried 
(Na2 SC>4) and concentrated to give 1 , 1  ’-bis[(^)-2 -tetrahydropyranyloxy-2 -phenylethyl]-o- 
xylenedioxide which was used without further purification.
A solution of the residue and p-toluenesulfonic acid (9.97 g, 0.04 mmol) in MeOH (60 ml) 
was stirred at room temperature for a further 2.5 h. The MeOH was then removed in the 
presence of NaHC0 3  (1.00 g), and the resulting residue was diluted with CH2CI2 (30 ml), 
the precipitate filtered off, and the filtrate concentrated. The crude mixture was purified by 
column chromatography (silica, 30 % EtOAc/pet. ether) to give 1,1’-di [(£)-2-hydroxy-2- 
phenylethyl]-oxylenedioxide 212 as a white solid (4.23 g, 0.01 mmol, 56 %).
'H NMR: 5 h (500 MHz, CDC13) 3.47-3.43 (2H, m, O C i^H BCHOH), 3.49 (2H, broad 
singlet, OH), 3.62 (2H, dd, J = 3.0, 9.9 Hz, OCHAHBCHOH), 4.57 (2H, d, J = 11.6 Hz, 
PhC/^HnO), 4.65 (2H, d, J = 11.6 Hz, PhCHA// flO), 4.85 (2H, dd, J = 3.0, 9.1 Hz, CtfOH), 
7.30-7.18 (14H, m, 14 x ArH).
iV,A'’-Oi|(S)-2-hydroxy-2-phenylethyl]-'V,iV’-diisopropylethylenediamine 21346
A solution of A^A'-diisopropylethylenediamine (1.20 g, 8.32 mmol) and (R)-styrene oxide 
(2.00 g, 16.6 mmol) was stirred in DMF : H20  (9:1, 6.60 ml) and the reaction mixture was 
heated to 100 °C and stirred for 18 h. The reaction mixture was quenched with aqueous 
saturated NaCl (5 ml) and then extracted with EtO Ac ( 3 x 1 5  ml). The organic layer was 
then dried (Na2 S0 4 ), and concentrated. The crude mixture was purified by column 
chromatography (silica, 5 % EtOAc/pet. ether) to give A, A ’-dilXS^-hydroxy^- 
phenylethyl]-//, A ’-diisopropylethylene diamine 213 as a clear oil (771 mg, 2.66 mmol, 32
213
%).
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'H NMR: 8 h (500 MHz, CDC13) 0.93 (6 H, d, J = 6 . 6  Hz, CH3), 0.96 (6 H, d, J = 6 . 6  Hz, 
CH3), 2.32 (2H, dd, J = 10.5, 13.7 Hz, N C/^H BCH), 2.43-2.55 (4H, m, NCH2CH2N), 2.67 
(2H, dd, J = 3.0, 13.7 Hz, NCHaHbCH), 2.98-2.93 (2H, m, NCH), 4.67 (2H, dd, J = 3.0, 
10.5 Hz, C.HOH), 5.84 (2H, br, OH), 7.28-7.09 (10H, m, 10 x ArH).
[a]D = -  137.5°, Lit. value = -  137.0° (CHC13).
(25/2R,4S,5R)-3,4-dimethyI-2-(3-((25/2R,4S,5R)-3,4-dimethyl-5-phenyloxazolidin-2- 
yl)phenyl)-5-phenyIoxazolidine 217 and (+)-(15,2/?)-bis[/V-methyl-7V-(2-hydroxy-2- 
phenyl-l-methyl)-ethyl]-m-xylenediamine 214122,123
A ^ P h
N\  I
4 °
V o
" V ' " ph
217
Isophthaldialdehyde 216 (1.69 g, 12.6 mmol) and (-)-ephedrine (4.16 g, 25.2 mmol) were 
stirred in CH2CI2 (50 ml) in the presence of 3 A molecular sieves (3 g) at room temperature 
for 24 h. The crude mixture was filtered through a pad of celite to give (25/2J?,4S,5R)-3,4- 
dimethyl-2-(3-((25/2/?,4S,5R)-3,4-dimethyl-5-phenyloxazolidin-2-yl)phenyl)-5-phenyloxa- 
zolidine 217 which was used without further purification.
]H NMR: 5h (500 MHz, CDC13) 0.86 (6 H, d, J = 6.0 Hz, CHCH3), 2.26 (6 H, s, NMe), 3.05 
(2H, dq, J = 6.0, 9.0 Hz, CHCU3), 4.82 (2H, s, NCHO), 5.22 (2H, d, J = 9.0 Hz, PhCHO), 
7.94-7.30 (14H, m, 14 x ArH).
The crude mixture in THF (40 ml) was added dropwise to a suspension of LiAfflU (944 mg, 
24.9 mmol) in THF (80 ml) and the reaction mixture was heated to reflux for 17 h. Upon 
cooling, the reaction mixture was treated sequentially with H2 O (0.9 ml), 15 % NaOH (2.7 
ml) and H20  (0.9 ml) before being stirred for 2 h. The white solids were removed by 
filtration, and the filtrate was dried (Na2 S0 4 ) and then concentrated. The crude mixture was
Ph
N OH
u
/ —
c '— N OH
Ph
214
177
purified by column chromatography (silica, 48 % EtO Ac /48 % pet. ether/4 % NEt3) to give 
(+)-(15',2^)-bis[A-methyl-iV-(2-hydroxy-2-phenyl-l-methyl)-ethyl]-w-xylenediamine 214 
as a clear oil (4.92 g, 11.3 mmol, 90 % over 2 steps).
‘H NMR: 5h (500 MHz, CDC13) 0.86 (6 H, d, J = 7.0 Hz, CHCHj), 2.02 (6 H, s, NMe), 2.76 
(2H, dt, J = 4.9, 7.0 Hz, CtfCH3), 3.43 (4H, s, NCH2), 4.68 (2H, d, J = 4.9 Hz, CHOH),
6.97-6.92 (3H, m, 3  x ArH), 7.12-7.06 (3H, m, 3  x ArH), 7.17-7.14 (8 H, m, 8  x ArH).
(25/2/?,45,5R)-3,4-dimethyl-2-(2-((2Sy21?,4S,5J?)-3,4-dimethyl-5-plieiiyloxazolidiii-2- 
yl)phenyl)-5-phenyloxazolidine 219 and (+)-(!£,2i?)-bis[/V-methyl-/V-(2-hydroxy-2- 
phenyI-l-methyl)-ethyl]-0 -xylenediamine 215122,123
/ N .
219
According to the procedure described for 217, phthaldialdehyde 218 (1.69 g, 12.6 mmol) 
was stirred with (-)-ephedrine (4.16 g, 25.2 mmol) and 3 A molecular sieves (3 g) in 
CH2C12 (50 ml) to give (25'/2^,45',5i?)-3,4-dimethyl-2-(2-((2(S,/2i?,45',5^)-3,4-dimethyl-5- 
phenyloxazolidin-2-yl)phenyl)-5-phenyloxazolidine 219 which was used without further 
purification.
*H NMR: 5h (500 MHz, CDCI3) 0.85 (6 H, d, J = 6.0 Hz, CHC//?), 2.23 (6 H, s, NMe), 
3.11-3.06 (2H, m, CHCU3),  5.25 (2H, d, J = 9.0 Hz, PhCHO), 5.42 (2H, s, NCHO), 8.12-
7.30 (14H, m, 14 x ArH).
According to the procedure described for 214, the crude mixture was treated with LiAlHU 
(944 mg, 24.9 mmol) to give (+)-(lS,2i?)-bis[Af-methyl-/V-(2-hydroxy-2-phenyl-l-methyl)- 
ethyl]-o-xylenediamine 215 as a clear oil (3.52 g, 8.32 mmol, 6 6  %).
]H NMR: 5h (500 MHz, CDC13) 0.82 (6 H, d, J = 12.6 Hz, CHC//3), 1.93 (6 H, s, NMe), 
2.61 (2H, dq, J = 6.0, 12.6 Hz, C//CH3), 3.22 (2H, d, AB system J = 13.3 Hz, N C/^H B),
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3.37 (2 H, d, AB system J = 13.3 Hz, NCHA/fr), 3.56 (2 H, br, OH), 4.54 (2 H, d, J = 6 . 0  Hz, 
C//OH), 7.12-7.00 (14H, m, 14 x ArH).
General procedure A for the reduction of a-heterosubstituted lactones:
3-Benzyldihydro-2(3//)-furanone 121 from the reduction-protonation of 3-benzyl-3-(4- 
benzyloxyphenoxy)dihydro-furan-2-one 119 using l,2-di[(*S)-2-hydroxy-2-phenylethoxy] 
benzene 2 1 0
O
121
A solution of SmB (8.0 ml, 0.80 mmol, 0.1 M in THF) was added to a solution of 1,2- 
di[(5)-2-hydroxy-2-pheny!ethoxy] benzene 210 (281 mg, 0.80 mmol) in THF (1 ml) that 
had been cooled to -20 °C. 3-Benzyl-3-(4-benzyloxyphenoxy)dihydro-furan-2-one 119 
(100 mg, 0.27 mmol) in THF (1.5 ml) was then added dropwise via cannula and the 
reaction mixture was stirred at -20 °C for 18 h. The reaction mixture was allowed to 
decolourise in air before being quenched with aqueous saturated NaCl (5 ml). The aqueous 
layer was then extracted with 30 % EtO Ac/pet. ether ( 3 x 5  ml). The organic layer was then 
dried (Na2 S0 4 ), and concentrated. The crude mixture was purified by column 
chromatography (silica, 15 % EtO Ac/pet. ether) to give 3-benzyldihydro-2(3//)-furanone 
121 as a yellow oil (22 mg, 0.13 mmol, 47 %, 0 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
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3-Benzyldihydro-2(3Z))-furanone 234 from the reduction-protonation of 3-benzyl-3-(4- 
benz/loxyphenoxy)dihydro-furan-2-one 119 in the presence of MeOD
O
234
A solution of Sml2 (9.60 ml, 0.96 mmol, 0.1 M in THF), was added to a solution of 3- 
benz/l-3-(4-benzyloxyphenoxy)dihydro-furan-2-one 119 (150 mg, 0.40 mmol) and MeOD 
(3.2 ml) in THF (3 ml) that had been cooled -20 °C. The mixture was then stirred at -20 °C. 
After 1 h, a further 2.4 equivalents of SmH (7.38 ml, 0.74 mmol, 0.1 M in THF) was added 
and the reaction was allowed to stir for another 4 h. The reaction mixture was quenched 
first with aqueous saturated NH4CI (3 ml) followed by H2 O (3 ml) and then extracted with 
Et2 0  ( 3 x 1 0  ml). The organic layer was then dried (MgS0 4 ), and concentrated. The crude 
mixture was purified by column chromatography (silica, 1 0 0  % CH2CI2) to give 3- 
benzyldihydro-2(3D)-furanone 234 as a yellow oil (7.6 mg, 0.04 mmol, 11 %).
‘H NMR: 8h (400 MHz, CDCI3) 2.16-2.06 (1H, m, C /^H BCH2 0), 2.40-2.33 (1H, m, 
CHaHbCH20), 2.90 (1H, d, J = 14.0 Hz, PhC/^He), 3.37 (1H, d, J = 14.0 Hz, PhCHAf t ) ,  
4.36-4.23 (2H, m, CH20), 7.53-7.31 (5H, m, 5  x ArH).
3-Benzyldihydro-2(3//)-furanone 121 from the reduction-protonation of 3-benzyl-3-(4- 
benzyloxyphenoxy)dihydro-furan-2-one 119 in the presence of BnOH
O
121
A solution of SmH (3.20 ml, 0.32 mmol, 0.1 M in THF), was added to a solution of 3- 
benzyl~3-(4-benzyloxyphenoxy)dihydro-furan-2-one 119 (50.0 mg, 0.13 mmol) and BnOH 
(55.0 pi) in THF (1 ml) that had been cooled -20 °C. The mixture was then stirred at -20 °C
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for 2h. The reaction mixture was quenched with D2 O (3 ml) and then extracted with 30 % 
EtO/c/pet. ether ( 3 x 5  ml). The organic layer was then dried (MgS0 4 ), and concentrated. 
The crude mixture was purified by column chromatography (silica, 1 0 0  % CH2 CI2) to give 
3-beizyldihydro-2(3Z))-furanone 121 as a yellow oil (4.23 mg, 0.06 mmol, 42 %). 
Specroscopic data corresponded to that reported earlier in this section.
3-Mtthoxy-dihydro-furan-2-one 237135
To asolution of a-hydroxy-y-butryolactone (2.50 g, 24.3 mmol) in DMF (15 ml) was added 
silver oxide (8.97 g, 72.9 mmol) and Mel (3.02 ml, 48.6 mmol) and the reaction mixture 
was stirred at room temperature for 22 h. 20 % EtO Ac/pet. ether (3 x 20 ml) was added to 
the reaction mixture and it was passed through a plug column and concentrated. The crude 
mixture was purified by column chromatography (silica, 30 % EtOAc/pet. ether) to give 3- 
mettoxy-dihydro-furan-2-one 237 as a clear oil (1.93 g, 16.5 mmol, 6 8  %).
*H NMR: 5h (500 MHz, CDC13) 2.32 (1H, dd, J = 6 .8 , 8.1 Hz, C /^H BCH2 0), 2.66-2.59
13C NMR: 5C (75 MHz, CDC13) 29.1 (CH2CH20), 57.9 (OMe), 65.2 (CH2 CH20), 74.8 
(CH), 174.7 (C=0).
vmax fCBr/cm' 1 2925 w, 1776 s (C=0), 1362 w, 1157 m.
MS (Cl): m/z 134 (((M+H)+NH3)+, 100 %), 8 6  (60).
HRMS: Found 134.0808, C5H 12O3N requires 134.0812.
O
237
(1H,m, CHAtf*CH2 0 ), 3.63 (3H, s, OMe), 4.14 (1H, t, J = 8.1 Hz, CH), 4.33 (1H, ddd, J = 
6 .8 , 8.4, 9.3 Hz, CH2C /^H bO), 4.49 (1H, dt, J = 8.4, 9.3 Hz, CH2CHAtfsO).
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3-Benzyl-3-methoxy-dihydro-fiiran-2-one 236
O
236
To a solution of diisopropylamine (2.41 ml, 17.2 mmol), in THF (4 ml) that had been 
cooled to -45 °C was added nBuLi (6.89 ml, 17.2 mmol, 2.5 M in hexane). The reaction 
mixture was then stirred for 30 min at -45 °C. A solution of 3-methoxy-dihydro-furan-2- 
one 237 (1.00 g, 8.61 mmol) in THF ( 6  ml) was then added dropwise by cannula and the 
reaction was stirred for a further 30 min. Finally, benzyl bromide (7.37 ml, 43.1 mmol) was 
added dropwise to the solution and the reaction mixture stirred for 8  h. The reaction 
mixture was quenched first with aqueous saturated N H 4 C I  (5 ml) then H2O (5 ml) and 
extracted with CH2CI2 (3 x 10 ml). The organic layers were then dried (MgSCU) and 
concentrated. The crude mixture was purified by column chromatography (silica, 20 % 
EtOAc/pet. ether) to give 3-benzyl-3-methoxy-dihydro-furan-2-one 236 as a yellow oil 
(629 mg, 3.01 mmol, 35 %).
lU NMR: 5h (500 MHz, CDCI3) 2.25 (1H, t, J = 6.4 Hz, C7^HBCH2 0), 2.26 (1H, t, J = 7.3 
Hz, CHaHbCU20), 3.11 (1H, d, AB system, J = 14.0 Hz, PhCH2C), 3.21 (1H, d, AB 
system, J = 14.0 Hz, PhCH2C), 3.49 (3H, s, OMe), 3.89 (1H, dt, J = 6.4, 8 . 8  Hz, C /^H bO),
4.30 (1H, dt, J = 7.3, 8 . 8  Hz, CUaHbO), 7.36-7.25 (5H, m, 5 x ArH).
13C NMR: 6 C (75 MHz, CDC13) 31.9 (CH2CH2 0), 38.5 (CH2Ph), 52.1 (OMe), 65.4 
(CH2CH2O), 80.2 (ArC), 127.1 (ArCH), 128.5 (2 x ArCH), 130.0 (2 x ArCH), 134.9 
(CC=0), 175.1 (0=0).
vmax KBr/cm ' 1 2936 w, 2330 s, 1759 s (C O ), 1142 w, 633 w.
MS (Cl): m/z 224 (((M+H)+NH3)+, 100 %), 91 (100).
HRMS: Found 224.1280 C 12H 18O3N requires 224.1281.
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3-Benzyloxy-dihydro-furan-2-one 238
To a solution of a-hydroxy-y-butryolactone (2.02 g, 19.8 mmol) in DMF (15 ml) was added 
silver oxide (7.30 g, 59.4 mmol) and benzyl bromide (4.71 ml, 39.6 mmol) and the reaction 
mixture was stirred at room temperature for 24 h. 40 % EtO Ac/pet. ether (3 x 20 ml) was 
added to the reaction mixture and it was passed through a plug column and concentrated. 
The crude mixture was purified by column chromatography (silica, 20 % EtO Ac/pet. ether) 
to give 3-benzyloxy-dihydro-furan-2-one 238 as a yellow oil (2.86 g, 14.9 mmol, 75 %).
'H NMR: 6  2.33-2.24 (1H, m, C ftH BCH2 0), 2.51-2.43 (1H, m, CHAtfsCH2 0), 4.25-4.15 
(2H, m, C H ^C H b O  and CH), 4.41 (1H, ddd, J = 4.1, 8.2, 9.1 Hz, CH2CHA% 0 ), 4.74 
(1H, d, AB system, J = 11.8 Hz, PhCH20), 4.95 (1H, d, AB system, J = 11.8 Hz, PhCH20),
7.45-7.28 (5H, m, 5 x ArH).
I3C NMR: 8  29.8 (CH2CH20), 65.3 (CH2CH20), (CH2Ph), 72.3 (CH), 128.1 (2 x ArCH), 
128.8 (3 x ArCH), 136.9 (ArC), 175.0 (C=0).
vmax KBr/cm ' 1 3536 br, 2915 m, 1772 br (C=0), 1454 s, 1025 m, 744 m.
MS (Cl): m/z 193 (M \ 97 %), 91 (Bn+, 100 %).
HRMS: Found 193.0866, CnHi20 3, requires 193.0865.
3-Benzyl-3-benzyloxy-dihydro-furan-2-oiie 239
O
239
To a solution of diisopropylamine (729 pi, 5.20 mmol), in THF (1 ml) that had been cooled 
to -45 °C was added "BuLi (2.25 ml, 5.20 mmol, 2.24 M in hexane). The reaction mixture
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was then stirred for 30 min at -45 °C. A solution of 3-benzyloxy-dihydro-furan-2-one 238 
(500 mg, 2.60 mmol) in THF (4 ml) was then added dropwise by cannula and the reaction 
was stirred for a further 30 min. Finally, benzyl bromide (1.55 ml, 13.0 mmol) was added 
dropwise to the solution and the reaction mixture stirred for 8  h. The reaction mixture was 
quenched with aqueous saturated N H 4 C I  (5 ml) then H2 O (5 ml) and the aqueous layer was 
extracted with 40 % EtO Ac/pet. ether ( 3 x 5  ml). The organic layer was then dried 
(MgS0 4 ), and concentrated. The crude mixture was purified by column chromatography 
(silica, 10 % EtO Ac/pet. ether) to give 3-benzyl-3-benzyloxy-dihydro-furan-2-one 239 as a 
clear oil (289 mg, 1.01 mmol, 39 %).
'H NMR: SH (400 MHz, CDCI3 ) 2.25-2.13 (2H, m, C //2 CH20), 3.12 (1H, d, AB system, J 
= 13.9 Hz, PhCH2C), 3.17 (1H, d, AB system, J = 13.9 Hz, PhCH2C), 3.78 (1H, ddd, J =
5.0, 7.4, 8 . 8  Hz, CH2C /^H B0), 4.20 (1H, dt, J = 7.3, 8 . 8  Hz, CH2CHAHsO), 4.56 (1H, d,
AB system, J = 11.1 Hz, PhCH20), 4.65 (1H, d, AB system, J = 11.1 Hz, PhCH20), 7.30-
7.15(1 OH, m, 10 x ArH).
,3C NMR: 8 c (100 MHz, CDCI3) 32.7 (CH2CH20), 39.0 (CH2Ph), 65.5 (CH2CH20), 66.7 
(PhCH2 0), 126.5 (ArC), 127.6 (ArCH), 127.7 (ArCH), 127.9 (ArCH), 128.1 (ArCH), 128.4 
(ArCH), 128.5 (ArCH), 128.8 (ArCH), 129.8 (ArCH), 130.1 (ArCH), 130.3 (ArCH), 134.9 
(CC=0), 137.5 (ArCO), 175.3 (C=0). 
vma* KBr/cm ' 1 2919 m, 1772 br (C=0), 1454 s, 1024 m, 700 s.
MS (Cl): m/z 283 (M+, 100 %), 91 (Bn+, 9 %).
HRMS: Found 283.1334, Ci8Hi90 3, requires 283.1334.
MP: 100.9- 102.1 °C.
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3-BenzyIdihydro-2(3//)-furaiione 121 from reduction-protonation of 3-benzyl-3- 
methoxy-dihydro-furan-2-one 236 using l,2-di[(S)-2-hydroxy-2-phenylethoxy] benzene 
210
O
121
According to general procedure A. 3-Benzyl-3-methoxy-dihydro-furan-2-one 236 (50.0 
mg, 0.26 mmol) was reduced using Smh (7.90 ml, 0.79 mmol, 0.1 M in THF) in the 
presence of l,2-di[(S)-2-hydroxy-2-phenylethoxy] benzene 210 (276 mg, 0.79 mmol) to 
give 3-benzyldihydro-2(3//)-furanone 121 (8.97 mg, 0.05 mmol, 20 %, 0 % ee). 
Spectroscopic data corresponded to that reported earlier in this section.
3-BenzyIdihydro-2(3/f)-furanone 121 from reduction-protonation of 3-benzyl-3- 
benzyloxy-dihydro-furan-2-one 239 using 1,2-di [(S)-2-hydroxy-2-phenylethoxy] benzene 
210
According to general procedure A. 3-Benzyl-3-benzyloxy-dihydro-furan-2-one 239 (100 
mg, 0.35 mmol) was reduced using SmH (8.50 ml, 0.85 mmol, 0.1 M in THF) in the 
presence of l,2-di[(*S)-2-hydroxy-2-phenylethoxy] benzene 210 (248 mg, 0.71 mmol) to 
give 3-benzyldihydro-2(3//)-furanone 121 (22.8 mg, 0.13 mmol, 37 %, 0 % ee). 
Spectroscopic data corresponded to that reported earlier in this section.
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3-BenzyI-3-(4-benzyloxy-phenyIsulfanyl)dihydro-furan-2-one 240
240
To a solution of diisopropylamine (196 pi, 1.40 mmol), in THF (2 ml) that had been cooled 
to -45 °C was added nBuLi (624 pi, 1.40 mmol, 2.24 M in hexane). The reaction mixture 
was then stirred for 30 min at -45 °C. A solution of 3-(4-benzyloxy-
phenylsulfanyl)dihydro-furan-2-one 136 (300 mg, 1.00 mmol) in THF ( 6  ml) was then 
added dropwise by cannula and the reaction was stirred for a further 30 min. Finally, 
benzyl bromide (594 pi, 4.99 mmol) was added dropwise to the solution and the reaction 
mixture was allowed to warm slowly and stirred for 3.5 h. The reaction mixture was 
quenched with aqueous saturated N H 4 C I  (5 ml), H2O (10 ml), and then diluted with 40 % 
EtO Ac/pet. ether ( 3 x 1 0  ml). The organic layer was then dried (MgS04) and concentrated. 
The crude mixture was purified by column chromatography (silica, 10 % EtO Ac/pet. ether) 
to give 3-benzyl-3-(4-benzyloxy-phenylsulfanyl)dihydro-furan-2-one 240 as an off-white 
solid (317 mg, 0.81 mmol, 81 %).
*H NMR: 5h (400 MHz, CDC13) 2.14 (1H, ddd, J = 2.2, 6.7, 13.8 Hz, C/^HbCHzO), 2.49- 
2.41 (1H, m, CHaHbCU20), 3.03 (1H, d, AB system, J = 13.8 Hz, CCH2Ph), 3.33 (1H, d, 
AB system, J = 13.8 Hz, CCH2Ph), 3.93 (1H, dt, J = 2.2, 8 . 8  Hz, C /^H bO), 4.17-4.12 (1H, 
m, CHa//sO), 5.10 (2H, s, PhCH2 0), 7.00 (2H, d, J = 8 . 8  Hz, 2 x ArH), 7.47-7.21 (10H, m, 
5 x ArH), 7.55 (2H, d, J = 8 . 8  Hz, 2 x ArH).
13C NMR: 6 C (100 MHz, CDC13) 32.2 (CH2CH20), 41.4 (CCH2Ph), 54.6 (CC=0), 64.9 
(CH2CH20), 70.1 (PhCH2 0), 115.4 (2 x ArCH), 120.2 (ArCS), 127.2 (2 x ArCH), 127.6 (2 
x ArCH), 128.2 (2 x ArCH), 128.6 (ArCH), 128.7 (2 x ArCH), 130.4 (ArCH), 135.8 (ArC),
136.4 (ArC), 138.9 (2 x ArCH), 160.6 (ArCO), 175.8 (C=0).
Vmax KBr/cm ' 1 1749 m (C=0), 1245 m, 1002 s, 831 s, 704 m.
MS (El): m/z 390 (M+, 27 %), 91 (Bn+, 100 %).
HRMS: Found 390.1292, C24H2 2 0 3 S, requires 390.1290.
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MP: 131.9-133.2 °C.
3-BenzyIdihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4- 
benzyloxy-phenylsulfanyl)dihydro-furan-2-one 240 using l,2-di[(S)-2-hydroxy-2- 
phenylethoxy] benzene 2 1 0
O
121
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-phenylsulfanyl)dihydro- 
furan-2-one 240 (100 mg, 0.26 mmol) was reduced using Smh (7.70 ml, 0.77 mmol, 0.1 M 
in THF) in the presence of l,2-di[(5)-2-hydroxy-2-phenylethoxy] benzene 210 (269 mg, 
0.77 mmol) to give 3-benzyldihydro-2(3#)-furanone 121 (19.0 mg, 0.12 mmol, 46 %, 0 % 
ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-BenzyIdihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4- 
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using 1,2-di[(S)-2-hydroxy-2- 
phenylethoxy] benzene 2 1 0
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
furan-2-one 139 (100 mg, 0.24 mmol) was reduced using SmH (5.70 ml, 0.57 mmol, 0.1 M 
in THF) in the presence of l,2-di[(<S)-2-hydroxy-2-phenylethoxy] benzene 210 (166 mg, 
0.47 mmol) to give 3-benzyldihydro-2(3/i)-furanone 121 (32.0 mg, 0.18 mmol, 76 %, 13 % 
ee).
Spectroscopic data corresponded to that reported earlier in this section.
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3-Benzylsulfanyl-dihydro-furan-2-one 243
a-Bromo-y-butyrolactone (3.72 ml, 40.3 mmol) was added to a solution of 
benzylmercaptan (945 pi, 8.05 mmol) and NEt3 (5.64 ml, 40.3 mmol) in DMF (20 ml), and 
the reaction mixture was stirred at room temperature for 1.5 h. The reaction mixture was 
quenched with aqueous saturated N H 4 C I  (5 ml), then H 20 (10 ml), and the organic layer 
was then extracted with C H 2 C I 2  (3 x  20 ml). The organic layer was then dried (MgSO^ and 
concentrated. The crude mixture was purified by column chromatography (silica, 30 % 
EtOAc/pet. ether) to give 3-benzylsulfanyl-dihydro-furan-2-one 243 as a clear oil (1.32 g, 
6.23 mmol, 78 %).
'H NMR: 6h (500 MHz, CDC13) 2.08-2.02 (1H, m, C /^H bC H ), 2.56 (1H, apparent dq, J = 
8 .6 , 13.5 Hz, CHA// 5 CH), 3.33 (1H, dd, J = 4.5, 8 . 6  Hz, CH), 3.84 (1H, AB system J = 13.5 
Hz, PI1CH2 S), 4.13 (1H, AB system J = 13.5 Hz, PhCH2 S), 4.32-4.28 (1H, m, C/^HbO), 
4.43-4.38 (1H, m, CHA//*0), 7.43-7.28 (5H, m, 5  x ArH).
13C NMR: 8 c (75 MHz, CDC13) 29.5 (CH2CH), 35.1 (CH2 S), 37.6 (CHC=0), 6 6 . 8  (CH20),
127.4 (2 x ArCH), 128.6 (2 x ArCH), 129.2 (ArCH), 137.0 (ArC), 175.5 (C=0). 
vmax KBr/cm' 1 2912 w, 1760 s (C=0), 1373 w, 1155 m, 699 s.
MS (Cl): m/z 226 (((M+H)+NH3)+, 100 %), 91 (59).
HRMS: Found 226.0896, CnHi60 2NS requires 226.0896.
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3-Benzyl-3-benzyIsulfanyl-dihydro-furan-2-one 241
To a solution of diisopropylamine (471 pi, 3.36 mmol), in THF (2 ml) that had been cooled 
to -45 °C was added DBuLi (1.34 ml, 3.36 mmol, 2.5 M in hexane). The reaction mixture 
was then stirred for 30 min. A solution of 3-benzylsulfanyl-dihydro-furan-2-one 243 (500 
mg, 2.40 mmol) in THF (3 ml) was then added dropwise by cannula and the reaction was 
stirred for a further 30 min. Finally, benzyl bromide (1.14 ml, 9.60 mmol) was added 
dropwise to the solution and the reaction mixture stirred for 6  h. The reaction mixture was 
quenched with aqueous saturated N H 4 C I  (2 ml), then H2 O (10 ml) and then extracted with 
C H 2 C I 2  ( 3 x 5  ml). The organic layers were then dried (Na2 S0 4 ), and concentrated. The 
crude mixture was purified by column chromatography (silica, 20 % EtOAc/pet. ether) to 
give 3-benzyl-3-benzylsulfanyl-dihydro-furan-2-one 241 as a clear oil (660 mg, 2.33 mmol, 
97 %).
'H NMR: 8 h  (500 MHz, CDCI3) 1.95-1.91 (1H, m, C///fHBCH20), 2.47-2.44 (1H, m, 
CHAflaCH20), 3.11 (1H, AB system, J = 14.0 Hz, PhCH2C), 3.45 (1H, AB system, J =
14.0 Hz, PhCH2C), 4.01 (1H, AB system J = 12.1 Hz, PhCH2 S), 4.09 (1H, AB system J =
12.1 Hz, PhCH2 S), 4.13-4.10 (1H, m, CHaUbO), 4.40-4.36 (1H, m, CHaHbO), 7.50-7.23 
(10H, m, 1 0  x ArH).
13C NMR: 6 c (75 MHz, CDCI3) 33.3 (CH2CH20), 33.9 (PhCH2 S), 40.9 (PhCH2C), 51.4 
(CC=0), 65.2 (CH20), 127.2 (2 x ArCH), 127.4 (2 x ArCH), 128.5 (2 x ArCH), 128.7 
(ArCH), 129.3 (2 x ArCH), 130.3 (ArCH), 135.7 (ArC), 136.6 (ArC), 175.4 (C=0). 
vmax ATR/cm' 1 1758 s (C=0), 1451 w, 1170 m, 707 s.
MS (Cl): m/z 316 ((M+H)+, 6  %), 176,91 (59).
HRMS: Found 316.1359, Ci8H220 2NS requires 316.1366.
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3-BenzyIdihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-
benzylsulfanyl-dihydro-furan-2-one 241 using 1,2-di [(S)-2-hydroxy-2-pheny lethoxy ]
benzene 210
O
121
According to general procedure A. 3-Benzyl-3-benzylsulfanyl-dihydro-furan-2-one 241 
(25.0 mg, 0.08 mmol) was reduced using Sml2 (2.50 ml, 0.25 mmol, 0.1 M) in the presence 
of l,2-di[(S)-2-hydroxy-2-phenylethoxy] benzene 210 (88.0 mg, 0.25 mmol) to give 3- 
benzyldihydro-2(3/7)-furanone 121 (15.4 mg, 0.04 mmol, 51 %, 0 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-Benzylsulfonyl-dihydro-furan-2-one 244
O
Bn02S v A Q
244
wCPBA (4.57 g, 26.5 mmol) was added to a solution of 3-benzylsulfanyl-dihydro-furan-2- 
one 243 (1.38 g, 6.63 mmol) in CH2 CI2 (20 ml) and the reaction mixture was stirred at 
room temperature for 3 h. The reaction mixture was quenched with aqueous saturated 
NaHCC>3 (10 ml), and then H2O (10 ml). The aqueous layer was then extracted with CH2CI2 
( 3 x 1 5  ml) before being dried (MgS0 4 ) and then concentrated. The crude mixture was 
purified by column chromatography (silica, 30 % EtO Ac/pet. ether) to give 3- 
benzylsulfonyl-dihydro-furan-2-one 244 as a white solid (1.19 g, 4.97 mmol, 75 %).
!H NMR: 5h (500 MHz, CDC13) 2.59-2.55 (1H, m, C /^H BCH20), 2.94-2.90 (1H, m, 
CHa// 5 CH2 0), 3.92 (1H, dd, J = 5.6, 10.4 Hz, CHC=0), 4.40 (1H, AB system, J = 14.1 Hz,
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PhCH2), 4.43-4.39 (1H, m, CffcHB0), 4.60-4.55 (1H, m, CHA/7fiO), 4.96 (1H, AB system, 
J = 14.1 Hz, PhCH2), 7.46-7.42 (3H, m, 3  x ArH), 7.60-7.56 (2H, m, 2  x ArH).
13C NMR: 6 C (75 MHz, CDC13) 21.6 (CH2CH2 0), 57.2 (CHC=0), 57.7 (PhCH2), 67.5 
(CH20), 127.2 (ArC), 128.2 (2 x ArCH), 129.4 (ArCH), 131.2 (2 x ArCH), 169.5 (C=0). 
vmax KBr/cm' 1 2938 s, 1757 s (C O ), 1306 m, 1130 s, 658 m 610 s.
MS (Cl): m/z 258 (((M+H)+NH3)+, 100 %), 176 (52), 91 (Bn+, 100 %).
HRMS: Found 258.0798, CnHi60 4NS, requires 258.0795.
MP: 125.7- 128.2 °C.
3-Benzyl-3-benzyIsulfonyl-dihydro-furan-2-one 245
0
245
Benzyl bromide (229 (0,1, 1.92 mmol) was added to a solution of 3-benzylsulfonyl-dihydro- 
furan-2-one 244 (100 mg, 0.48 mmol), K2C 0 3 (332 mg, 2.40 mmol) and KI (16.0 mg, 0.10 
mmol) in DMF (2 ml), and the reaction mixture was heated to 60 °C for 5 h. The reaction 
mixture was quenched with aqueous saturated NaHC03 (2 ml), and then H20  (2 ml). The 
aqueous layer was extracted with CH2C12 ( 3 x 5  ml) before being dried (Na2S04), and then 
concentrated. The crude mixture was purified by column chromatography (silica, 15 % 
EtO Ac/pet. ether) to give 3-benzyl-3-benzylsulfonyl-dihydro-furan-2-one 245 as a white 
solid (126 mg, 0.42 mmol, 8 8  %).
'H NMR: 5h (500 MHz, CDC13) 2.41-2.36 (1H, m, C /^H BCH20), 3.01-2.97 (1H, m, 
CHa/^CHzO), 3.21 (1H, AB system, J = 13.1 Hz, PhCH2), 3.69-3.64 (1H, m, PhCH2), 3.69 
(1H, apparent d, J = 13.0 Hz, Cf^H B0), 4.34 (1H, m, CHa//bO), 4.59 (1H, AB system, J =
13.2 Hz, PhCH2 S02), 4.82 (1H, AB system, J = 13.2 Hz, PhCH2 S02), 7.23-7.22 (2H, m, 3 
x ArH), 7.39-7.35 (6 H, m, 6  x ArH), 7.50-7.49 (2H, m, 2 x ArH).
I3C NMR: 6 c (75 MHz, CDC13) 25.2 (CH2CH2 0), 37.6 (CCH2Ph), 54.7 (PhCH2 S02), 6 6 . 6  
(CH20), 72.5 (CC=O), 125.5 (ArC), 127.0 (ArCH), 127.7 (2 x ArCH), 128.2 (ArCH),
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128.6 (ArCH), 128.9 (ArCH), 129.2 (ArCH), 130.1 (2 x ArCH), 131.7 (ArCH), 132.9 
(ArC), 173.2 (C=0).
vmax KBr/cm' 1 1751 s (C O ), 1381 w, 1311 m, 1018 m, 692 s.
MS (Cl): m/z 348 (((M+H)+NH3)+, 97 %), 194,96.
HRMS: Found 348.1267, Ci8H22 0 4NS, requires 348.1264.
MP: 137.7- 139.1 °C.
3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3- 
benzylsulfonyl-dihydro-furan-2-one 245 using l,2-di[(S)-2-hydroxy-2-phenylethoxy] 
benzene 2 1 0
According to general procedure A. 3-Benzyl-3-benzylsulfonyl-dihydro-furan-2-one 245 
(25.0 mg, 0.08 mmol) was reduced using Sml2 (2.30 ml, 0.23 mmol, 0.1 M) in the presence 
of l,2-di[(5)-2-hydroxy-2-phenylethoxy] benzene 210 (80.0 mg, 0.23 mmol) to give 3- 
benzyldihydro-2(3//)-furanone 121 (7.00 mg, 0.04 mmol, 53 %, 13 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-[l-Phenyl-meth-(£)-ylidene]-dihydro-furan-2-one 246136
O
121
O
246
1-Butyrolactone-triphenyl phosphorane 247 (500 mg, 1.44 mmol) was added to a solution 
of benzaldehyde (0 . 1 1  ml, 1 . 1 1  mmol) in CH2CI2 ( 1 0  ml) and the reaction mixture was 
stirred at room temperature for 4 h. The reaction mixture was quenched with aqueous
saturated NH4C1 (5 ml), then H2O (5 ml) and extracted with CH2 CI2 (3 x 10 ml). The 
organic layers were then dried (MgS0 4 ) and concentrated. The crude mixture was purified 
by column chromatography (silica, 30 % EtO Ac/pet. ether) to give 3 - [ 1 -pheny l-meth-(£)- 
ylidene]-dihydro-furan-2-one 246 as a white solid (192 mg, 1.10 mmol, 99 %).
'H NMR: 5 h  (400 MHz, CDC13) 3.28 (2H, dt, J = 2.9, 7.4 Hz, CH2C=CH), 4.49 (2H, t ,  J =
7.4 Hz, CH2 0), 7.55-7.42 (5H, m, 5 x ArH), 7.60 (1H, t, J = 2.9 Hz, CH2C=CH). 
nC NMR: 8 c (100 MHz, CDCI3) 27.4 (CH2C=CH), 65.4 (CH20), 109.7 (ArC), 123.5 (2 x 
ArCH), 128.9 (ArCH), 129.8 (ArCH), 130.0 (ArCH), 134.6 (CC=0), 136.6 (C=CH), 172.5 
(CC=0).
vmax ATR/cm ' 1 3441 w, 2922 w, 1729 s (C=0, a,p-unsaturated lactone), 1173 m, 1003 w, 
758 w, 673 m.
MS (Cl): m/z 192 (((M+H)+NH3)+, 100 %), 175 (32).
HRMS: Found 192.1020 CnHi40 2N requires 192.1019.
MP: 109.7-111.9 °C.
General procedure B for the reduction of a,p-unsaturated lactones:
3-BenzyIdihydro-2(3/f)-furanone 121 from reduction-protonation of 3-[l-phenyl-meth- 
(£)-ylidene]-dihydro-furan-2-one 246 using l,2-di[(iS)-2-hydroxy-2-phenylethoxy] benzene 
210
O
121
A solution of Sml2 (8.60 ml, 0.86 mmol, 0.1 M) was added to a solution of 1, 2-di[(S)-2- 
hydroxy-2-phenylethoxy] benzene 210 (302 mg, 0.86 mmol) in THF (1 ml) that had been 
cooled to -20 °C. 3-[l-Phenyl-meth-(is)-ylidene]-dihydro-furan-2-one 246 (50.0 mg, 0.29 
mmol) in THF (1.5 ml) was then added dropwise via cannula and the reaction mixture was 
stirred at -20 °C for 18 h. The reaction mixture was allowed to decolourise in air before
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being quenched with aqueous saturated NaCl (5 ml). The aqueous layer was then extracted 
with 30 % EtOAc/pet. ether ( 3 x 5  ml). The organic layer was then dried (Na2SC>4), and 
concentrated. The crude mixture was purified by column chromatography (silica, 15 % 
EtOAc/pet. ether) to give 3-benzyldihydro-2(3//)-furanone 121 as a yellow oil (40.9 mg,
0.24 mmol, 81 %, 13 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3-[l-phenyl-meth- 
(.£)-ylidene]-dihydro-furan-2-one 246 using l,2-di[(S)-2-hydroxy-2-phenylethoxy] benzene 
211
According to general procedure B. 3-[l-Phenyl-meth-(£)-ylidene]-dihydro-furan-2-one 246 
(23.0 mg, 0.13 mmol) was reduced using Sml2 (3.90 ml, 0.39 mmol, 0.1 M in THF) in the 
presence of 2,2,-di[(«S)-2-hydroxy-2-phenylethoxy]-l,r-biphenyl 211 (168 mg, 0.39 mmol) 
to give 3-benzyldihydro-2(3//)-furanone 121 (11.1 mg, 0.06 mmol, 47 %, 10 % ee). 
Spectroscopic data corresponded to that reported earlier in this section.
3-Benzyldihydro-2(3//)-furanoiie 121 from reduction-protonation of 3-[l-phenyl-meth- 
(£)-ylidene]-dihydro-furan-2-one 246 using l,2-di[(S)-2-hydroxy-2-phenylethoxy] benzene 
212
According to general procedure B. 3-[l-Phenyl-meth-(£)-ylidene]-dihydro-furan-2-one 246 
(25.0 mg, 0.14 mmol) was reduced using Sml2 (4.30 ml, 0.43 mmol, 0.1 M in THF) in the 
presence of l,r-di-[(*S)-2-hydroxy-2-phenylethyl]-o-xylenedioxide 212 (163 mg, 0.43 
mmol) to give 3-benzyldihydro-2(37/)-furanone 121 (14.1 mg, 0.08 mmol, 55 %, 41 % ee). 
[<x]d = -17.8°
Spectroscopic data corresponded to that reported earlier in this section.
3-BenzyIdihydro-2(3//)-furanone 121 from reduction-protonation of 3-[l-phenyl-meth- 
(£)-ylidene]-dihydro-furan-2-one 246 using l,2-di[(*S)-2-hydroxy-2-phenylethoxy] benzene 
213
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According to general procedure B. 3-[l-Phenyl-meth-(£)-ylidene]-dihydro-furan-2-one 246 
(27.0 mg, 0.16 mmol) was reduced using Sml2 (4.70 ml, 0.47 mmol, 0.1 M in THF) in the 
presence of A,A,-di[(5)-2-hydroxy-2-phenylethyl]-A^A,-diisopropylethylene diamine 213 
(181 mg, 0.47 mmol) to give 3-benzyldihydro-2(3//)-furanone 121 (12 mg, 0.07 mmol, 43 
%, 7 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-BenzyIdihydro-2(3//)-furanoiie 121 from reduction-protonation of 3-[l-phenyl-meth- 
(£)-ylidene]-dihydro-furan-2-one 246 using l,2-di[(5)-2-hydroxy-2-phenylethoxy] benzene
214
According to general procedure B. 3-[l-Phenyl-meth-(FT)-ylidene]-dihydro-furan-2-one 246 
(19.0 mg, 0.11 mmol) was reduced using SmH (3.30 ml, 0.33 mmol, 0.1 M in THF) in the 
presence of (+)-(l£,2i?)-bis|7V-methyl-./V-(2-hydroxy-2-phenyl-1 -methyl)-ethyl]-o- 
xylenediamine 214 (142 mg, 0.33 mmol) to give 3-benzyldihydro-2(3//)-furanone 121 
(12.0 mg, 0.07 mmol, 62 %, 6  % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3-[l-phenyl-meth- 
(FT)-ylidene]-dihydro-furan-2-one 246 using l,2-di[(5)-2-hydroxy-2-phenylethoxy] benzene
215
According to general procedure B. 3-[ 1 -Phenyl-meth-(FT)-ylidene]-dihydro-furan-2-one 246 
(30.0 mg, 0.17 mmol) was reduced using SmH (5.10 ml, 0.51 mmol, 0.1 M in THF) in the 
presence of (+)-(l£,2i?)-bis|W-inethyl-J/V-(2-hydroxy-2-phenyl-l -methyl)-ethyl]-w- 
xylenediamine 215 (221 mg, 0.51 mmol) to give 3-benzyldihydro-2(3//)-furanone 121 
(21.0 mg, 0.18 mmol, 69 %, 4 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
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3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4-
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using 2,2’-di[(S)-2-hydroxy-2-
pheny lethoxy ] -1,1’ -biphenyl 211
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
fiiran-2-one 139 (40.0 mg, 0.10 mmol) was reduced using Sml2 (2.80 ml, 0.28 mmol, 0.1 M 
in THF) in the presence of 2,2’-di[(*S)-2-hydroxy-2-phenylethoxy]-1,1’-biphenyl 211 (121 
mg, 0.28 mmol) to give 3-benzyldihydro-2(3//)-furanone 121 (12.1 mg, 0.07 mmol, 69 %, 
1 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4- 
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using l , l ’-di [(S)-2-hydroxy-2- 
pheny lethy 1] -o-xy lenedioxide 2 1 2
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
furan-2-one 139 (32.0 mg, 0.08 mmol) was reduced using SmH (2.30 ml, 0.23 mmol, 0.1 M 
in THF) in the presence of l , l ’-di [(5)-2-hydroxy-2-phenylethyl]-o-xylenedioxide 212 
(87.0 mg, 0.23 mmol) to give 3-benzyldihydro-2(3F/)-furanone 121 (10.2 mg, 0.07 mmol, 
71 %, 16 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-BenzyIdihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4- 
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using (S)-(+)-pantolactone 248
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
furan-2-one 139 (50.0 mg, 0.12 mmol) was reduced using SmH (3.60 ml, 0.36 mmol, 0.1 M 
in THF) in the presence of (S)-(+)-pantolactone 248 (46.0 mg, 0.36 mmol) to give 3- 
benzyldihydro-2(37/)-furanone 121 (18.0 mg, 0.10 mmol, 8 6  %, 0 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
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3-Benzyldihydro-2(3//)-fiiranone 121 from reduction-protonation of 3-benzyl-3-(4- 
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using camphorsultam 249
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
furan-2-one 139 (50.0 mg, 0.12 mmol) was reduced using Sml2 (3.60 ml, 0.36 mmol, 0.1 M 
in THF) in the presence of camphorsultam 249 (77.0 mg, 0.36 mmol) to give 3- 
benzyldihydro-2(3//)-furanone 121 (16.0 mg, 0.09 mmol, 77 %, 0 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4- 
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using A^ ,Ar'-di[(5)-2-hydroxy-2- 
phenylethyl]-7V,./V’-diisopropylethylenediamine 213
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
furan-2-one 139 (23.0 mg, 0.05 mmol) was reduced using Sml2 (1.60 ml, 0.16 mmol, 0.1 M 
in THF) in the presence of AfN'-di[(,S)-2-hydroxy-2-phenylethyl]-AfA^- 
diisopropylethylenediamine 213 (63.0 mg, 0.16 mmol) to give (+)-3-benzyldihydro-2(3F/)- 
furanone 121 (7.00 mg, 0.04 mmol, 74 %, 20 % ee). [a]o =+10°.
Spectroscopic data corresponded to that reported earlier in this section.
3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4- 
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using (+)-(liS,27?)-bis [N-methy 1-^(2- 
hydroxy-2-phenyl-l -methyl)-ethyl]-o-xylenediamine 214
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
furan-2-one 139 (25.0 mg, 0.06 mmol) was reduced using Sml2 (1.80 ml, 0.18 mmol, 0.1 M 
in THF) in the presence of (+)-(l*S,27?)-bis[7/-methyl-A^-(2-hydroxy-2-phenyl-l-methyl)- 
ethyl]-o-xylenediamine 214 (77.0 mg, 0.18 mmol) to give (+)-3-benzyldihydro-2(3i7)- 
furanone 121 (7 mg, 0.04 mmol, 71 %, 10 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
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3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4-
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using (+)-(lS,2.K)-bis[7V-methyl-Af-(2-
hydroxy-2-phenyl-l -methyl)-ethyl]-w-xylenediamine 215
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
furan-2-one 139 (26.0 mg, 0.06 mmol) was reduced using Smh (1.90 ml, 0.19 mmol, 0.1 M 
in THF) in the presence of (+)-(1 S,2R)-bis [A-methyl-A-(2-hydroxy-2-pheny 1-1 -methy 1)- 
ethyl]-m-xylenediamine 215 (80.0 mg, 0.19 mmol) to give (+)-3-benzyldihydro-2(3//)- 
furanone 121 (7.00 mg, 0.04 mmol, 67 %, 19 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-BenzyIdihydro-2(3//)-furanone 121 from reduction-protonation of 3-benzyl-3-(4- 
benzyloxy-benzenesulfonyl)dihydro-furan-2-one 139 using (i?)-(+)-BINOL 250
According to general procedure A. 3-Benzyl-3-(4-benzyloxy-benzenesulfonyl)dihydro- 
furan-2-one 139 (50.0 mg, 0.12 mmol) was reduced using SmH (3.60 ml, 0.36 mmol, 0.1 M 
in THF) in the presence of (Z?)-(+)-BINOL 250 (102 mg, 0.36 mmol) to give 3- 
benzyldihydro-2(3/i)-furanone 121 (6.00 mg, 0.04 mmol, 29%, 6 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
Diethyl 2-oxo-tetrahydro-2//-pyran-3-yl-phosphonate 252 and 3-[l-phenyl-meth-(Zs)- 
ylidine]-tetrahydro-pyran-2-one 251
(EtO)2P>
To a solution of diisopropylamine (1.55 ml, 11.0 mmol), in THF (30 ml) that had been 
cooled to -50 °C was added "BuLi (4.40 ml, 11.0 mmol, 2.5 M in hexane). The reaction 
mixture was then stirred for 30 min at -50 °C. A solution of S-valerolactone (1.0 g, 9.99
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mmol) in THF (5 ml) was then added dropwise by cannula and the reaction was stirred for 
a further 30 min at -50 °C. A solution of DMPU (1.33 ml, 11.0 mmol) and 
diethylchlorophosphate (1.59 ml, 11.0 mmol) in THF (5 ml) was then added dropwise by 
cannula and the reaction was allowed to warm to room temperature and stirred for 1 h. The 
reaction mixture was then cooled to -50 °C and a solution of LDA (2.2 eq; 
diisopropylamine (3.10 ml, 21.98 mmol), "BuLi (8.80 ml, 22.0 mmol), THF (20 ml)) was 
added and the reaction mixture was stirred overnight at -50 °C. The reaction mixture was 
quenched with AcOH (10 ml, 1M in Et2 0 ) and the crude product was purified by plug 
column (100 % Et2 0 ) and concentrated to give diethyl 2-oxo-tetrahydro-2//-pyran-3-yl- 
phosphonate 252 as a yellow oil which was used without further purification.
*H NMR: 5h (500 MHz, CDC13) 1.33 (6 H, m, 2 x OCH2 CH3\  1.86-1.77 (1H, m, 
C/frHBCH2 0), 2.08-2.00 (1H, m, CHa//bCH20), 2.30-2.14 (2H, m, CH2 CH), 3.13 (1H, dt, 
J = 27.3, 7.3Hz, C//P), 4.27-4.14 (4H, m, 2 x C/ftCHs), 4.38-4.32 (1H, m, C /^H bO), 4.47- 
4.43 (1H, m, CH\HbO).
K2 CO3 (357 mg, 2.59 mmol) and 18-crown-6 (621 mg, 2.35 mmol) were added to a 
solution of diethyl 2-oxo-tetrahydro-2//-pyran-3-yl-phosphonate 252 (555 mg, 2.35 mmol) 
in THF (10 ml) and the reaction mixture was stirred at room temperature for 2 h. 
Benzaldehyde (287 pi, 2.82 mmol) was then added dropwise and the reaction mixture was 
stirred at room temperature for 17 h. The reaction mixture was quenched with aqueous 
saturated N H 4 C I  (5 ml), then H2O (5 ml) and the aqueous layer was extracted with CH2CI2 
( 3 x 5  ml). The organic layer was then dried (Na2 SC>4) and concentrated. The crude mixture 
was purified by column chromatography (silica, 20 % EtOAc/pet. ether) to give 3-[l- 
phenyl-meth-(£)-ylidine]-tetrahydro-pyran-2-one 251 as a clear oil (259 mg, 5.79 mmol, 58 
% over 2  steps).
lU NMR: §H (500 MHz, CDCI3) 2.01 (2H, m, CH2CH20), 2.90 (2H, dt, J = 2.4, 6 . 6  Hz, 
CH=CCH2), 4.41 (2H, t, J = 5.3 Hz, CH20), 7.60-7.37 (5H, m, 5 x ArH), 7.94-7.93 (1H, t, 
J = 2.4 Hz, CH=C).
13C NMR: 8 C (75 MHz, CDC13) 23.0 (CH=CCH2), 26.3 (CH2CH2 0), 68.7 (CH20), 125.7 
(CC=0), 128.5 (2 X ArCH), 129.1 (2 x  ArCH), 130.2 (ArCH), 134.9 (ArC), 141.6 (C=CH), 
166.9 (C=0).
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vmax KBr/cm ' 1 2968 br, 1705 s (C=0, a,p-unsaturated lactone), 1612 m, 1257 m, 1168 m, 
771 w, 694 w.
MS (Cl): m/z 189 ((M+H)+, 100 %).
HRMS: Found 189.0911 Ci2H 130 2 requires 189.0910.
3-Benzyl-tetrahydropyran-2-one 257 from reduction-protonation of 3-[l-phenyl-meth- 
(fT)-ylidine]-tetrahydro-pyran-2-one 251 using 1, 2-di[(S)-2-hydroxy-2-phenylethoxy] 
benzene 2 1 0
O
257
According to general procedure B. 3-[l-Phenyl-meth-(£)-ylidine]-tetrahydro-pyran-2-one 
251 (25.0 mg, 0.13 mmol) was reduced using Sml2 (3.90 ml, 0.39 mmol, 0.1 M in THF) in 
the presence of 1, 2-di[(S)-2-hydroxy-2-phenylethoxy] benzene 210 (164 mg, 0.39 mmol) 
to give 3-benzyl-tetrahydropyran-2-one 257 (9.61 mg, 0.06 mmol, 42 %, 7 % ee).
‘H NMR: 8 h  (500 MHz, CDC13) 1.58-1.30 (1H, m, C /^H BCHC=0), 1.83-1.82 (1H, m, 
CHa//bCHC=0), 1.92-1.88 (2H, m, C //2CH20), 2.75-2.72 (2H, m, PhCH2), 3.31 (1H, d, J 
= 9.6 Hz, CH), 4.32-4.27 (2H, m, CH20), 7.33-7.20 (5H, m, 5  x ArH).
13C NMR: 8 c (75 MHz, CDCI3) 21.9 (CH2 CHC=0), 24.0 (CH2CH20), 37.2 (CH2Ph), 41.5 
(CH), 68.5 (CH20), 126.5 (2 x ArCH), 128.5 (2 x ArCH), 129.2 (ArCH), 138.9 (ArC),
174.0 (C=0).
Vmax ATR/ cm ' 1 2920 br, 1737s(C=0), 1259w, 1151 m, 1054w.
MS (Cl): m/z 208 (((M+H)+NH3)+, 100 %), 190, 91 (Bn+, 100 %).
HRMS: Found 208.1336, Ci2H ,80 2N, requires 208.1332.
3-Benzyl-tetrahydropyran-2-one 257 from reduction-protonation of 3-[l-phenyl-meth- 
(£)-ylidine]-tetrahydro-pyran-2-one 251 using 2,2’-di[(5)-2-hydroxy-2-phenylethoxy]-1,1’- 
biphenyl 2 1 1
200
According to general procedure B. 3-[l-Phenyl-meth-(£)-ylidine]-tetrahydro-pyran-2-one 
251 (25.0 mg, 0.13 mmol) was reduced using Sml2 (3.90 ml, 0.39 mmol, 0.1 M in THF) in 
the presence of 2,2’-di[(S)-2-hydroxy-2-phenylethoxy]-1,1’-biphenyl 211 (164 mg, 0.39 
mmol) to give 3-benzyl-tetrahydropyran-2-one 257 (8.69 mg, 0.05 mmol, 38 %, 6  % ee). 
Spectroscopic data corresponded to that reported earlier in this section.
Diethyl 2-oxo-oxepan-3-yl-phosphonate 260 and 3-[l-phenyl-meth-(£)-ylidme]- 
oxepan-2-one 258
(EtO)2P.
260 258
To a solution of diisopropylamine (1.36 ml, 9.64 mmol), in THF (30 ml) that had been 
cooled to -50 °C was added "BuLi (4.10 ml, 9.64 mmol, 2.5 M in hexane). The reaction 
mixture was then stirred for 30 min at -50 ° C .  A solution of e-caprolactone 259 (1.00 g, 
8.76 mmol) in THF (5 ml) was then added dropwise by cannula and the reaction was stirred 
for a further 30 min at -50 ° C .  A solution of DMPU (1.17 ml, 9.64 mmol) and 
diethylchlorophosphate (1.39 ml, 9.64 mmol) in THF (5 ml) was then added dropwise by 
cannula and the reaction was allowed to warm to room temperature and stirred for 1 h. The 
reaction mixture was then cooled to -50 °C and a solution of LDA (2.2 eq in THF) was 
added and the reaction mixture was stirred overnight at -50 °C. The reaction mixture was 
quenched with aqueous saturated N H 4 C I  (10 ml) then H2 O (10 ml). The organic layers 
were extracted with CH2CI2 ( 3 x 1 5  ml), dried (Na2 S0 4 ), and concentrated to give diethyl
2-oxo-oxepan-3-yl-phosphonate 260 as an orange oil which was used without further 
purification.
*H NMR: 5h  (500 MHz, C D C 13)  1.20-1.11 (1H, m, CHAH B C H ) ,  1.29 (3H, t, J  = 4.3 Hz, 
C H 3 ) ,  1.32 (3H, t, J  = 7.1 Hz, C H 3) ,  1.67-1.60 (1H, m, CHAHBCH), 1.80-1.72 (2H, m, 
C i / 2 C H 2 C H 20) ,  2.09-2.02 (1H, m, C / ^ H B C H 20) ,  2.32-2.21 (1H, m, C H A/ / 5 C H 20) ,  3.20-
201
3.14 (1H, m, CH), 4.11-4.05 (1H, m, CHaUbO), 4.26-4.15 (4H, m, 2  x C //2CH3), 4.45-4.40 
(1H, m, CHaHbO).
K2CO3 (1.59 g, 11.5 mmol) and 18-crown-6 (2.77 g, 10.5 mmol) were added to a solution 
o f diethyl 2-oxo-oxepan-3-yl-phosphonate 260 (2.62 g, 10.5 mmol) in THF (10 ml) and the 
reaction mixture was stirred at room temperature for 2 h. Benzaldehyde (1.28 ml, 12.6 
mmol) was then added dropwise and the reaction mixture was stirred at room temperature 
for 17 h. The reaction mixture was quenched with aqueous saturated NH4CI (5 ml) and then 
extracted with CH2CI2 ( 3 x 1 0  ml) before being dried (Na2SC>4), and then concentrated. The 
crude mixture was purified by column chromatography (silica, 20 % EtOAc/pet. ether) to 
give 3-[l-phenyl-meth-(£)-ylidine]-oxepan-2-one 258 as a white solid (295 mg, 1.49 
mmol, 17 % over 2  steps).
'H NMR: §h (500 MHz, CDCI3) 1.98-1.89 (4H, m, CH2CH2CH20 ), 2.64-2.62 (2H, m, 
CH2CC=0), 4.31-4.29 (2H, m, CH20 ), 7.37-7.32 (1H, m, CH=C), 7.41-7.38 (5H, m, 5 x 
ArH).
,3C NMR: 6 c (75 MHz, CDC13) 25.2 (CH2CH2CH20 ), 27.1 (CH2CC=0), 28.2 
(CH2CH2CH2O), 68.3 (CH20), 128.4 (2 x ArCH), 128.5 (2 x ArCH), 129.2 (ArCH), 134.8 
(ArC), 135.0 (CC=0), 137.2 (CH=C), 174.0 (C=0).
vmax KBr/cm ' 1 2924 m, 1697 s (C=0, a,P-unsaturated lactone), 1151 m, 1033 m, 773 m.
MS (Cl): m/z 220 (((M+H)+NH3)+, 100 %), 203 ((M+H)+, 53 %).
HRMS: Found 220.1332, Ci3Hi80 2N, requires 220.1332.
MP: 7 9 .8 -8 1 .2  °C.
3-Benzyloxepan-2-one 261
O
261
A solution of Sml2 (3.71 ml, 0.37 mmol, 0.1 M in THF), was added to a solution of 3-[l- 
phenyl-meth-(£)-ylidine]-oxepan-2-one 258 (25 mg, 0.12 mmol) in THF (0.25 ml) and
202
MeOH (1 ml) at room temperature, and the mixture was stirred. The reaction mixture was 
quenched first with aqueous saturated N H 4 C I  (2 ml) followed by H2 O (2 ml) and then 
extracted with Et2 0  ( 3 x 5  ml). The organic layer was then dried (MgS0 4 ), and 
concentrated. The crude mixture was purified by column chromatography (silica, 20 % 
EtOAc/pet. ether) to give 3-benzyloxepan-2-one 261 as a clear oil (23.0 mg, 0.11 mmol, 91
%).
'H NMR: 8 h  (500 MHz, CDC13) 1.33-1.28 (2H, m, Cf72 CH2 CH20), 1.49-1.44 (2H, m, 
CK2CR20), 1.62-1.59 (2H, m, C/72CH2CH2CH20), 2.65-2.60 (1H, m, CHC=0), 2.67 (1H, 
dd, J = 6 .8 , 13.5 Hz, C /^H BPh), 2.87 (1H, dd, J = 8.2, 13.5 Hz, CHA/ / BPh), 3.55-3.53 (2H, 
m, CH20), 7.22-7.07 (5H, m, 5 x ArH).
I3C NMR: 8 c (75 MHz, CDCI3) 23.5 (CH2CH2CH20), 31.7 (CH2 CH2CH2CH20), 32.5 
(CH2CH20), 38.5 (CH2Ph), 47.6 (CH), 62.6 (CH2 0), 126.3 (ArCH), 128.4 (2 x ArCH), 
128.8(2 x ArCH), 139.3 (ArC), 176.1 (C=0).
Vmix ATR/ cm-1 2938 s, 1733 m (C=0), 1163 s, 700 m.
MS (El): m/z 222 (((M+H)+NH3)+, 4 %), 91 (Bn+, 100 %).
HRMS: Found 222.1479, Ci3H20O2N, requires 222.1489.
3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-HeptadecafluorodecylsulfanyI)dihydrofuran- 
2(3H)-one 263
O
263
a-Bromo-y-butyrolactone (480 pi, 5.21 mmol) was added to a solution of
3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecane-l-thiol 196 (500 mg, 1.04 mmol 
and NEt3 (732 pi, 5.21 mmol) in DMF (10 ml) and the reaction mixture was stirred at room 
temperature for 17 h. The reaction mixture was quenched with aqueous saturated NaCl (5 
ml) and then H2O (5 ml), before being extracted with 10 % EtO Ac/pet. ether (3 x 10 ml), 
dried (Na2S0 4 ) and then concentrated. The crude product was purified by fluorous
203
chromatography to give 3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-
heptadecafluorodecylsulfanyl)dihydrofuran-2(3H)-one 263 as a white solid (556 mg, 0.99 
mmol, 95 %).
‘H NMR: 5 h  (500 MHz, CDC13) 2.10 (1H, apparent d d ,  J = 7.5, 13.7 Hz, C/frHBCH2 0),
(1H, m, C /^H bO), 4.33-4.19 (1H, dt, J = 7.5,9.0 Hz, CHA% 0 ).
13C NMR: 8 C (75 MHz, CDCI3) 22.3 (CH2S), 29.6 (CH2 CH20), 31.7 (CH2CF2), 39.3 (CH), 
6 6 . 8  (CH2 0), 174.9 (C=0).
vmax ATR/cm ' 1 1762 m (C=0), 1332 w, 1144 s, 955 m.
MS (Cl): m/z 582 (M+NH3)+, 22 %), 121,104.
HRMS: Found 582.0389, Ci4Hi30 2NFi7S, requires 582.0390.
3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecylsulfonyl)dihydrofuran- 
2(3H)-one 264
mCPBA (431 mg, 1.92 mmol) was added to a solution of 3-
263 (543 mg, 0.96 mmol) in CH2CI2 (10 ml) and the reaction mixture was stirred at room 
temperature for 2 h. The reaction mixture was quenched with aqueous saturated NaCl (5 
ml) and then H2 O (5 ml), before being extracted with CH2CI2 (3 x 10 ml). The organic 
layers were then dried (Na2 S0 4 ) and then concentrated. The crude product was then 
purified using fluorous silica (eluting with 80 % MeCN/TkO then MeCN) to give 3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)dihydrofuran-2(3H)-one
264 as a white solid (400 mg, 0.67 mmol, 70 %).
‘H NMR: 8 h  (500 MHz, CDC13) 2.80-2.73 (3H, m, CN2 CF2, C7^HBCH20), 3.05-3.02 (1H, 
m, CHaHbCH20), 3.58-3.66 (1H, m, CH4 HBS), 3.79-3.86 (1H, m, CHA7/BS), 4.07 (1H, dd,
2.53-2.40 (2H, m, CH2CF2), 2.68 (1H, dd, J = 8.4, 13.7 Hz, CFLAHBCFL20), 2.91-2.87 (1H, 
m, C/^HbS), 3.14-3.04 (1H, m, C/^HbS), 3.55 (1H, dd, J = 4.9, 8.4 Hz, CH), 4.34-4.31
264
204
J = 5.3, 10.2 Hz, CH), 4.51 (1H, dt, J = 4.8, 8.5 Hz, C /^H bO), 4.61 (1H, dd, J = 8.5, 9.8 
Hz, CHaHsO).
,3C NMR: 5C (75 MHz, CDC13) 29.6 (CH2CH20), 31.7 (CH2CF2), 39.8 (CH2S), 40.5 (CH),
69.2 (CH20), 175.0 (C=0).
vmax ATR/ cm’ 1 1760 s (C=0), 1298 w, 1200 m, 1139 s, 958 m.
MS (Cl): m/z 614 (M+, 56 %), 295,185,102.
HRMS: Found 614.0279, C 14H 13O4F 17S, requires 614.0288.
3-(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecylsulfonyl)-3-benzyl- 
dihydrofuran-2(3H)-one 262
262
Benzyl bromide (297 p.1, 2.50 mmol) was added to a solution of 3-
(3,3,4,4,5,5,6 ,6 ,7,7,8 ,8 ,9,9,10,10,10-heptadecafluorodecylsulfonyl)dihydrofuran-2(3H)-one 
264 (372 mg, 0.62 mmol), K2 CO3 (431 mg, 3.12 mmol) and KI (21 mg, 0.13 mmol) in 
DMF (10 ml), and the reaction mixture was heated to 60 °C for 18 h. The reaction mixture 
was quenched with aqueous saturated NH4CI (5 ml), and then extracted with CH2 CI2 ( 3 x 5  
ml) before being dried (Na2SC>4), and then concentrated. The crude product was then 
purified using fluorous silica (eluting with 80 % MeCKTbO then MeCN) to give 3- 
(3,3,4,4,5,5,6 ,6 ,7,7,8 ,8 ,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3-benzyl-dihydrofuran- 
2(3H)-one 262 as a white solid (362 mg, 0.53 mmol, 85 %).
‘H NMR: SH (500 MHz, CDCI3) 2.45-2.40 (1H, m, C7^HBCH20), 2.84-2.68 (2H, m, 
CH2CF2), 3.03-3.01 (1H, m, CHA% CH 20), 3.25 (1H, d, J = 13.1 Hz, C /^H BPh), 3.55-3.46 
(1H, m, C/^HeS), 3.64-3.60 (1H, m, Cf^HsO), 3.66 (1H, d, J = 13.1 Hz, CHAtf/,Ph), 
3.98-3.94 (1H, m, CHA7/AS), 4.32 (1H, dt, J = 1.9, 8 . 8  Hz, CHaHbO), 7.23-7.22 (2H, m, 2 
x ArH), 7.39-7.34 (3H, m, 3  x ArH).
205
13C NMR: 8 c (75 MHz, CDC13) 23.7 (CH2CF2), 24.7 (CH2CH20), 37.6 (CH2Ph) 40.6 
(CH2S), (CH20 ), 72.3 (CC=0), 128.5 (ArCH), 129.4 (2 x ArCH), 130.1 (2 x ArCH), 132.2 
(ArC), 172.4 (C=0).
vmax ATR/ cm' 1 1751 s (C=0), 1299 w, 1203 s, 1134 s, 1027 m, 968 m.
MS (El): m/z 6 8 6  (M+, 4 %), 193,174,91 (Bn+, 100 %).
HRMS: Found 686.0416, C2 iH150 4Fi7S, requires 686.0414.
3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3-benzyl-dihydrofuran- 
2(3H)-one 262 using l,2-di[(£)-2-hydroxy-2-phenylethoxy] benzene 210
O
121
According to general procedure A. 3 -(3 ,3 ,4,4,5,5,6 ,6 ,7,7,8 ,8 ,9,9,10,10,10- 
Heptadecafluorodecylsulfonyl)-3-benzyl-dihydrofuran-2(3H)-one 262 (100 mg, 0.15 
mmol) was reduced using Sml2 (4.40 ml, 0.44 mmol, 0.1 M in THF) in the presence of 1,2- 
di[(5)-2-hydroxy-2-phenylethoxy] benzene 210 (153 mg, 0.44 mmol) to give 3- 
benzyldihydro-2(3/7)-furanone 121 (20 mg, 0.12 mmol, 78 %, 14 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
3-Benzyldihydro-2(3//)-furanone 121 from reduction-protonation of 3- 
(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-heptadecafluorodecylsulfonyl)-3-benzyl-dihydrofuran- 
2(3H)-one 262 using l , l ’-di [(*S)-2-hydroxy-2-phenylethyl]-o-xylenedioxide 212
According to general procedure A. 3-(3,3,4,4,5,5,6 ,6 ,7,7,8 ,8 ,9,9,10,10,10- 
Heptadecafluorodecylsulfonyl)-3-benzyl-dihydrofuran-2(3H)-one 262 (79.0 mg, 0.12 
mmol) was reduced using Smh (3.50 ml, 0.35 mmol,, 0.1 M in THF) in the presence of
206
l , l ’-di [(S)-2-hydroxy-2-phenylethyl]-o-xylenedioxide 212 (131 mg, 0.35 mmol) to give 3- 
benzyldihydro-2(3//)-furanone 121 (17 mg, 0.01 mmol, 82 %, 18 % ee).
Spectroscopic data corresponded to that reported earlier in this section.
i n n
3- Benzyl-5-bromo-l-propyl-l,3-dihydro-indol-2-one 266
Bn
266
According to general procedure A. 3-Benzyl-5-bromo-3-(3,3,4,4,5,5,6,6,7,7,8,8,
9,9,10,10,10-heptadecafluorodecylsulfonyl)-1 -propyl-1,3-dihydro-indol-2-one 265 (60.0 
mg, 0.07 mmol) was reduced using Smh (2.20 ml, 0.22 mmol, 0.1 M in THF) in the 
presence of l , l ’-di[(5)-2-hydroxy-2-phenylethyl]-o-xylenedioxide 212 (83.0 mg, 0.22 
mmol) to give 3- benzyl-5-bromo-1 -propyl-1,3-dihydro-indol-2-one 266 (24.0 mg, 0.07 
mmol, 95 %, 6 % ee).
'H NMR: 5 h (500 MHz, CDC13) 0.75 (3H, t , J = 7.4 Hz, CH3), 1.41-1.53 (2H, m, CT/2CH3), 
2.90 (1H, dd, J = 13.7, 8.5 Hz, PhC/^Ho), 3.33-3.43 (2H, m, PhCHAHB, CHAHBN), 3.54- 
3.64 (1H, m, CHa7/bN, CH), 6.53 (1H, d, J = 8.3 Hz, ArH), 6.92 (1H, s, ArH), 7.03-7.07 
(2H, m, 2  x ArH), 7.10-7.19 (3H, m, 3  x ArH), 7.24 (1H, d, J = 8.3 Hz, ArH).
HPLC analysis for 266 was obtained using an AD column using a hexane : IPA mixture 
(90 : 10) with a flow rate of 0.5 mintin' 1 at 230 tun. Retention times = 12.53 min, 12.56 
min.
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